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 Abbreviations 
abs.   absolute 
Ac  acetyl 
AIBN  azobisisobutyronitrile 
aq.  aqueous 
ar. (arom.)  aromatic 
A498  renal cancer cell line 
Bn   benzyl 
br   broad (NMR) 
b.p.  boiling point 
Bu   butyl 
Bz  benzoyl 
c   concentration 
CDI  1,1’-carbonyldiimidazole 
COSY   correlation spectroscopy 
CSA   camphor sulfonic acid 
   chemical shift in ppm (NMR) 
d   doublet (NMR) 
DBU  1,8-diazabicyclo[5.4.0]undec-7-en 
DCC  N,N'-dicyclohexylcarbodiimide 
DCM  dichloromethane 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD  diethyl azodicarboxylate 
DET  diethyl tartrate 
DHP  dihydropyran 
DIBAL-H  diisobutylaluminium hydride 
DIPEA  diisopropylethylamine 
DMAP  4-dimethylaminopyridine 
DME  Ethyleneglycoldimethylether 
DMF  N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
dr  diastereomeric ratio 
 E  trans  
ee  enantiomeric excess 
Eq.  equation 
ESI  electronspray ionization 
Et  ethyl 
Et2O  diethyl ether 
EtOAc  ethyl acetate 
g  gram(s) 
h  hour(s) 
HMBC  heteronuclear multiple bond correlation (NMR) 
HMPA  hexamethylphosphoramide 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectrometry 
HUVEC  primary endothel cells 
Hz  Hertz 
IC50  half maximal inhibitory concentration 
IMDA  intramolecular Diels-Alder 
Ipc  isopinocampheyl 
iPr  isopropyl 
J  coupling constant 
KB-3-1  HeLa cells 
L  liter(s) 
LDA  lithium diisopropylamide 
LiHMDS  lithium bis(trimethylsilyl)amide 
L929  mouse fibroblasts (cell line) 
m  multiplet (NMR) 
M  mol/L 
MCF-7  breast cancer cells 
mCPBA  meta-chloroperbenzoic acid 
Me  methyl 
MeOH  methanol 
mg  milligram 
g  microgram 
MOM  methoxymethyl 
 Ms  methanesulfonyl 
NBS  N-bromosuccinimide 
NMR  nuclear magnetic resonance 
NOESY  nuclear Overhauser effect spectroscopy 
Oct  octanoate 
PCC  pyridinium chlorochromate 
Piv  pivaloyl 
Ph  phenyl 
PMB  p-methoxybenzyl 
PMP  p-methoxyphenyl 
ppm  parts per million 
PPTS  pyridinium para-toluenesulfonate 
Pr  propyl 
pTSA  para-toluenesulfonic acid 
PtK2  potoroo kidney cell line 
PTT  phenyltrimethylammonium tribromide 
Py  pyridine 
q  quartet (NMR) 
RCM  ring-closing metathesis 
Red-Al  sodium bis(2-methoxyethoxy)aluminiumhydride 
Rf  retention factor (TLC) 
r.t.  room temperature (ca. 23 °C) 
s  singlet (NMR) 
sec  secondary 
t  triplet (NMR) 
TBAF  tetrabutylammonium fluoride 
TBDMS  tert-butyldimethylsilyl 
TBDPS  tert-butyldiphenylsilyl 
TBHP  tert-butylhydroperoxide 
TBS  tert-butyldimethylsilyl 
TES  triethylsilyl 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TfO  trifluoromethanesulfonate 
 TMS  trimethylsilyl 
Triflate  trifluoromethanesulfonate 
Z  cis 
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Introduction and Goal of Research 
Natural products play a highly significant role in the drug discovery and development 
process.
1
 Only in 2005, plant-derived drugs sold for an established $ 18 billion.
2
 For example, 
in the area of cancer treatment, 49% of the small molecules are either natural products or 
directly derived therefrom. Plants are a valuable source of new bioactive molecules that can 
also serve as structural “muse” for the design of small molecule libraries, in particular to 
define library scaffolds based on the activity of the parent molecule.
3
 Although many natural 
products have impressive biological activity, they are usually presented in organisms in low 
quantities. This significantly hampers elucidation of the mode of action or extensive clinical 
research of these compounds. Thus, chemical synthesis is called to provide access to the 
required amounts as well as modified analogues that may have improved biological profile. 
Another important role of total synthesis is to prove the assigned structure and to determine 
absolute stereochemistry of the new molecule.
4
 In recent decades several concepts like atom- 
and step-economy
5
 or protecting group-free synthesis
6
 have stimulated the development of 
powerful synthetic methodologies, which allow organic chemists to construct complex 
molecules in a more efficient manner. The desire to imitate nature has led to establishment of 
biomimetic approaches. 
To this moment more than 50 000 terpenes are known and they represent one of the largest 
group of natural products, which often have intriguing biological activities. These natural 
products play important role in communication, defense and many other functions.
7
 Selection 
of a specific molecule for the synthesis is dependent on many issues: impressive biological 
activity, challenging structural features, an idea to test scope and limitations of newly 
developed methods etc. Renal cancer is the cause of over 12 000 deaths every year in the 
United States.
8
 Modern drugs used in chemotherapy (sorafenib, sutinib, everolimus) have 
moderate efficiency, require long-term administration for disease control, and have serious 
side effects.
9
 Therefore, the identification of novel compounds that posses specific activity 
against renal cancer cells is highly desirable. Thus, the novel sesquiterpene englerin A with 
unique anticancer activity appeared as an interesting object for our studies that are highlighted 
in the first chapter. Crotogoudin – a new atisane diterpenoid attracted our synthetic interest 
due to its challenging structural features and interesting biological profile. Studies towards the 
synthesis of this novel diterpenoid are presented in the second chapter. 
   
  
 
 
 
 
 
 
 
Chapter I 
Studies Towards the Total Synthesis of Englerin A 
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1 Literature Review 
1.1 Introduction 
Terpenes can be divided into subgroups based on the number of isoprenoid units.
10
 A 
large subgroup of the terpene family are sesquiterpenes (C15) which originate from farnesyl 
diphosphate.
11
 Among various ring systems that result from this precursor, the 
perhydroazulene skeleton, or bicyclo[5.3.0]decane, is quite common. The core structures 
might differ in the oxidation level and the relative stereochemistry at the ring fusion. Some of 
these guaiane-type terpenes feature an oxygen bridge in the seven-membered ring (Figure 
1).
12
  
 
Figure 1. Examples for oxa-bridged guaiane-type natural products. 
The guaiane sesquiterpene englerin A (1-7) was isolated from the plant extract of Phyllanthus 
engleri by Beutler et al.
13
 The compound features an oxygen bridge in the seven-membered 
ring and seven contiguous stereocenters, including two quarternary centers. This novel 
guaianolide showed very high selectivity and potency against various cell lines that are 
involved in renal cancer having GI50 values under 20 nM (Table 1). Interestingly, englerin B 
(1-8) was significantly less active and less selective, while englerin B acetate (1-9) showed an 
approximately 400-fold selectivity against the renal cell line. 
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renal cell line 1-7 taxol 
786–0 ˂  0.01 0.034 
A498 ˂  0.01 0.10 
ACHN ˂  0.01 0.65 
CAKI-1 15.5 0.35 
RFX-393 0.011 0.041 
SN12C 0.087 0.018 
TK-10 15.5 0.11 
UO-31 ˂  0.01 0.45 
Table 1. GI50 values in µM for englerin A (1-7) for different renal cancer cell lines, compared 
to average values for taxol. 
As it was mentioned above, the tricyclic core structure of guaiane sesquiterpenes originates 
from acyclic farnesyl diphosphate (1-10),
11
 which undergoes cationic cyclization to decaline 
structure germacratriene (1-12) (Scheme 2). Protonation of the desired double bond, followed 
by intramolecular cyclization gives the 6,6-fused ring system 1-14. Subsequent Wagner-
Meerwein shift converts carbocation 1-14 to guaiadiene (1-15), from which the exocyclic 
double bond is moved into the cycle to give guaiane (1-1). The oxygen bridge possibly 
originates from transannular epoxide opening in 1-16. 
 
Scheme 2. Possible biosynthesis of oxa-bridged guaiane sesquiterpenes. 
 
Literature Review  7 
1.2 Overview of the Reported Studies Towards the Synthesis of Englerin A 
The absolute stereochemistry of natural (–)-englerin A (1-7) was clarified by the group 
of Christmann.
14
 They prepared ent-1-7 [(+)-englerin A] from cis,trans-nepetalactone (1-18), 
a terpene which can be obtained by distillation of commercially available catnip oil (Scheme 
3). Thus, lactone 1-18 was converted to aldehyde 1-20 in a two step sequence utilizing 
epoxidation followed by methanolysis via the corresponding alkoxyformyl ester. Protected 
diol 1-23 was synthesized in nine steps involving a diastereoselective Barbier reaction of 
aldehyde 1-20 with an organozinc species, epimerization at C-5 and Wittig olefination of 
aldehyde 1-22 followed by ring-closing metathesis. Regioselective esterification
15
 of the 
secondary alcohol function gave glycolate ester 1-24, whose stereoselective epoxidation and 
subsequent acid-catalyzed transannular epoxide opening
16
 resulted in the oxygen bridge 
formation. This strategy for the ether formation certainly corresponds to the likely 
biosynthetic pathway (Scheme 2). In two further steps, including Yamaguchi esterification
17
 
and final deprotection the (+)-enantiomer of englerin A (1-7) was prepared, establishing the 
absolute stereochemistry of natural (–)-englerin A (1-7). 
 
Scheme 3. Synthesis of ent-1-7 by Christmann et al. 
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Application of a Barbier reaction/ring-closing metathesis strategy for the construction of 
englerin’s 7-membered ring was also reported by Hatakeyama et al.18 Highly functionalized 
cyclopentane 1-28 was prepared in a nine-step sequence from optically active 3-
methylcyclopentenone (1-26) utilizing base-promoted cyclization
19
 of epoxynitrile 1-27 to a 
cyclopentane 1-28 (Scheme 4). Barbier reaction on aldehyde 1-29 using an allylindium 
species afforded 1-30 in excellent yield. The high diastereoselectivity observed in the indium 
mediated allylation is attributable to a predominant attack of the allylindium to a nonchelation 
Felkin–Ahn model. Completion of the synthesis of (–)-englerin A (1-7) features a ring-closing 
metathesis, transannular epoxide opening and Yamaguchi esterification
17
 with cinnamic acid, 
as previously reported by Christmann et al.
14
 
 
Scheme 4. Total synthesis of (–)-englerin A (1-7) by Hatakeyama et al. 
Another example of a Barbier reaction/ring-closing metathesis strategy was reported by 
Parker et al.
20
 Starting from geraniol (1-32) acyclic aldehyde 1-35 was prepared in a five step 
sequence involving a selective allylic oxidation, enantioselective Sharpless epoxidation of 1-
33 and epoxide opening by lithium acetylide (Scheme 5). Barbier addition of 2-bromomethyl-
3-methyl-1-butene to aldehyde 1-35 provided a substrate for the relay ene-yne-ene metathesis, 
which was achieved using the Stewart-Grubbs catalyst. This way, bicyclic diene 1-37, that is 
disubstituted on the both ends and that contains a tetrasubstituted olefin, was prepared with 
good yield. Transannular etherification was achieved via regio- and stereoselective 
oxymercuration, followed by treatment with NaCl/NaHCO3 leading to organomercurial 
intermediate 1-39. Oxidative demercuration provided known tertiary alcohol 1-40
21
 as a 
mixture of diastereomers at C-4. 
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Scheme 5. A formal synthesis of (–)-englerin A (1-7) by Parker et al. 
Two conceptually similar total syntheses of (–)-englerin A (1-7) appeared independently 
utilizing gold-catalysis for the cyclization of an acyclic precursor to a tricyclic englerin core 
structure.
21,22
 In both cases the oxatricyclic core was fashioned by gold(I) catalyzed 
cyclization of an acyclic enyneketone 1-41.
23
 A clear analogy can be drawn between the 
biosynthetic route (Scheme 1) and the laboratory synthesis (Scheme 6).
24
 The key gold-
catalyzed domino process started with a 5-exo-dig cyclization leading to cyclopropyl gold 
carbene 1-43 which reacted with the carbonyl oxygen releasing the strain on the cyclopropane 
ring and producing oxonium ion 1-44. Then, a Prins-cyclization took place followed by proto-
deauration to give englerin’s tricyclic skeleton. By this gold-catalyzed cyclization three new 
bonds and three stereocenteres were created in a highly selective fashion. Completion of the 
both syntheses relied on functionalization of 1-45 featuring allylic oxidation and 
stereoselective reduction of the double bond to establish a trans-fused ring orientation. 
Hoewever, one should mention that in both cases, conversion of 1-45 to englerin A (1-7) 
required a significant number of steps 
10  Literature Review 
 
Scheme 6. The mechanism of gold-catalyzed domino cyclization reported by groups of Ma 
and Echavarren. 
Echavarren’s cyclization precursor21 (R = OTES, 1-51) was prepared in an eight step-
sequence starting from geraniol (1-32) involving Sharpless asymmetric epoxidation followed 
by a stereoselective Denmark aldol reaction
25
 (Scheme 7). 
 
Scheme 7. Preparation of precursor 1-51, according to Echavarren et al. 
The precursor for Ma’s approach22 (R = H, 1-55) was obtained in five steps from (R)-(+)-
citronellal (1-52) utilizing a boron-aldol reaction (Scheme 8). Noteworthy is that this 
synthesis was performed without using protection groups. 
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Scheme 8. Preparation of precursor 1-55, according to Ma et al. 
The Nicolaou/Chen group achieved the synthesis of englerin A (1-7) via a [5+2] 
cycloaddition to fashion the [3.2.1]oxabicyclic ring system followed by annulation of the 
cyclopentane ring (Scheme 9).
26
 Starting from propargylic alcohol 1-56 furan 1-58 was 
prepared in four steps featuring a gold(I)-catalyzed furan formation.
27
 Vilsmeier-Haack 
formylation
28
 followed by Grignard addition and subsequent mCPBA mediated Achmatowicz 
rearrangement
29
 provided key dihydropyranone 1-60. Oxydopyrylium species 1-61 was 
formed by treatment of 1-60 with mesyl chloride and diisopropylethylamine and participated 
in a [5+2] cycloaddition reaction
30
 with ethyl acrylate to afford oxabicyclic enone 1-62. The 
five-membered ring was closed by intramolecular base-mediated aldol condensation. Baeyer-
Villiger oxidation
31
 was applied for degradation of methyl ketone 1-65 to acetate 1-66. The 
authors also developed an asymmetric formal synthesis: camphor-derived acrylate 1-67 was 
used as a cycloaddition partner. Transformation of the resulting cycloadduct to (–)-1-7 
required additional four steps. 
12  Literature Review 
 
Scheme 9. Total synthesis of (±)-englerin A (1-7) via Achmatowicz rearrangement/[5+2] 
cycloaddition strategy. 
A reductive Heck reaction was applied for the synthesis of the hydroazulene ring system in a 
formal synthesis of (±)-englerin A (1-7) reported by Cook et al.
32
 Starting from the known 
racemic , -unsaturated ketone 1-68
33
, trans-hydroazulene core 1-71 was prepared in a three-
step sequence involving alkylation of the enolate, generated from 1-68, with Wichterle iodide 
(1-69)
34
 followed by copper-catalyzed Grignard addition and reductive Heck reaction 
(Scheme 10). During the installation of the isopropyl group on 1-71, the desired trans-fused 
ring configuration was lost resulting in cis-hydroazulene derivative 1-72. A hydroxyl function 
in an -position to the carbonyl group was introduced via Rubottom oxidation.
35
 Epoxidation 
of the double bond provided a substrate for an acid-mediated transannular epoxide opening 
furnishing the desired oxa-bridged englerin core 1-76. This approach could be considered as 
an alternative to Christmann’s14 biomimetic ether formation. Alcohol 1-77, prepared in 
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several steps from ketone 1-76 is a known compound, used in the synthesis of englerin A (1-
7) by Ma et al.
22
  
 
Scheme 10. A formal synthesis of (±)-englerin A (1-7) via reductive Heck 
reaction/transannular epoxide opening by Cook et al. 
The group of Theodorakis achieved an enantioselective formal synthesis of (–)-englerin A (1-
7) via a Rh-catalyzed [4+3] cycloaddition reaction.
36
 The desired seven-membered oxabicycle 
1-81 was obtained via a Rh-catalyzed cyclopropanation/Cope rearrangement sequence
37
 from 
substituted furan 1-78 and chiral diazo ester 1-79 (Scheme 11). Removal of the chiral 
auxiliary, followed by Lewis acid-mediated rearrangement
38
 resulted in exocyclic enone 1-82. 
The hydroxyl group at C-6 was introduced via Rubottom oxidation.
35
 Stetter reaction
39
 
provided substrate 1-84 for a base-induced intramolecular aldol condensation in order to 
construct the five-membered ring of 1-85. Diol 1-86 is a known compound, and can be 
elaborated to (–)-englerin A (1-7) according to the method reported by Ma et al.22 
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Scheme 11. A formal synthesis of (–)-Englerin A (1-7) via Rh-catalyzed [4+3] 
cycloaddition reaction. 
Another approach towards the synthesis of (–)-englerin A (1-7) utlizing a [4+3] cycloaddition 
strategy was reported by Lin et al.
40
 Organocatalyzed cycloaddition between furan 1-78 and 
iminium salt, generated from aldehyde 1-87 and MacMillan catalyst (1-88)
41
 afforded 
cycloadduct 1-89 in moderate yield and enantioselectivity (Scheme 12). Englerin’s core 
structure 1-91 was completed using base-mediated intramolecular aldol condensation. 
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Scheme 12. Studies towards the synthesis of Englerin A (1-7) utilizing organocatalytic 
[4+3] cycloaddition reaction. 
A concise and elegant enantioselective total synthesis of (–)-englerin A (1-7) was reported by 
Chain et al.
42
 Treatment of the lithium enolate, generated from 3-furanone 1-92
43
 with 1-93
44
 
provided Michael adduct 1-94 in good yield (Scheme 13). Advantage of this strategy is a 
simultaneous establishment of the relative stereochemistry at C-1, C-4, C-5 and C-10 of the 
final natural product in the course of the Michael addition. Intramolecular reductive radical 
carbonyl-alkene cyclization mediated by samarium(II) iodide
45
 was applied to furnish 
englerin’s core structure 1-95. Completion of the synthesis relies on the method reported by 
Ma et al.
22 
 
Scheme 13. A brief total synthesis of (–)-Englerin A (1-7) via Michael addition and Sm-
mediated reductive carbonyl-alkene cyclization. 
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In summary, many different approaches were disclosed in the last 3 years to the intriguing 
englerin’s architecture. Gold- and samarium(II)-mediated cyclizations reported by 
Ma/Echavaren
22,21
 and Chain
42
 respectively, together with Barbier reaction/ring closing 
metathesis sequence reported by Christmann,
13
 seem to be the most efficient and elegant 
approaches to englerin A (1-7). 
The first structure-activity relationship (SAR) investigations were reported together with 
racemic synthesis of englerin A (1-7) by Nicolaou/Chen.
26
 One year letter Chen et al. 
published advanced SAR studies on analogues with modified cinnamate and glycolate 
domain.
46
 It turned out that mostly analogues with the above-mentioned modifications 
showed significant loss of cytotoxic activity with selected renal cancer cell lines (UO31, 
A498). Albeit, some analogues were found to be promising (Figure 2, Table 2). 
 
Figure 2. Synthetic analogues bearing improved activity profile. 
Compd GI50 in µM 
UO31 A498 A549 
1-96 0.007 0.049 > 10 
1-97 0.014 0.086 > 10 
1-98 0.035 0.048 > 10 
1-99 0.047 0.020 > 10 
(±)-1-7 0.037 0.045 > 10 
Taxol 0.009 0.008 0.006 
Table 2. Cytotoxicity of synthetic englerins against selected cancer cell lines. 
Independent SAR studies on enantiomerically pure derivatives were reported by Christmann 
et al. together with an optimized multigram synthesis of (–)-englerin A (1-7),47 based on their 
privous findings (Figure 3, Table 3).
14
 It was found that the unnatural enantiomer of 1-7 
showed diminished cytotoxicity (GI50 > 1 µM) against the A498 cell line. Substitution of the 
isopropyl group to a methyl or ethyl group led to loss of cytotoxic activity (4.64 and 2.93 µM 
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respectively). Analogues with modified glycolate domain did not show any enhanced activity 
in comparison with natural (–)englerin A (1-7), while some analogues (especially 1-101) with 
a modified cinnamate domain showed improved cytotoxicity and selectivity.  
 
Figure 3. Synthetic analogues bearing improved activity profile. 
Compd GI50 in µM 
Caki-1 A498 HEK293 HeLa MD-AMB-468 
1-7 – 0.045 24.8 15.9 17.7 
1-100 – 0.025 29.2 > 30 > 30 
1-101 – 0.024 > 30 > 30 > 30 
1-102 – 0.026 13.9 15.2 19.4 
Table 3. Cytotoxicity of synthetic englerins against selected cancer cell lines. 
In conclusion, englerin A (1-7) – a novel guaianolide with unique anticancer activity and 
intriguing molecular architecture attracted a lot of interest within the synthetic community: to 
this moment the original publication by Beutler et al.
13
 collected 36 citings. Taken together 
with six total, three formal syntheses and several approaches to the guaiane carbone 
backbone, englerin A (1-7) became a “hot topic” in natural product synthesis.48 Several 
analogues with improved biological profile were developed. However so far, not much 
information regarding the mode of action nor the status in clinical development is available.
49
 
Recently the group of Neckers
50
 found that englerin A (1-7) binds and activates protein kinase 
C-Ɵ  (PKCƟ ) that induces an insulin-resistant phenotype, limiting the access of tumor cells to 
glucose. At the same time, englerin A (1-7) causes PKCƟ -mediated phosphorylation and 
activation of the transcription factor heat shock factor 1, an inducer of glucose dependence. 
By promoting glucose addiction, while simultaneously starving cells of glucose, englerin A 
(1-7) proves to be synthetically lethal to highly glycolytic tumors. Englerin A (1-7) remains 
one of the most promising drug candidates in development for curing kidney cancer without 
the severe side effects of other treatments. 
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2 Results and Discussion 
2.1 Towards the Synthesis of Englerin A via [3+2] Cycloaddition Reaction
*
 
This project was started in October 2009, half a year after presentation of englerin A 
(1-7) to the synthetic community.
13
 To that moment total syntheses or studies towards 
englerin A (1-7) mentioned in the literature review had not been reported as well as the 
absolute stereochemistry of the natural product. 
In our first retrosynthetic plan a bimolecular carbonyl ylide – alkyne cycloaddition reaction 
played a key role in formation of the guaiane skeleton.
51,52
 As an advantage of this strategy 
appeared to us the simultaneous formation of the oxygen bridge in the course of the 
cycloaddition, where propiolate 1-106 would be expected to approach the carbonyl ylide 1-
105 from the opposite site to the C-4 methyl group. The intermediate carbonyl ylide 1-105 
should be available by rhodium(II)-catalyzed decomposition of diazoketoester 1-107. The 
latter can be traced back to (R)-(–)-carvone (1-108). The hydroxyl group at C-9 in 1-103 
would be generated from the acyl azide 1-104 via a Curtius rearrangement/vinyl isocyanate 
hydrolysis sequence. The isopropyl group would be installed via double Grignard addition to 
an ester function, followed by deoxygenation of a resulting tertiary alcohol. 
 
*
 This work was done together with graduate student Vaidotas Navickas and some of the 
results presented in this chapter are already highlighted in his doctoral thesis (University of 
Tübingen, 2011) 
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Scheme 14. Retrosynthetic disconnection of (–)-englerin A (1-7) utilizing a [3+2] 
cycloaddition reaction as a key step. 
The synthesis commenced with commercially available (R)-(–)-carvone (1-108) (Scheme 15). 
Following known procedures,
53
 this terpene was transformed into a highly functionalized 
cyclopentanecarboxylate 1-111 in a five-step sequence featuring stereoselective nucleophilic 
enone epoxidation, regioselective epoxide opening and a stereoselective Favorskii 
rearrangement on chlorohydrine 1-109 resulting in ring contraction. Use of THP as a 
protecting group made analysis and work up inconvenient (mixture of diastereomers on the 
acetal carbon), however other protecting groups were less satisfactory in the subsequent 
rearrangement reaction.
54
 The hydroxyl group was then removed utilizing the 
Barton−McCombie protocol on the corresponding xanthogenate55 giving ester 1-113 in 67% 
yield over two steps. Deoxygenation of the alcohol with tetrabutylammonium peroxydisulfate 
and formate ion
56
 as a softer and tin-free method was not successful.  
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Scheme 15. Synthesis of cyclopentanecarboxylate 1-113 from (R)-(–)-carvone (1-108). 
At this stage, epimerization at C-5 (englerin numbering) was considered. However, all 
attempts to invert the configuration on ester 1-113, under basic conditions (DBU, DIPEA, 
LDA, Et3N), gave inadequate results. Therefore, the ester 1-113 was successfully transformed 
into the corresponding aldehyde 1-116 utilizing a two step protocol, namely LiAlH4 reduction 
and Parikh−Doering oxidation57 (Scheme 16). We found that this two step procedure was 
more reliable to perform on a large scale (25 g, 87%), as DIBAL-H reduction gave just the 
corresponding alcohol which was then oxidized with Dess-Martin periodinane
58
 (5.0 g, 49% 
over two steps). Also we found that primary alcohol 1-114 was not stable under acidic 
conditions (CHCl3, overnight, r.t.) and underwent intramolecular ether formation leading to 1-
115. Base-induced epimerization of aldehyde 1-116 was achieved with DBU in refluxing 
toluene (Table 4) leading to trans orientation of the aldehyde group with respect to the larger 
isopropenyl group (trans/cis = 2:1).  
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Scheme 16. Preparation of aldehyde 1-117. 
Entry Base Solvent Temperature Time, h Ratio  
1-117:1-116 
1 DIPEA CH2Cl2 reflux 30 1:1 
2 DBU CH2Cl2 r.t. 30 1:4 
3 DBU CH2Cl2 reflux 48 1.3:1 
4 DBU toluene reflux 48 2:1 
5 LDA THF r.t. 20 1:1 
6 LDA THF reflux 20 decomp. 
Table 4. Screening for the optimal epimerization conditions (Scheme 16). 
An unseparable diastereomeric mixture of aldehydes 1-116 and 1-117 was used in the next 
step, where ozonolysis and reaction with ethyl diazoacetate catalyzed by tin (II) chloride
59
 
provided -ketoester 1-119 as a single isomer in 66% yield over two steps (Scheme 17). 
Ketoaldehyde 1-118 turned out to be volatile and proceeding the reaction in one pot was 
found to be crucial to obtain -ketoester 1-119 in good yield. One should mention that the 
other diastereomer of -ketoester was not detected after work up (diastereomeric mixture of 
1-117 and 1-116 was used in this sequence). As a control experiment we made ozonolysis 
with not epimerized (cis) aldehyde 1-116 followed by reaction with ethyl diazoacetate. After 
work up we isolated a new compound to which we assigned structure 1-122. It seems, that an 
intramolecular Knovenagel-type condensation took place when ketone and -ketoester groups 
are close to each other. Finally, a diazotransfer reaction with sulfonyl azide 1-120
60
 furnished 
diazoketone 1-121 in 71% yield. This thirteen step sequence allowed us to prepare gram 
quantities of 1-121 starting from (R)-(–)-carvone (1-108). 
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Scheme 17. Synthesis of diazoketone 1-121. 
With diazoketone 1-121 in hand, we tested the proposed intramolecular carbonyl ylide 
formation of 1-123 promoted by Rh(II) and its subsequent cycloaddition with allyl propiolate 
(1-124) (Scheme 18). We chose 1-124
61
 as a dipolarophile due to ease of further 
functionalization and absence of a new stereocenter at C-9 in 1-125. After careful 
experimentation, we found that heating of a mixture containing allyl ester 1-124, 1 mol % of 
Rh2(OAc)2, and diazo compound 1-121 in toluene (100 °C) for 15 min led to the formation of 
cycloadduct 1-125 as a single isomer. Decreasing the temperature and/or increasing the 
reaction time led to lower yields of the cycloadduct 1-125. When ethyl acrylate was used as a 
dipolarophile a mixture of diastereomers was isolated in 16% yield. In case of methyl vinyl 
ketone no desired product was detected. 
 
Scheme 18. The key [3+2] cycloaddition step between cyclic carbonyl ylide 1-123 and allyl 
propiolate (1-124). 
The cycloadduct 1-125 turned out to be sensitive to epimerization at C-5 even upon silica gel 
chromatography, leading exclusively to the corresponding cis-isomer. Therefore, crude 
ketodiester 1-125 was selectively reduced under Luche conditions
62
 and the resulting alcohol 
converted to TES-ether 1-127 in 59% over three steps (starting from 1-121) (Scheme 19). At 
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this stage we were not able to determine for sure the stereochemistry of the newly formed 
centres in 1-127 via NOESY experiments (orientation of the oxygen bridge).  
 
Scheme 19. Synthesis of silyl ether 1-127. 
Further functionalization of the seven-membered ring called for degradation of the acrylate to 
a keto function. This was achieved via a Curtius rearrangement/hydrolysis sequence.
63
 The 
proposed mechanism for this sequence relies on the formation of vinyl isocyanate 1-131, via 
the corresponding nitrene 1-130 (Scheme 20). It seems that isocyanate moiety in 1-131 
hydrolyzes first, followed by the hydrolysis of the resulting enamine 1-132. 
 
Scheme 20. Mechanism of Curtius rearrangement/vinyl isocyanate hydrolysis. 
It was found that the allyl ester in 1-127 could be easily removed using 10 mol% of 
Wilkinson’s catalyst in an ethanol/water mixture (Scheme 21).64 In contrast, palladium-based 
methods failed to provide carboxylic acid 1-135. Now, acid 1-135 was converted to acyl azide 
1-136 in presence of trichloracetonitrile and PPh3.
65
 Upon heating, azide 1-136 rearranged to 
the vinyl isocyanate which was selectively hydrolyzed to ketone 1-137 under acidic 
conditions. It should be noted that under this conditions (HCl aq. (5%), THF, r.t.) no 
deprotection of the TES group at C-6 was observed.  
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Scheme 21. Transformation of cycloadduct 1-127 into bis-silyl ether 1-139 via degradation of 
acrylate moiety. 
At this stage, key NOESY cross peaks between 1-H/8-H, 4-H/5-H, and 5-H/6-H suggested a 
structure of 1-137 where the oxygen bridge is on the opposite site with respect to the C-4 
methyl group (Figure 4).  
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Figure 4. Key NOESY correlations between 1-H and 8-H in 1-137. 
Nevertheless, we continued with further functional group manipulations to prove the NMR 
studies by X-ray (the intensity of the cross peak between 8-H and 1-H was not very high in 
Figure 4) and to prepare a carbon backbone common of many other guaiane sesquiterpenes. 
Accordingly, reduction of the carbonyl group and TES-protection provided bis silyl ether 1-
139 as a single diastereomer (Scheme 21). 
Subsequent addition of freshly prepared MeMgI (6.0 equiv) to ester 1-139 at 0 °C gave 
tertiary alcohol 1-140 in quantitative yield (Scheme 22). As next, we thought to use the same 
radical deoxygenation conditions applied earlier (Barton-McCombie method). However, 
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neither the xanthogenate
55
 nor the corresponding trifluoro acetate,
66
 did undergo 
deoxygenation. On the other hand, Burgess reagent (MeO2CN
−
SO2N
+
Et3)
67
 did the job 
providing alkene 1-141 which led to silyl ether 1-143 via catalytic hydrogenation. TES 
deprotection on alkene 1-141 was achieved with TBAF to give alkenediol 1-142 in 65% yield.  
 
Scheme 22. Transformation of ester function to the isopropylene group. Completion of the 
synthesis of guaianolides 1-142 and 1-143. 
Crystallization of 1-142 from a hexane/diethyl ether mixture provided crystals suitable for X-
ray analysis (Figure 5) indicating the configuration of all stereocenters and conformation of 
the structure. The X-ray structure additionally proved the facial selectivity in the 
cycloaddition step which corroborated the NOESY data of ketone 1-137. 
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Figure 5. X-ray structure of diol 1-142. 
The synthesized analogue 1-142 was tested against five cancer cell lines (L929, A498, KB-3-
1, MCF-7, HUVEC), using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay.
68
 The obtained IC50 values were > 40 µg/mL with all tested cell lines. 
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2.2 Construction of the Oxabicyclo[3.2.1]octane System of the Englerins via 
Oxidopyrylium/Alkyne [5+2] Cycloaddition 
According to this approach, the oxygen-bridged seven-membered ring would be 
contracted first, followed by annulation of the five-membered ring. The retrosynthetic 
analysis features an oxidopyrylium/alkyne [5+2] cycloaddition reaction as a key step,
30,69
 
where 1,3-dipole 1-145 would be generated via elimination of acetic acid from 1-146 
(Scheme 23). The required hydroxypyranone should be available from furan 1-147 via 
Achmatowicz rearrangement.
29,70
 
 
Scheme 23. Retrosynthetic analysis of englerin’s core structure (1-17) utilizing [5+2] 
cycloaddition strategy. 
Starting from commercially available furfural 1-147, furfuryl alcohol 1-148 was prepared via 
Grignard addition of iPrMgBr to the carbonyl group of 1-147 (Scheme 24). Further oxidation 
with H2O2/pTSA induced the Achmatowicz rearrangement, resulting in hydroxypyranone 1-
149. During preparation of acetate 1-146 we faced the problem, that diketone 1-150 was 
formed under all tested conditions (AcCl, Py, DMAP, CH2Cl2; Ac2O, Py; Ac2O, AcOH, 
CH2Cl2; Ac2O, Et3N, CH2Cl2; Ac2O, AcONa, THF etc.), and we were not able to observe any 
amounts of the desired 1-146. 
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Scheme 24. Preparation of hydroxypyranone 1-149 via Achmatowicz rearrangement. 
The proposed mechanism for the Achmatowicz rearrangement relies on directed electrophilic 
epoxidation of allylic double bond of the furan ring, protonation of epoxide, epoxide opening 
with formation of oxonium ion 1-153 and intramolecular hemiacetal formation (Scheme 25). 
 
Scheme 25. The proposed mechanism for H2O2/pTSA-mediated formation of 
hydroxypyranone 1-149. 
Finally, we decided to introduce hydroxypyranone 1-149 in the key cycloaddition reaction, 
suggesting that acetate would form in situ. In our first experiment, we were able to obtain the 
desired cycloadduct 1-144 in 13% yield (Scheme 26). Unfortunately, we could not 
significantly increase the yield during optimization studies (only up to 20%), due to the 
favored formation of diketone 1-150.  
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Scheme 26. Synthesis of oxygen-bridged seven-membered ring 1-155 via [5+2] 
cycloaddition. 
One month after receiving the best results for the cycloaddition reaction Nicolaou et al.
26
 
published a conceptually similar synthesis of (±)-englerin A (1-7), where a mesylate was used 
instead of acetate as a leaving group (Scheme 9). 
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2.3 Studies Towards the Synthesis of Englerin A Exploiting Ag(I)-catalyzed 
Oxidative Radical Cyclization as a Key Step 
Being impressed by the total synthesis of sordarin reported by Narasaka et al.,
71
 where 
the authors used an Ag(I)-catalyzed oxidative radical cyclization of a cyclopropanol 
derivative for the construction of bicyclo[5.3.0]decan-3-one skeleton,
72
 we decided to apply 
that strategy for our synthesis of (±)-englerin A (1-7). The retrosynthetic bond disconnections 
are presented below (Scheme 27). 
 
Scheme 27. Retrosynthetic analysis for englerin’s core structure (1-17), utilizing an Ag-
catalyzed oxidative radical cyclization. 
The synthesis commenced with Birch reduction of anisole (1-161),
73
 followed by hydrolysis 
of methyl enol ether 1-162.
74
 A subsequent mCPBA-mediated epoxidation of nonconjugated 
enone 1-163 followed by epoxide ring opening by alumina gave allylic alcohol 1-160,
75
 
whose hydroxyl group was protected as a TBS ether.
76
 Copper-catalyzed 1,4-Grignard 
addition of 3-butenylmagnesium bromide, followed by treatment of the resulted enolate with 
TMSCl afforded silyl enol ether 1-165.
77
 Diastereoselective Simmons-Smith 
cyclopropanation
78
 and hydrolysis of TMS-ether provided cyclopropanol 1-159, which was 
introduced in the crucial Ag(I)-catalyzed oxidative radical cyclization. This way the 
bicyclo[5.3.0]decane skeleton 1-157 of the englerins was prepared.  
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Scheme 28. Synthesis of hydrozone 1-166 via Ag-mediated oxidative radical cyclization. 
Hydrazone 1-166, prepared from ketone 1-157 in perfect yield, was introduced in a Shapiro 
reaction
79
 with acetone. Unfortunately, we were not able to obtain the desired allylic alcohol 
1-156 even in moderate yield. A mixture of regioisomers (1:1) was obtained in all 
experiments, using different bases (LDA, LiHMDS, KHMDS) and temperatures (r.t., –78 °C). 
Regioselective enolization of ketone 1-157 was also not fruitful. 
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2.4 Studies Towards the Synthesis of Englerin A via an Oxy-Cope Ring 
Expansion/Transannular Epoxide Opening Strategy 
Our next retrosynthetic plan for (–)-englerin (1-7) featured a transannular ether 
formation leading to azulene derivative 1-168 (Scheme 29). This cyclization could be induced 
by acid or by activation of the double bond with mercurinium ion. The tetrasubstituted double 
bond of 1-168 could be possibly introduced via aldol condensation using acetone as a C3 
building block. Allylic oxidation of unsaturated enone 1-169 was considered to introduce the 
hydroxyl group at C-9. The annulated 5,7-ring system might originate from an intramolecular 
epoxide opening of a ketone enolate 1-170 which would be generated from cyclic enone 1-
171.
80
 By considering an oxy-Cope rearrangement
81,82
 on dienol 1-172 to generate cyclodec-
5-enone 1-171, (–)-isopulegol (1-173) appeared as a suitable starting material, providing 
stereochemical information for C-4 in (–)-englerin A (1-7). 
 
Scheme 29. Retrosynthetic disconection of (–)-englerin A (1-7) utilizing transannular epoxide 
opening as a key step. 
The synthesis commenced with commercially available (–)-isopulegol (1-173), which was 
converted to diene 1-172 in two steps utilizing a Corey-Suggs oxidation
83
 followed by 
treatment of the resulting ketone with freshly prepared vinylmagnesium bromide
84
 (Scheme 
30). Only one diastereomer of 1-172 was formed, which could be expected from an equatorial 
attack of the nucleophile on the ketone. Anionic oxy-Cope rearrangement of vinyl carbinol 1-
172 was achieved with KH in THF under reflux, resulting in ring expansion to cyclodecenone 
1-171. We found that addition of catalytic amounts of 18-crown-6 ether resulted in increase of 
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the rate and the yield up to 89% in 12 h (without 18-C-6, the reaction took 16 h and gave 71% 
of 1-171). 
 
Scheme 30. Transformation of (–)-isopulegol (1-173) to epoxide 1-176 via oxy-Cope 
rearrangement. 
One should mention, that up to this step, purification of all compounds relied on a simple 
vacuum distillation. Several signals in the 
1
H and 
13
C NMR spectra of cyclodecenone 1-171 
were rather broad, indicating the slow movement with regard to the NMR time scale (Figure 
6). 
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Figure 6. Broad signals in a fragment of the 
13
C NMR spectrum of 1-171. 
Stereoselective mCPBA mediated epoxidation resulted in epoxide 1-176, whose structure was 
confirmed by X-ray analysis (Figure 7). Explanation of the stereoselectivity in this step relies 
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on a macrocyclic control,
85
 where the methyl group at C-5 prevents rotation of the double 
bond which would lead to diastereomers. 
 
Figure 7. X-ray structure of epoxide 1-176. 
A regioselective enolate formation on keto epoxide 1-176, in order to prepare the desired 5,7-
fused ring system was found to be challenging. Thus, when a freshly prepared LDA solution 
was added dropwise to a stirred solution of ketone 1-176 at –78 °C a mixture of regioisomers 
1-177 and 1-179 was obtained (1:4, 83%) (Scheme 31). Increase of the reaction temperature 
up to ambient conditions resulted in improved regioselectivity (1:0.7, 77%). Usage of 
LiHMDS provided similar results. Changeover from the big base to NaH and proceeding the 
reaction under reflux, resulted in formation of only the desired isomer 1-177 in perfect yield 
(90%). This way ketone 1-177 could be obtained on 6.0 g scale. The order of addition (base to 
ketone or ketone to base) did not influence the enolate formation: in all experiments the 
respective product ratios were the same. 
 
Scheme 31. The optimized conditions for the transannular epoxide opening. 
We were not able to prove the stereochemistry and constitution of 1-177 at that stage, while 
the hydroxyketone 1-177 exists in equilibrium with its cyclic hemiacetal 1-178 (3:7 ratio, 
CDCl3, r.t.). Therefore we transformed a mixture of 1-177 and 1-178 into the derived diol 1-
180 (Scheme 32).  
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Scheme 32. Reduction of 1-177. Key NOESY and HMBC correlations in 1-180. 
The cis-orientation of 1-H, 5-H and the 4-CH3 group could be inferred from the NOESY 
spectrum. 
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Figure 8. Fragment of the NOESY spectrum of 1-180. 
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The connectivity in diol 1-180 was esteblished by a HMBC spectrum. Correlation between 
protons in 4-CH3 and carbon C-1 and/or C-5 proved our assumption (Figure 9). Noteworthy, 
the chemical shift of C-1 and C-5 in 
13
C NMR have the same value, resulting in one peak with 
higher intencity (confirmed by integration of peaks in 
13
C spectra). With another constitution 
of 5,7-fused ring system (1-179), the 4-CH3 group is too far from C-1 or C-5 (
5
J) and the 
cross peaks would not be obeserved. Independent confirmation of the connectivity by X-ray 
analysis was performed after several steps. 
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Figure 9. Fragment of the HMBC spectrum of 1-180. 
It turned out that for further functionalization of the seven-membered ring it was necessary to 
block the hydroxy group of 1-177. Selective dehydration of hydroxyketone 1-177 to alkene 1-
183, in order to solve the problem with the hemiketal and to introduce a hydroxy group at C-
9, was found to be challenging (Scheme 33). 
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Scheme 33. Dehydration of 1-177 led to a mixture of alkenes. 
Dehydration with Burgess reagent was found to be the most successful, however with low 
yield of the desired isomer 1-183. Results are summarized in the Table 5. Transformation of 
the hydroxy group to a better leaving group (–OMs, –OTf etc.) under basic conditions was 
impossible, due to prevailing formation of the corresponding acetal.  
Conditions Ratio 1-181/1-182/1-183 Yield of the 3 possible isomers 
pTSA, benzene, reflux complex mixture 0% 
KHSO4, toluene, reflux no reaction 0% 
Burgess, toluene, reflux 1.00 : 0.05 : 0.20 82% 
DEAD, PhP3, benzene, r.t. no reaction 0% 
SOCl2, Py, CH2Cl2, r.t. 1.00 : 0.00 : 0.00 80% 
SOCl2, benzene, reflux 1.00 : 0.00 : 0.23 64% 
a) Ac2O, Sc(OTf)3, MeCN, 0 
°C; b) Et3N, CH2Cl2, 0 °C 
 
1.00 : 0.00 : 0.30 
 
67% 
b) THF, DBU, r.t. no reaction 0% 
Table 5. Conditions for the dehydration reaction of 1-177. 
When the elimination of the hydroxy group did not work selectively, we concentrated our 
efforts on protection of the hydroxyl group in ketone 1-177. We assumed that protection of 
the hydroxy function under basic conditions would shift the equilibrium towards hemiacetal 
1-178: for example, treatment of a mixture of 1-177 and 1-178 with TESOTf and LDA gave 
only 1-184 in nearly quantative yield (Scheme 34). Thus, esterification in presence of a 
catalytic amount of acid (or Lewis acid) would be optimal. Selective 4-OH protection as a 
pivalic ester
86
 allowed us to separate ketone 1-185 in 60% yield from the oxygen bridged 
pivalic ester 1-186 by SiO2 chromatography. Furthermore, hydroxy ketone 1-177 could be 
easily recycled via base mediated transesterification of 1-186 with methanol.  
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Scheme 34. Separation of hemiketal 1-178 and hydroxyketone 1-177 via acid catalyzed 
esterification. 
With ketone 1-185 in hand, we tested various conditions in order to prepare enone 1-170. The 
simpliest method for convertion of ketone 1-185 to the -unsaturated enone relies on o-
iodobenzoic acid (IBX) mediated oxidation,
87
 which was not successful in our case in all 
possible modifications.
88
 Our second attempt to introduce a double bond in -position of 
ketone 1-185 utilized an -bromination/base induced elimination sequnce. When ketone 1-
185 was treated with phenyltrimethylammonium tribromide (C6H5N
+
(CH3)3Br3
−
)
89
 as a source 
of Br2, a bromine atom was introduced at the most substituted position of the keto function to 
afford bromide 1-187 as a single regio- and stereoisomer (Scheme 35).  
 
Scheme 35. Bromination of 1-185. 
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Crystallization of 1-187 from a hexane/diethyl ether mixture provided crystals suitable for X-
ray analysis, which additionally proved formation of the desired 5,7-fused ring system in the 
transannular epoxide opening step (Figure 10). 
 
Figure 10. X-ray structure of 1-187. 
Next we tried generation of the kinetic enolate from 1-185, followed by formation of 
phenylselenyl ether and subsequent elimination of phenylselenoxide (Scheme 36). Enolate 
generation at –78 °C was not successful, therefore we encreased the temperature to –5 °C. 
However, after work up we isolated unexpected product 1-189, whose structure was assigned 
via X-ray analysis (Figure 11). 
 
Scheme 36. The unexpected formation of lactone 1-189. 
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Figure 11. X-ray structure of 1-189. 
The following mechanism for 1-189 formation was proposed: upon treating ketone 1-185 with 
LDA at −20 °C and then warming the reaction mixture to −5 °C, a pivaloyl migration (Claisen 
condensation) occurred, followed by a retro-Claisen condensation (Scheme 37). The enolate 
1-195 was quenched with PhSeCl to give a diastereomeric mixture of selenides 1-196, which 
after oxidative elemination with hydrogen peroxide resulted in enone 1-189. One can see the 
similarity between 1-189 and ent-1-121, which was used in Christmann’s synthesis of 
englerin A.
14
 We did not study this convertion, but application of this strategy in prepartion of 
related lactones seems to be promising. 
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Scheme 37. Proposed mechanism for the formation of 1-189. 
Another method for the synthesis of α,β-unsaturated ketones relies on treatment of an enolate 
with N-tert-butyl phenylsulfinimidoyl chloride (1-198) (Scheme 38).
90
 In our case, this 
method was found to be unfruitful as well. 
 
Scheme 38. One-pot dehydrogenation by N-tert-butyl phenylsulfinimidoyl chloride (1-198). 
Being disappointed with the introduction of an -unsaturated double bound on 1-185, we 
checked the possibility of oxy-Cope rearrangement on alkyne 1-201, which was prepared via 
treatment of isopulegone (1-174) with protected lithium acetylenide (Scheme 39). 
Interestingly, nucleophile addition to (–)-isopulegone (1-174) proceeded with poor 
stereoselectivity (1.2:1), that is in contrast to Grignard addition described above (Scheme 30). 
This could be possibly explained by the higher reactivity of lithium acetylide. The oxy-Cope 
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rearrangement was studied with both diastereomers of 1-201, however no single experiment 
allowed us to make a ring extension. Introduction of -unsaturated double bound on the 
earlier prepared cyclodecenone 1-171 by Se- or IBX-mediated procedures was not fruitful. 
 
Scheme 39. Reversed strategies towards 1-168 via introduction of an -unsaturated double 
bond on the earlier steps. 
Finally, after careful experimentation we found that treatment of the kinetic enolate, generated 
from 1-185 under low temperatures (−40 °C), with TMSCl resulted in the corresponding silyl 
ether (Scheme 40). Subsequent Pd(II)-mediated Saegusa-Ito
91
 oxidation gave desired enone 
1-190. We established that the temperature control was crucial in this reaction: at –78 °C no 
enolate could be generated from 1-185, while at –5 °C Claisen rearrangement led to the 
lactone 1-189. 
 
Scheme 40. Preparation of -unsaturated ketone 1-190 via Saegusa-Ito oxidation. 
Now, allylic C-H activation was called for introduction of the hydroxyl group at C-9. 
Selenium(IV) dioxide is known as the most popular reagent for an allylic oxidation. To reduce 
the amount of metal, catalytical processes are known, involving co-oxidation by TBHP or 
H2O2.
92
 Dirhodium(II) caprolactamate is also supposed to catalyze allylic oxidation with 
TBHP as a terminal oxidant.
93
 Another way for generation of a tert-butylperoxy radical is by 
treatment of PhI(OAc)2 with TBHP.
94
 Kharasch-Sosnovsky reaction could be also used for an 
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allylic oxidation, where tert-butyl peroxybenzoate is used as an oxidizing agent in presence of 
copper(I) salt.
95
 We tried all these methods, however we could not obtain even trace amounts 
of the desired allylic alcohol/diketone. Another well established approach for introduction of a 
hydroxyl group in allylic position utilizes a three step sequence, namely, Ziegler-Wohl 
bromination,
96
 nucleophilic substitution of bromide with acetate,
97
 followed by its 
saponification. It was found that bromine atom atacked C-5, the most substituted position, as 
it was observed on the ketone 1-185 (Scheme 41). In order to temporary deactivate the ketone 
as an intramolecular acetal we chose reductive removal of pivaloate with LiAlH4, followed by 
reoxidation of the secondary alcohol with Dess-Martin reagent.
58
 Interestingly, 1-169 does not 
exist in acetal form, which is in contrast to hydroxyketone 1-177. Enone 1-169 was subjected 
to Ziegler-Wohl bromination, and the isolated product was assigned to structure 1-204, where 
bromine added to a rearranged allyl radical. 
 
Scheme 41. Attempts to make Wohl-Ziegler bromination. 
Thereby we were not able to perform a C-H activation at C-9 and we could not continue the 
synthesis of englerin A (1-7) with this strategy.  
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2.5 Total Synthesis of 9-Deoxy-englerin 
To that moment several total syntheses of (–)-englerin A (1-7) were published, including SAR 
investigations, indicating the importance of the glycolate at C-9 (see literature review). In 
order to complete the core structure of englerins and to prove the significance of the glycolate 
domain, we decided to change the title compound to 9-deoxy-englerin (1-205), where the 
problematic functionalization at C-9 is not required. The revised retrosynthetic plan features a 
transannular ether formation as it was planned earlier for the natural englerin A (1-7) 
(Scheme 42). The tetrasubstituted double bond in 1-206 could be possibly introduced via 
aldol reaction between previously prepared ketone 1-185 and acetone. Base-induced 
epimerization should provide the desired trans-stereochemistry of the 5,7-fused ring system. 
 
Scheme 42. Retrosynthetic plan for 9-deoxy-englerin (1-205). 
The synthesis continued with aldol reaction between the kinetic zinc-enolate, generated from 
1-185, and acetone that yielded hydroxyketone 1-207 as a single diastereomer (Scheme 43). 
Chelation on the zinc provided control of the stereochemistry in this reaction.
98
 This way, -
alkylation turned out to be more efficient, than quencing of the enolate with ethyl 
chloroformate that resulted in the corresponding -keto ester (52% yield).  
 
Scheme 43. Alkylation of the kinetic enolate, generated from 1-185. 
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Subsequent dehydration of tertiary alcohol 1-207 under acidic conditions (pTSA, benzene, 
reflux) failed, whereas usage of thionyl chloride (benzene, reflux) resulted in 1-209 with 
nonconjugated double bond, however with moderate yield (52%). Dehydration with Burgess 
reagent
67
 was found to be the most efficient method and the desired alkene 1-209 was 
prepared in quantitative yield (Scheme 44). By use of K2CO3 in methanol under reflux, 
migration of the double bond was observed with further epimerization at C-5 (trans/cis = 
1:1).
99
 The two stereoisomers were separated by flash chromatography, and the wrong isomer 
was reintroduced in the epimerization reaction. Interestingly, the pivalic ester remained 
untouched under the isomerization conditions. This is in contrast to pivalic ketal ester 1-186, 
which underwent smooth transesterification under the same conditions. Saponification of the 
pivaloyl group with LiOH (water/MeOH, r.t.) or tBuOK (water/diethyl ether, r.t.) as well as 
acid mediated hydrolysis (3N HCl in water/dioxane, reflux) did not yield the desired free 
alcohol. Only reduction with LiAlH4 led to the cleavage of pivalic ester 1-210, but resulted in 
reduction of the keto group as well, providing diol 1-211 as a single diastereoisomer. 
 
Scheme 44. Preparation of allylic alcohol 1-211. 
With dihydroxy alkene 1-211 in hand, we tested various conditions in order to promote the 
transannular cyclization. Acid-induced cyclization (CHCl3, SiO2/CHCl3, TFA/CH2Cl2)
100
 
failed, as well as electrophile-mediated cyclization (PhSeCl, SnCl4, CH2Cl2, followed by 
Bu3SnH, AIBN, toluene).
101
 After careful experimentation we found that reaction of alkene 
diol 1-211 with mercury(II) trifluoroacetate and reduction of the resulting organomercurial 
intermediate with NaBH4 provided oxygen-bridged compound 1-212 in perfect yield (Scheme 
45), whose structure was confirmed by X-ray analysis (Figure 12). As it was expected from 
the NOESY experiments on 1-212, the hydroxyl group at C-6 had a wrong orientation with 
respect to the one required for C-6 of 9-deoxy-englerin (1-205). The trans orientation of the 
hydroxyl group at C-6 and 5-H results in a small coupling constant and the signal from 6-H in 
the 
1
H-NMR spectrum looks like a broad singlet. Unfortunately, esterification of 1-212 under 
Mitsunobu conditions
102
 (Ph3P, DEAD, THF, –10 °C to r.t.) with cinnamic acid was 
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unsuccessful, as well as with other acids (AcOH, 4-nitrobenzoic acid). Therefore, inversion 
by an oxidation/reduction sequence was tried. Oxidation of alcohol 1-212 with Dess-Martin 
periodinane
58
 provided ketone 1-213, whose stereoselective reduction was found to be 
challenging. While various hydride reagents (LiAlH4, NaBH4, L-selectride, DIBAL-H), as 
well as reduction with SmI2
45
 provided again alcohol 1-212 as a single diastereomer, we 
discovered that ionic reduction with Et3SiH and TiCl4 proceeded with exclusive formation of 
the desired alcohol 1-214.
103
 Here coupling constant between 5-H and 6-H is big and the 
signal from 6-H in the 
1
H NMR appears as a dublet (J = 10.4 Hz). Esterification of 1-214 with 
cinnamic acid under Yamaguchi conditions
17
 provided (–)-9-deoxy-englerin (1-205). 
 
Scheme 45. Completion of the synthesis of (–)-9-deoxy-englerin (1-205). 
Albeit the stereochemistry of the hydroxyl group at C-6 in 1-212 was clear from the NMR 
spectra, we confirmed this additionally with an X-ray analysis.  
 
Figure 12. X-ray structure of 1-212. 
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(–)-Englerin A (1-7),104 (–)-9-deoxy-englerin (1-205) and ketone 1-213 were tested on 
different cell lines, using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay.
68
 The results are summarized in Table 6. 
Compd L929 A498 KB-3-1 MCF-7 HUVEC 
1-7 29 0.4 12 18 4.3 
1-213 > 170 > 170 > 170 > 170 > 170 
1-205 65 35 41 41 9.8 
Table 6. Cytotoxicity (IC50 in µM) of (–)-englerin A (1-7) and its analogues (1-205, 1-213) 
against selected cell lines. 
As expected, englerin A (1-7) was quite active with the renal cancer cell line (A498), while 
ketone 1-213 was essentially inactive. In general 1-7 was more active than 1-205 with the 
other cell lines as well, pointing to the importance of the glycolate at C-9. However, the 
difference in activity between 1-7 and 1-205 is much less pronounced with the other cell 
types. The inhibition curve of 1-7 with the A498 cells is actually rather shallow and the curves 
of 1-7 and 1-205 meet at 37 µg mL
–1
 (100% growth inhibition). Neither with 1-7 nor 1-205 a 
distinct phenotype could be seen which would provide hints regarding the mode of action. 
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3 Conclusion 
In summary, we developed four conceptually different approaches to the guainolide 
core structure of the englerins. The first generation approach to (–)-englerin A (1-7) features 
generation of a cyclic carbonyl ylide from diazoketone precursor 1-121 by a Rh2(OAc)4-
catalyzed reaction which was trapped with allyl propiolate (Scheme 46). The 1,3-dipolar 
cycloaddition led to the stereoselective formation of an oxygen-bridged polycycle 1-127. Via 
Curtius degradation, the cycloadduct 1-127 was transformed to the ring skeleton typical of the 
sesquiterpene family of guaianolides. X-ray of 1-142 showed the opposite stereochemistry of 
the ether bridge compared to natural (–)-englerin A (1-7). The guianolide structure common 
for many other terpenes was prepared in 3.9% overall yield in the longest linear sequence of 
24 steps. 
 
Scheme 46. Application of [3+2]-cycloaddition strategy for the synthesis of englerins core. 
Our second approach to the guaianolide core features an oxidopyrylium/alkyne [5+2] 
cycloaddition reaction as a key step (Scheme 47). The desired hydroxypyranone 1-149 was 
prepared from furan 1-147 via mCPBA/pTSA-mediated Achmatowicz rearrangement. 
Racemic oxygen-bridged cycloheptenone 1-155 was prepared in 6.5% over 3 steps starting 
from commercially available furanal 1-147. The poor yield in the cycloaddition step together 
with the similar approach, reported by Nicolaou et al. forced us to change the retrosynthetic 
plan. 
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Scheme 47. Application of [5+2]-cycloaddition strategy for the synthesis of oxygen-bridged 
cycloheptenone 1-155. 
Next we tried to apply an Ag-catalyzed oxidative radical cyclization of cyclopropanol 
derivative 1-159 for the construction of the bicyclo[5.3.0]decan-3-one skeleton (Scheme 48). 
Unfortunately, further regioselective functionalization of the seven-membered ring in 1-157 
was impossible. This way ketone 1-157 was prepared in 16.8% yield over 9 steps. 
 
Scheme 48. Synthesis of trans-5,7-fused ring system via Ag-mediated oxidative radical 
cyclization. 
Finally, a highly efficient synthesis of the 5,7-fused ring system 1-177 was achieved via an 
anionic oxy-Cope rearrangement/transannular epoxide opening sequence starting from (–)-
isopulegol (1-173) (Scheme 49). Unfortunately, neither different allylic oxidations nor a 
Wohl-Ziegler bromination/substitution sequence did allow us to introduce an oxygen-
containing functionality to the allylic position in enone 1-190. To that moment several total 
syntheses of natural englerin A (1-7) were published including SAR, suggesting the important 
role of the glycolate at C-9. Therefore we decided to prepare 9-deoxy-englerin (1-205) to 
confirm the role of the glycolic acid at C-9. An effective synthesis of (–)-9-deoxy-englerin (1-
205) has been achieved from 1-177. Aldol reaction of 1-177 with acetone and subsequent 
dehydration followed by base-catalyzed migration of the double bond caused epimerization at 
C-5. Ether formation was achieved with mercury(II) trifluoroacetate from the corresponding 
hydroxyalkene followed by reduction with NaBH4 of the resulting organomercurial 
intermediate. This way 9-deoxy-englerin (1-205) was prepared in 13.4% overall yield with a 
longest linear sequence of 15 steps, utilizing one protecting group. 
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Scheme 49. Synthesis of 9-deoxyenglerin (1-205) via an anionic oxy-Cope 
rearrangement/transannular epoxide opening sequence. 
Studies on the cytotoxic activity of different englerin analogues proved the importance of the 
hydroxyl group and glycolic acid at C-9, as well as the orientation of the oxygen bridge. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II 
Studies Towards the Total Synthesis of Crotogoudin 
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1 Literature Review 
1.1 Introduction 
The screening of plant extracts from Madagascan plants Croton barorum and C. 
goudotii with a cytotoxicity assay led to the discovery of two closely related 3,4-seco-atisane 
diterpenes: crotogoudin (2-1) and crotobarin (2-2) (Figure 13).
105
 While the enone moiety 
presented in these two novel diterpenoids might prohibit their development as drugs, this 
functional group might help to elucidate the target in the cell by affinity-based methods.
106
 
Initial cell cycle analysis led to the conclusion, that these two compounds arrest the cells at 
the G2/M stage. We focused our research on the simpler of the two compounds, namely 
crotogoudin (2-1). This novel diterpene contains a polycyclic ring system with four 
contiguous stereocenters, where a six-membered ring is fused to a bicyclo[2.2.2]octane 
subunit. 
 
Figure 13. The structures of crotogoudin (2-1), crotobarin (2-2) and atisane (2-3). 
This new natural product belongs to a diterpene (C20) family whose biosynthesis starts from 
copalyl diphosphate (2-4) leading to cation 2-6 (Scheme 50).
107
 The sequence of 1,3-hydride 
shift and 1,2-shift gives atiserene (2-8) after elimination of a proton. The last steps require 
oxidative cleavage of the A ring and further oxidations to form the lactone and enone 
moieties.  
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Scheme 50. The proposed biosynthesis of crotogoudin (2-1). 
A large number of 3,4-seco terpenoids have been reported in the literature
108
 (Figure 14) and 
almost all of them are postulated to have been formed from 3-keto-4,4-dimethyl terpenoids by 
Baeyer-Villiger type oxidation to furnish the lactones which ultimately yielded the 3,4-seco 
compounds under some biogenetic conditions.
109
 
 
Figure 14. Some examples of 3,4-seco natural products. 
To this moment neither a total synthesis of crotogoudin (2-1) nor its absolute stereochemistry 
have been published yet. 
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1.2 Literature Overview on the Approaches to the Bicyclo[2.2.2]octane Ring 
System 
Three approaches towards atisane-type diterpenes are described in the literature. 
According to the first one, an intramolecular domino Michael reaction is applied for the late 
stage synthesis of bicyclo[2.2.2]octane ring system by Fukumoto et al.
110
 For example, in the 
synthesis of atisirene
111
 the key intermediate 2-17 was prepared from optically active 
Wieland-Miescher ketone (2-14), utilizing oxidative cleavage of -hydroxy ketone 2-15 with 
lead tetra-acetate in methanol (Scheme 51). Enone 2-17 was subjected to a double Michael 
reaction resulting in tetracyclic compound 2-19, as a single stereoisomer. The remarkable 
stereoselectivity could be explained by lithium-chelation in intermediate 2-18. 
 
Scheme 51. Synthesis of atisane skeleton via intramolecular domino Michael reaction 
according to Fukumoto et al. 
Another synthetic approach to atisane-type diterpenes relies on the homoallyl-homoallyl 
radical rearrangement to convert a bicyclo[3.2.1]octane to a bicyclo[2.2.2]octane motif in the 
CD rings, followed by intramolecular Diels-Alder reaction for the construction of the AB ring 
system.
112
 According to the most recent application of this strategy reported by the 
Toyota/Ihara group,
113
 serofendic acids A and B were synthesized utilizing the following 
sequence (Scheme 52). A palladium-catalyzed cycloalkenylation of TBS enol ether, 
generated from enone 2-20 and subsequent tin-free radical skeleton rearrangement resulted in 
the thermodynamically more stable bicyclo[2.2.2]octane 2-25. Stereoselective intramolecular 
Diels-Alder reaction provided tetracyclic compound 2-28. 
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Scheme 52. Application of a homoallyl-homoallyl radical rearrangement for the construction 
of bicyclo[2.2.2]octane motif by Ihara/Toyota et al. 
An intramolecular Diels-Alder reaction was also used for the construction of rings A and B in 
the approach reported by Abad et al.
114
 The formation of the bicyclo[2.2.2]octane ring system 
called for an intramolecular diazoketone cyclopropanation, followed by an endocyclic 
cyclopropane ring cleavage. By this unified method several atisane-related natural products 
were synthesized: for example, the synthesis of antiquorin,
115
 commenced with transformation 
of (S)-(+)-carvone (1-108) to a advanced intermediate 2-29, which underwent thermo-induced 
IMDA reaction (Scheme 53). The resulting tricyclic compound 2-30, was converted to 
diazoketone 2-31, which was used in an intramolecular copper(II)-catalyzed cyclopropanation 
reaction. SmI2-mediated cyclopropane opening resulted in formation of the desired 
bicyclo[2.2.2]octane constitution of rings C and D. While in principle it seems possible to 
adopt the above strategies towards crotogoudin, the problem is the lack of functionality at C-9 
(double bond, alcohol etc.) required for lactonization. 
 
Literature Review  61 
 
Scheme 53. The construction of atisane ring system according to Abad et al. 
Platencin (2-34), a novel antibiotic isolated a few years ago
116
 is structurally related to 
crotogoudin (2-1) (Figure 15). This molecule was a “hot topic” in synthetic organic chemistry 
and to this moment many strategies towards platencin or its core structure were presented in 
the literature.
117
 Due to their structural similarity, synthetic approaches towards the 
platencin’s core have to be also considered.  
 
Figure 15. The comparison of the structures of crotogoudin (2-1) and ent-platencin (2-34). 
Nicolaou et al.
118
 used a gold-catalyzed cyclization of enol ether 2-36 to generate 
bicyclo[3.2.1]octane 2-37 (Scheme 54). Subsequent homoallyl radical rearrangement resulted 
in bicyclo[2.2.2]octane 2-40 via the corresponding xanthogenate. The closure of the A ring 
relied on a base-mediated intramolecular aldol condensation. 
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Scheme 54. The synthesis of platencin’s core structure 2-42 according to Nicolaou et al. 
In the synthesis of platencin’s core structure (2-42) reported by Maier et al.119 a palladium(II)-
catalyzed cycloalkenylation of the silyl enol ether 2-43 and radical-mediated reductive 
rearrangement of the tosylhydrazone 2-46 were used for the construction of the 
bicyclo[2.2.2]octane motif (Scheme 55). For the closure of the A ring an intramolecular aldol 
condensation was applied, previously utilized by Nicolaou et al.
118
 
 
Scheme 55. The construction of the tricyclic core structure 2-42 according to Maier et al. 
The total synthesis of (±)-platencin (2-34), reported by Yoshimitsu et al.
120
 features a 
stereoselective titanium(IV)-mediated radical cyclization of epoxide 2-49, prepared via Pd-
catalyzed cyclization of enone 2-48 (Scheme 56). The diastereomeric mixture of epoxides 2-
49 (dr 2:3) yielded 2-51 as a single isomer in 87% yield. Probably rapid epimerization of the 
radical center in 2-50 takes place, so that the bulky OTBS group is situated at the equatorial 
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position. Tricyclic compound 2-52 underwent homoallyl radical rearrangement via the 
corresponding xanthogenate resulting in the desired bicyclo[2.2.2]octane structure 2-53. This 
is an example for a late stage formation of the bicyclic subunit. 
 
Scheme 56. The construction of tricyclic core structure 2-53 via titanium(IV)-mediated 
radical cyclization and homoallyl radical rearrangement. 
These three methods start with the formation of a bicyclo[3.2.1] ketone motif, which 
undergoes skeleton rearrangement to afford the required bicyclo[2.2.2]octane ring system. 
The next strategy involves an intramolecular Diels-Alder reaction for the formation of the 
bicyclo[2.2.2]octane framework. In the work published by Chen et al.
121
 phenol 2-54 was 
converted to o-benzoquinone derivative 2-55,
122
 which in situ underwent the key Diels-Alder 
reaction (Scheme 57). 
 
Scheme 57. Diels-Alder reaction approach according to Chen et al. 
In situ formation of a cyclic diene by oxidative dearomatization of a phenol, followed by 
IMDA reaction was also reported by Singh et al. (Scheme 58).
123
 Interestingly the reaction 
led not to the desired cycloadduct 2-59 directly, instead dimer was obtained, which was 
64  Literature Review 
introduced into a thermal retro-Diels-Alder reaction to give the required tricyclic compound 
2-59.  
 
Scheme 58. Diels-Alder reaction approach according to Singh et al. 
Another example for an IMDA reaction, where the substrate has aromatic origin is reported 
by Banwell et al. (Scheme 59).
124
 
 
Scheme 59. Intramolecular Diels-Alder approach according to Banwell et al. 
According to the next strategy a radical cyclization was called for the construction of a 
bicyclic system. Lee et al.
125
 reported about an addition of tributylstannyl radical to the triple 
bond that resulted in formation of homoallyl radical 2-63, which underwent skeletal 
rearrangement to the required bicyclo[2.2.2]octane 2-66 (Scheme 60).
126
 Completion of the 
synthesis could be achieved either by an intramolecular aldol condensation or ring closing 
metathesis. 
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Scheme 60. Synthesis of the core structure 2-42, according to Lee et al.  
A late-stage radical cyclization approach was reported by Ghosh et al.
127
 Their formal 
synthesis of platencin (2-34) features an intramolecular base-catalyzed Michael cyclization of 
enone 2-67, followed by radical cyclization of iodoalkyne 2-69 (Scheme 61). 
 
Scheme 61. Michael and radical cyclizations, reported by Ghosh et al. 
In the strategy reported by Rawal et al.
128
 cis-decaline 2-72, available from a Diels-Alder 
reaction between Rawal diene (2-71)
129
 and enone 2-70, was introduced into a nickel-
mediated intramolecular 1,4-conjugate addition
130
 resulting in the desired 
bicyclo[2.2.2]octane skeleton (Scheme 62). 
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Scheme 62. The construction of bicyclo[2.2.2]octane framework via [Ni(cod)2]-promoted 
cyclization. 
Mulzer et al.
131
 used the same diene 2-71
129
 for a Diels-Alder reaction in their formal 
synthesis of platencin (2-34) (Scheme 63). Wittig olefination of the cycloadduct resulted in 
decaline 2-78, which was subjected to a ring-closing metathesis to afford tricyclic structure 2-
79. 
 
Scheme 63. Diels-Alder/ring-closing metathesis strategy towards platencin’s core structure 2-
79 according to Mulzer et al. 
A similar Diels-Alder reaction of (–)-perillaldehyde (2-77) and Danishefsky’s diene (2-80)132 
was applied for the synthesis of the platencin core by Rutjes et al. (Scheme 64).
133
 The 
construction of the bicyclo[2.2.2]octane motif was then realized through a SmI2-mediated 
pinacol coupling.
45
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Scheme 64. Diels-Alder/pinacol coupling strategy towards platencin’s core structure 2-83, 
according to Rutjes et al. 
Yamamoto et al.
134
 applied an amino acid salt catalyzed (2-86 as catalyst) intramolecular 
Robinson annulation for the construction of two rings (A and B) in one step (Scheme 65). 
 
Scheme 65. Robinson annulation approach towards platencin’s core structure 2-42, according 
to Yamamoto et al. 
 
The most recent approach to platencin (2-34) published by Nakada et al.
135
 involves an 
intramolecular cyclopropanation to construct a decaline system 2-88. After opening of the 
cyclopropane with thiophenolate,
136
 a samarium(II)-mediated Michael addition of an aldehyde 
function to a vinylsulfone moiety resulted in 2-91. 
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Scheme 66. Strategy towards platencin by Nakada et al. 
In conclusion, many approaches towards a bicyclo[2.2.2]octane framework are described in 
literature. The high functionalization of crotogoudin’s core structure including lactone, 
isopropenyl and enone moieties required the development of a flexible synthesis to access 
stereogenic and structural analogues that might help to identify the biological target. In this 
regard, we aimed to investigate the utility of the developed methodologies mentioned above 
for the total synthesis of crotogoudin (2-1).   
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2 Results and Discussion 
2.1 Studies Towards the Synthesis of Crotogoudin via a Late-stage 
Formation of Bicyclo[2.2.2]octane Ring System 
Our first retrosynthetic plan for (±)-crotogoudin (2-1) features a Baeyer-Villiger-type 
oxidation, followed by translactonization leading to lactone 2-92, which itself would originate 
from tricyclic ketone 2-93 (Scheme 67). This step certainly corresponds to the likely 
biosynthetic pathway. We were impressed by the excellent stereoselectivity, which was 
observed in intramolecular double Michael reactions, reported by Fukumoto et al. in their 
synthesis of atisirene and atisane.
110,111
 For our retrosynthetic consideration we proposed an 
intermolecular version of the domino Michael reaction, which is called for the construction of 
a bicyclo[2.2.2]octane ring system from enone 2-94 and methyl acrylate. Construction of this 
bicyclic motif by intermolecular domino Michael reaction has been broadly described in the 
literature,
137
 however application of this strategy for the synthesis of atisane-related 
compounds was unknown. Tricyclic enone 2-95 could be generated by Robinson annulation 
from decalinone derivative 2-96. Wieland-Miescher ketone (2-14) appeared as an appropriate 
starting material for our synthesis.  
 
Scheme 67. Retrosynthetic plan for the synthesis of crotogoudin (2-1). 
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The synthesis commenced with monomethylation of 1,3-cyclohexadione (2-97) (Scheme 
68).
138
 Racemic Wieland-Miescher ketone (2-14) was prepared in a two step sequence 
involving intramolecular Michael reaction between dione 2-98 and methyl vinyl ketone, 
followed by pyrrolidine-catalyzed intramolecular aldol condensation.
139
 We decided to 
investigate a racemic synthesis for initial studies, however optically active Wieland-Miescher 
ketone (2-14) can be prepared with high ee values.
140
 Regioselective ketalization with 
ethylene glycol resulted in enone 2-99 with the , -unsaturated ketone remaining 
untouched.
141
 Now, bis-methylation at C-5 can be achieved by alkylation of enone 2-99 with 
excess of methyl iodide in the presence of tBuOK that results in a concomitant migration of 
the double bond, which could be hydrogenated in the next step.
142
 An alternative method was 
chosen, due to high yields, scalability and perfect stereoselectivity. Namely, a Kirk-Petrow 
reaction (reaction of the enone with thiophenol and formaldehyde in the presence of base)
143
 
was followed by Stork reductive methylation (reduction of the enone with lithium in liquid 
ammonia that results in the lithium enolate, which is quenched with methyl iodide) to furnish 
trans-decalone 2-101 as a single diastereomer.
144
 Reduction of the ketone at C-6 with sodium 
borohydride in ethanol
145
 resulted in a diastereomeric mixture of alcohols (2-103/2-102 13:1). 
Crystallization of this mixture from petroleum ether/ethyl acetate gave the desired alcohol 2-
103, while ketone 2-101 could be recycled from the mother liquor by reoxidation of 2-102 
with Dess-Martin reagent.
58
  
 
Scheme 68. Preparation of alcohol 2-103 from 1,3-cyclohexadion (2-97) via Wieland-
Miescher ketone (2-14). 
A proposed mechanism for the Kirk-Petrow reaction
143
 involves a conjugated nucleophilic 
addition of thiophenol to an enone moiety and the resulting enolate is quenched with 
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intermediate 2-104, which forms in situ from a second molecule of thiophenol and 
formaldehyde (Scheme 69). Further elimination of thiophenolate results in enone 2-100. 
 
Scheme 69. The proposed mechanism for the Kirk-Petrow reaction. 
Acid-mediated cleavage of the acetal protecting group resulted in ketone 2-96, where the 
hydroxyl group was supposed to be protected as a silyl ether (Scheme 70). This 
transformation is known in the literature, however either expensive TBSOTf is used 
(TBSOTf, pyridine, CH2Cl2, r.t. (83%))
146
 or moderate yield is observed (TBSCl, DMAP, 
Et3N, reflux, 5 days (74%)).
147
 It was found that protection of this sterically hindered 
secondary alcohol at C-6 proceeds nicely even at ambient temperature when dimethyl 
formamide is used as a solvent. Further annulation was achieved by formylation of the ketone 
2-106, followed by Robinson annulation employing methyl vinyl ketone, with concomitant 
removal of the formyl group, to afford the enone 2-95 in 78% overall yield.
148
 Using 
LiHMDS as base the enolate of 2-106 reacted with methyl vinyl ketone (THF, –78 °C, to r.t.) 
directly to enone 2-95, albeit in lower yield (43%).  
 
Scheme 70. The synthesis of enone 2-95 via Robinson annulation. 
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The next challenge involved transposition of the enone functionality to set the stage for the 
key domino Michael reaction or preparation of a diene for a Diels-Alder reaction. Thus, a 
stereoselective nucleophilic epoxidation of , -unsaturated enone 2-95 resulted in desired 
epoxide 2-109 in 70% yield (Scheme 71). Wharton rearrangement
149
 on the derived 
hydrazone provided allylic alcohol 2-112.  
 
Scheme 71. Synthesis of allylic alcohol 2-112 via Wharton rearrangement. 
The stereochemical outcome in epoxidation step can be explained by steric hindrance of 4a-
CH3 blocking attack to the upper side ( -face) of the double bond (Figure 15). 
 
Figure 15. Epoxidation of 2-95 
It was found that allylic alcohol 2-112 was unstable under acidic conditions (pTSA, benzene, 
r.t.) and underwent smooth dehydration to a mixture of three dienes 2-113, 2-114 and 2-115 
(Scheme 72). Short reaction time (5 min, reflux) led to the formation of 2-113 and 2-114 in 
ratio 1.00:0.78 (Figure 16). 
Results and Discussion  73 
7.0 6.5 6.0 5.5
ppm
1.571.011.00 0.78
Benzene-d6
7.
16
6.
06 6.
03
5.
94 5
.9
3
5.
78 5
.7
7
5.
76
5.
75
5.
65 5.
64
5.
62
5.
61
5.
60
 
Figure 16. The fragment of 
1
H NMR spectrum of the diene mixture 2-113 and 2-114. 
Longer stirring with acid (1 h, reflux) resulted in exclusive formation of the 
thermodynamically most stable diene 2-115 (Scheme 72). Thermo-induced Diels-Alder 
reaction between 2-113 and allyl propiolate resulted in a mixture of aromatic compounds 2-
116 and 2-117. The formation of these compounds can be explained from the sequence of 
Diels-Alder/retro Diels-Alder reactions with loss of ethylene.
150
 Lewis-acid catalyzed (AlCl3, 
NbCl5, Me2AlCl, MeAlCl2) Diels-Alder reactions were not successful as well, and provided 
diene 2-115 as a main product. No reaction was observed, when methyl acrylate was used as a 
dienophile. The reaction between 2-chloroacrylonitrile
151
 and 2-113 resulted in a complex 
mixture of products. 
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Scheme 72. Attemps to perform a Diels-Alder reaction. 
As mentioned above, use of an intermolecular double Michael reaction could be an alternative 
way for the construction of the desired tetracyclic ring system. Thus, allylic alcohol 2-112 
was subjected to a stereoselective mCPBA-mediated epoxidation (Scheme 73). Nucleophilic 
opening of the epoxide may occur either at C-1a or C-9c position (Scheme 74). According to 
the Fürst-Plattner rule
152
 the major product formed results from attack at the C-9c position 
since the alternative attack at C-1a would give an unfavorable twist-boat transition state. 
However reductive epoxide opening with lithium aluminum hydride afforded diol 2-119 as a 
single regioisomer, whose constitution did not correspond to our expectations. This could be 
explained by the smaller steric hindrance of the C-1a position and ease of nucleophilic attack. 
With diol 2-119 in hand, we studied the regioselective oxidation of the secondary alcohol in 
presence of the tertiary hydroxyl group. While Dess-Martin oxidation of 2-119 resulted in 
keto aldehyde 2-121,
153
 Parikh-Doering oxidation
57
 provided the desired -hydroxy ketone 2-
120 in 73% yield (Scheme 73). The next challenge involved dehydration of 2-120 to , -
unsaturated ketone 2-94. When Burgess reagent
67
 was applied for this purpose, the required 
enone 2-94 was obtained only in 50% yield (Burgess regent, toluene, reflux, 1 min). After 
careful experimentation it was found that treatment of 2-120 in a pyridine solution with 
thionyl chloride (r.t., 20 min) provided enone 2-94 in 84% yield. These conditions were 
optimized (0 °C, 30 min) and the required , -unsaturated ketone 2-94 was prepared in 
quantitative yield. 
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Scheme 73. Synthesis of enone 2-94. 
 
Scheme 74. Comparison of nuclephilic epoxide opening pathways. 
Unfortunately generation of the desired enolate 2-125 from 2-94 by action of different bases 
failed. -Deprotonation took place under all tested conditions with different bases (LDA, 
LiHMDS, KHMDS) and temperatures (–78 °C, 0 °C) resulting in dienolate 2-124. Treatment 
of 2-94 with TBSOTf in presence of triethylamine (CH2Cl2, –78 °C) provided mixture of enol 
ethers 2-124 and 2-125 that could not be separated by chromatography (ratio 1:0.9).  
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Scheme 75. Preparation of enolate 2-125 for a key domino Michael reaction. 
Thus, we were not able to find conditions, that would generate the desired enolate for the key 
domino Michael reaction. Also we were not successful with the preparation of the required 
diene system for an intermolecular Diels-Alder reaction. The challenging late-stage 
construction of the bicyclo[2.2.2]octane motif forced us to reconsider our retrosynthetic plan 
(see 2.3). 
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2.2 Total Synthesis of Moluccanic Acid Methyl Ester 
Enone 2-95 prepared in the previous part of this chapter (2.1) has a similar tricyclic 
motif as podocarpane (2-126) (Figure 17). We decided to apply our synthetic strategy 
described in 2.1 for the synthesis of one of the padocarpane diterpenes, where the problematic 
formation of the bicyclo[2.2.2]octane ring system is not required. It was also interesting for us 
to try the Baeyer-Villiger oxidation for the oxidative cleavage of the ring A, that could later 
be applied for the synthesis of crotogoudin (2-1). Thus, we selected the recently discovered 
3,4-seco-podocarpane trinorditerpenoid moluccanic acid methyl ester (2-11) as a title 
compound for our spin-off synthesis. This molecule was isolated from plant extracts of 
Aleurites moluccana in 2008.
154
 Methyl ester 2-11 displays moderate cytotoxic activity 
against the HepG2 cell line with an IC50 value of 32 µM, while the free acid 2-10 was 
essentially inactive (IC50 > 360 µM). 
 
Figure 17. The structures of moluccanic acid (2-10), its methyl ester (2-11) and podocarpane 
(2-126). 
Our retrosynthetic plan for (±)-moluccanic acid methyl ester (2-11) features a Baeyer-
Villiger-type oxidation leading to lactone 2-127, which itself would originate from ketone 2-
128 (Scheme 76). The aromatic ring in ketone 2-128 could be introduced via aromatization
155
 
of the previously prepared tricyclic enone 2-95. 
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Scheme 76. Retrosynthetic analysis of moluccanic acid methyl ester (2-11). 
The synthesis commenced with treatment of earlier prepared enone 2-95 with catalytic 
amounts of CuBr2 (5 mol%, CH3CN, r.t.). However, only TBS deprotection was observed.
156
 
Addition of excess (1.7 equiv) CuBr2 provided phenol 2-129 in quantitative yield (Scheme 
77).
157
 With hydroxyphenol 2-129 in hand we tested various conditions in order to promote 
the oxidation of the secondary hydroxyl group in the presence of the phenol. Standard 
procedures for oxidation of alcohols to ketones (Dess-Martin, Swern, PCC, Parikh-Doering 
oxidations) failed.
158
 After careful experimentation we found that selective TBS protection of 
the phenol to give silyl ether 2-130 was possible. This was followed by oxidation with Dess-
Martin periodinane,
58
 which provided ketone 2-131 in 91% yield over two steps. Then the 
silyl protecting group was smoothly removed by pTSA in methanol to afford phenol 2-128 in 
quantitative yield. 
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Scheme 77. Preparation of phenol 2-128 via Cu(II)-mediated aromatization. 
The crucial Baeyer-Villiger oxidation of ketone 2-131 was achieved with mCPBA and 
NaHCO3 leading to lactone (Scheme 78).
159,31
 Gratifyingly, transesterification
160
 with MeOH 
in presence of pTSA completed the synthesis of (±)-moluccanic acid methyl ester (2-11) as an 
amorphous solid. In addition, a second product was isolated from the transesterification 
reaction. The structure of this by-product was assigned to the hydroxyester 2-133 (combined 
yield 90%, ratio 2-11/2-133 = 1:2), that upon standing overnight as a chloroform solution 
underwent dehydration to give the desired alkene 2-11 in quantitative yield.  
 
Scheme 78. Synthesis of moluccanic acid methyl ester (2-11) via Baeyer-Villiger oxidation. 
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Moluccanic acid methyl ester (2-11), as well as the phenols 2-128, 2-129 and 2-133 were 
tested against three cancer cell lines using an MTT assay (Table 7).
161
  
compound cell line 
L-929 KB-3-1 PtK2 
2-129 96 15 104 
2-128 124 109 105 
2-133 >130 46 >130 
2-11 80 19 66 
Table 7. Cytotoxicity (IC50 in µM) of (±)-moluccanic acid methyl ester (2-11) and its possible 
precursors 2-128, 2-129 and 2-133 against selected cell lines. 
The cancer cell line KB-3-1 turned out to be the most sensitive against all compounds tested. 
For this cell line, ester 2-11 and the phenol 2-129 showed similar IC50 values. The other two 
compounds, ketone 2-128 and hydroxyester 2-133 did not show any significant cytotoxicity. 
For phenol 2-128 and ester 2-11 also impedance curves were recorded since the course of 
these curves is characteristic for the mode of action of a particular compound.
162
 The two 
compounds were found to cluster with microtubule effecting compounds. Ester 2-11 clustered 
with taxol and epothilone (Figure 18). One the other hand phenol 2-129 seems to be similar 
to tubulysin, griseofulvin, and nocodazole in the cluster analysis. 
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Figure 18. Hierarchical cluster analysis of the reference compounds together with the 
compounds with unknown mode of action. 
Finally, these compounds were tested for their effect on actin (Figure 19). Potoroo kidney 
cells PtK2 were incubated with 2-11 (69 µM) (right) or the vehicle only (left) for 24 h and 
stained for microtubules. With compound 2-11 we observed weak and bended mitotic 
spindles. 
  
Figure 19. Effect of 2-11 on microtubules. 
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2.3 Studies Towards the Synthesis of Crotogoudin via an Early-stage 
Formation of the Bicyclo[2.2.2]octane Ring System 
Our second retrosynthetic plan towards crotogoudin (2-1) features an early-stage 
formation of the bicyclo[2.2.2]octane motif via a double Michael reaction (Scheme 79). The 
ring B could be constructed by intramolecular cyclopropanation/thiophenolate-mediated 
cyclopropane opening strategy, which was applied by Nakada et al. in the synthesis of 
platencin (2-34).
136
 For this purpose diazo -keto ester 2-136 could be prepared from 
aldehyde 2-137, according to the sequence used in our studies towards the synthesis of 
englerin A (1-7) (Scheme 17). Vinylogous ester 2-139 appeared as an appropriate starting 
material for our plan (Scheme 79).  
 
Scheme 79. Retrosynthetic analysis of crotogoudin (2-1). 
The synthesis commenced with Grignard addition of readily available 3-chloropropan-1-ol 
with temporary protected hydroxyl group 2-141 to vinylogous ester 2-139,
163
 which can be 
prepared in one step from commercially available 1,3-cyclohexadione (Scheme 80).
164
 Acid-
mediated hydrolysis of the enol ether obtained from the Grignard reaction led to enone 2-142 
in 86% yield. Enone 2-142 exists in equilibrium with ether 2-143. Protection of primary 
hydroxyl group in enone 2-142 as a silyl ether resulted in 2-138 in 93% yield. Oxa-Michael 
product from the previous step was not detected after this reaction. Treatment of the lithium 
enolate, generated from 2-138 using LiHMDS as a base with methyl acrylate resulted in 
formation of bicyclic compound 2-145 as a single stereoisomer.
165
 A remarkable 
84  Results and Discussion 
stereoselectivity in this reaction arises from the chelation effect of the enone oxygen with 
lithium enolate in intermediate 2-144. 
 
Scheme 80. Synthesis of bicyclo[2.2.2]octane derivative 2-145 via domino Michael reaction. 
The further functionalization called for a conversion of the carbonyl group to an endocyclic 
double bond. Thus, the carbonyl group in 2-145 was reduced by NaBH4 to afford a 
diastereomeric mixture of diols 2-146 (ratio 4.3:1) (Scheme 81). With hydroxyester 2-146 we 
tried various conditions in order to promote the dehydration reaction. Water elimination by 
Burgess reagent
67
 failed as well as reaction with MsCl/Et3N. After careful experimentation we 
found that a Chugaev reaction
166
 (xanthogenate formation, followed by syn-elimination) 
resulted in the desired alkene 2-147 in good overall yield. Fluoride-mediated cleavage of the 
silyl ether converted ester 2-147 to primary alcohol 2-148, which was then oxidized with 
Dess-Martin reagent
58
 to afford aldehyde 2-137 in quantitative yield. 
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Scheme 81. Synthesis of aldehyde 2-137 via Chugaev dehydration. 
Aldehyde 2-137 was subjected to reaction with ethyl diazoacetate, catalyzed by tin (II) 
chloride,
59
 and provided -ketoester 2-149 in nearly quantitative yield (Scheme 82). 
Diazotransfer reaction with sulfonyl azide 1-120
60
 furnished diazoketone 2-136 in 80% yield. 
Intramolecular cyclopropanation reaction was found to be challenging. Several rhodium- or 
copper-based catalysts (Rh2(OAc)4; Cu(acac)2; CuSO4; CuI; Rh(PPh3)3Cl; Rh(cod)2Cl; 2-
150
167
) were used in order to promote carbene formation and its reaction with the double 
bond. However, we were not able to detect even trace amounts of the desired cycloadduct 2-
135. A complex mixture of different C-H insertion products was obtained in all experiments. 
Most likely the desired cyclopropane 2-135 cannot be formed, because the double bond and 
carbene generated from 2-136 are too far from each other. Possible cyclopropanation is 
possible by an intermolecular reaction. 
 
Scheme 82. Synthesis of diazo -keto ester 2-136 and attempts to perform an intramolecular 
cyclopropanation. 
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Although we were not able to perform the key intramolecular cyclopropanation, we found that 
the bicyclo[2.2.2]octane ring system can be constructed via domino Michael reaction with 
high yield and stereoselectivity. The double bond could be installed via Chugaev reaction. 
These findings could be used in the following studies, where construction of the B ring relies 
on another method, namely intramolecular aldol condensation. 
Our revised retrosynthetic approach features a Pummerer rearrangement
168
 to install the 
isopropenyl group at C-5 (Scheme 83). The quaternary center at C-10 could be constructed 
via double copper-catalyzed 1,4-Grignard addition. The desired tricyclic ring system would 
originate from intramolecular aldol condensation of aldehyde 2-154 that has an additional 
methylene group in the side chain in comparison to the earlier prepared 2-137. The synthesis 
of aldehyde 2-154 relies on a domino Michael reaction between enolate generated from 2-155 
and methyl acrylate under the conditions disclosed before.  
 
Scheme 83. Retrosynthetic plan for the synthesis of crotogoudin (2-1) via domino Michael 
reaction/intramolecular aldol condensation. 
Starting from vinylogous ester 2-139, hydroxy ester 2-160 was prepared by the previously 
described five-step sequence (Scheme 84). The moderate yield observed in the Grignard 
addition could be explained from intramolecular cyclization of 2-156 to a tetrahydrofuran 
during its preparation. In a contrast to the use of 3-cloropropan-1-ol (Scheme 80) the 
intramolecular oxa-Michael product was not detected and 2-157 was isolated as a single 
compound (Scheme 84). The protecting group for the primary hydroxyl group was changed to 
a smaller TBS, that was supposed to survive under the planned reaction conditions. The key 
intermolecular domino Michael reaction proceeded with quantitative yield and resulted in 
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stereoselective formation of ester 2-159. The orientation of the ester group could be inferred 
from the NOESY spectrum which shows a cross-peak between 15-H and 14-H (atisane 
numbering). This assignment was confirmed by X-ray analysis on a similar compound in the 
synthesis of the core structure of palhinine A.
165
  
 
Scheme 84. Synthesis of hydroxy ester 2-160. 
To avoid furan formation during preparation of the Grignard reagent we investigated a 
slightly modified route to 2-160 which utilizes readily available THP-protected 4-
chlorobutan-1-ol 2-161 for the Grignard addition to vinylogous ester 2-139 (Scheme 85).
169
 
We were not able to prepare a Grignard reagent from a readily available TBS-protected 4-
chlorobutanol. Acid-mediated hydrolysis of the vinylogous hemiacetal obtained from the 
Grignard reaction led to enone 2-162 in 86% yield. Treatment of the lithium enolate, 
generated from 2-162 using LiHMDS as base with methyl acrylate resulted in formation of 
bicyclic compound 2-163 also in high yield and as a single isomer (diastereomers on the 
acetal carbon of the THP group). Acid-induced cleavage of the THP-protecting group 
provided alcohol 2-160 as well. Although the use of THP as a protecting group made work up 
and NMR analysis inconvenient (diastereomeric mixture at the acetal carbon), the yields were 
higher in comparison to the use of the previous method (Scheme 84). Subsequent Dess-
Martin oxidation
58
 of primary alcohol 2-160 gave keto aldehyde 2-164 in good yield (Scheme 
85).  
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Scheme 85. Synthesis of keto aldehyde 2-164 via improved method. 
The next challenge involved -methylenation of the aldehyde group in 2-164. This was 
achieved by Mannich-type reaction on a transiently formed methyleneammonium salt 
(Scheme 86).
170
 Subsequent base-mediated aldol condensation provided enone 2-153, while 
acid-mediated condesation (pTSA, benzene, reflux) failed. Intramolecular Michael adduct as 
well as the intermediate -hydroxyketone (aldol reaction product) were not detected in that 
reaction. Treatment of dienone 2-153 with thiophenol resulted in formation of several 
products, however formation of the required enone 2-168 was not observed. Allylic oxidation 
by traces of oxygen (all reactions were performed under N2 with degassed reagents and 
absolute solvents) proceeded smoothly and 2-165 and 2-166 were formed in almost all 
experiments even as main products in some of them. It was found that deconjugation of the 
double bond took place as well. This could probably be explained from release of strain if the 
double bond shifts. 
 
Scheme 86. Synthesis of dienone 2-153 and its treatment with thiophenol. 
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Conditions Yields 
2-165 2-166 2-167 2-168 
PhSH, Et3N, benzene, air 70 20 0 0 
PhSH, Et3N, benzene, CHCl3 air 68 17 0 0 
Et3N, benzene, air 0 0 0 0 
PhSH, K2CO3, MeOH, air 36 0 44 0 
PhSH, K2CO3, MeOH, N2 10 0 61 0 
Table 7. Conditions for conjugated addition of thiophenol to dienone 2-153. 
Thus, we found a very efficient strategy for construction of the tricyclic core structure of 
crotogoudin, however further functionalization via 1,4-Grignard addition and Pummerer 
rearrangement was found to be challenging due to deconjugation of the enone system. Thus, 
we proposed a new revised retrosynthetic plan for the completion of the synthesis of 
crotogoudin (2-1), where deconjugation would be impossible due to tetrasubstitution at C-5. 
According to this plan a biomimetic Baeyer-Villiger oxidation and intramolecular 
translactonization leads to ketone 2-93 (Scheme 86). The A ring in ketone 2-93 could be 
introduced via a Stork reductive alkylation strategy on an advanced intermediate 2-169.
171
 
The latter could be prepared from previously synthesized keto aldehyde 2-164. 
 
Scheme 87. Retrosynthetic analysis of crotogoudin (2-1) 
The first challenge involved allylic C-H activation on enone 2-170, which is readily available 
by base-mediated aldol condensation from keto aldehyde 2-164 (Scheme 88). Being 
disappointed by inefficiency of different selenium and chromium-based methods in order to 
introduce a carbonyl moiety in the allylic position of enone 2-164, we tried to deactivate the 
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carbonyl group at C-11 by its protection as an acetal. Transposition of the double bond was 
observed, which parallels our findings about the stability of this double bond in the previous 
approach (Scheme 86). However, we were successful with a four-steps sequence starting with 
allylic bromination of enone 2-170 in order to functionalize the allylic position (Scheme 88). 
Thus, a diastereomeric mixture of bromides 2-172 (1:1), prepared utilizing Ziegler-Wohl 
bromination, was transformed to the corresponding acetate 2-173. It was found that the 
stereochemistry of the products in the nucleophilic substitution strongly depends on the 
reaction conditions. The results are summarized in the Table 8. With the use of silver acetate 
in presence of acid we prepared acetate 2-173 as a single stereoisomer with high yield. We 
attribute this to a SN1-type mechanism. At this stage we tried to introduce a methyl group at 
C-10 via copper-catalyzed 1,4-Grignard addition, however we isolated the unexpected 
product 2-174 with a deconjugated double bond.
172
 Migration of the double bond and 
formation of 2-174 was also observed when bromides 2-172 were heated with indium and 
acetone in order to introduce the isopropyl functionality in C-5. Saponification of acetate 2-
173 led to allylic alcohol 2-175 and a final Dess-Martin oxidation resulted in diketone 2-165 
(66%, 4 steps). 
 
Scheme 88. Introduction of carbonyl group at C-5. 
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Conditions Yields (dr) 
AcONa, DMF, 80 °C 90 (1:1) 
AcONa, DMF, r.t. 0 
AcOH, NaHCO3, DMF, 80 °C 90 (1:1) 
AgOAc, AcOH, r.t. 92 (1:0) 
AgOAc, dioxane, r.t. 88 (1:1) 
AcOK, KI, 18-C-6, acetone, 80°C 22 (1:0) 
AcOK, KI, Et4NCl, acetone, 80 °C 10 (1:0) 
AcOH, Et3N, acetone, 80 °C 87 (1:1) 
Table 8. Conditions for the nucleophilic substitution on bromide 2-172. 
After further experimentation we found even a single step procedure for the desired 
transformation of enone 2-170 to 1,4-enedione 2-165, namely a Pd-catalyzed oxidation using 
tert-butylhydroperoxide (Scheme 89).
173
  
 
Scheme 89. Single-step allylic oxidation. 
We next faced the challenge of introducing substituents at C-10. This was achieved by [3+2]-
cycloaddition of freshly prepared diazomethane to the electron poor double bond of enedione 
2-165 (Scheme 90).
174
 This resulted in formation of a pyrazoline derivative, which underwent 
nitrogen elimination even under ambient temperature to give diketone 2-169. Hydrogenation 
of the double bond with zinc in glacial acid furnished diketone 2-177 as a mixture of two 
diastereomers (1.6:1). Unfortunately acid-mediated Robinson annulation neither with ethyl 
vinyl ketone nor with 1-chloropentan-3-one was fruitful;
175
 therefore a Stork reductive 
alkylation strategy was applied for the construction of ring A. Accordingly, dienolate 2-178, 
prepared by treatment of diketone 2-169 with lithium in liquid ammonia, was quenched with 
allyl bromide. After work up only one regio- and stereoisomer was detected and its structure 
was assigned to 2-179. As it can be seen, C-alkylation took place on the less hindered carbon 
atom (C-10), while the other enolate underwent O-alkylation. Unfortunately the 
stereochemistry of the newly formed stereocenter was opposite with respect to the one 
required for C-10 of crotogoudin (2-1). This can be explained by shielding of the enolate face 
syn to the ester group at C-15.  
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Scheme 90. Functionalization at C-10. 
A proposed mechanism for the reductive alkylation of enedione 2-169 involves single 
electron reduction of enone moiety leading to radical 2-181, followed by second single 
electron reduction resulting in dienolate 2-178 (Scheme 91). 
 
Scheme 91. The proposed mechanism for the reduction of enedione 2-169. 
Confirmation of the stereochemistry at C-10 in 2-179 was possible through a NOESY 
experiment, where we observed a relatively strong cross peak between the allyl CH and 14-H 
(methylene group) (Figure 20). In addition, the other 14-H showed a NOE correlation with 
15-H, confirming the endo orientation of the ester group at C-4 and that it remained 
untouched during the synthesis.  
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Figure 20. The fragment of NOESY spectrum of 2-179. 
In order to reverse the stereochemical outcome in the alkylation step we tried a degradation of 
the ester group at C-15. We were inspired by the work of Yamamoto et al,
176
 where they 
describe a nitrosobenzene-mediated C-C bond cleavage via formation of an oxazetidin-4-one. 
Protection of the two keto groups was necessary to generate a selective enolate from the 
carboxyl group. Thus, double protected ester 2-182 was treated with LDA, followed by 
addition of nitrosobenzene (Scheme 92). The resulting oxazetidin-4-one underwent smooth 
fragmentation to imine 2-185. Subsequent acid-mediated hydrolysis furnished the desired 
ketone 2-186 albeit with poor yield. 
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Scheme 92. Nitrosobenzene-mediated decarboxylation. 
Next we tried epimerization of the ester group at C-15 in order to release the space on the -
side of the molecule. This was achieved with the use of DBU as base (ratio 1:1) (Scheme 93). 
The two stereoisomers were separated by SiO2 column chromatography, and recovered 2-169 
was reintroduced in the epimerization reaction again. A key reductive Stork allylation led to a 
complex mixture of overreduced products, and the desired product 2-188 was not detected. 
 
Scheme 93. Epimerization at C-15. 
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3 Conclusion 
In summary, we investigated several approaches to the carbocyclic core structure of 
crotogoudin (2-1), based on a domino Michael reaction. A late- or early stage formation of the 
bicyclo[2.2.2]octane subunit can be chosen. The first generation approach to crotogoudin (2-
1) features generation of the bicyclic motif at the end of the synthesis. The synthesis 
commenced with the transformation of readily available Wieland-Miescher ketone to a double 
methylated derivative 2-106 (Scheme 94). Its Robinson annulation with methyl vinyl ketone, 
followed by transposition of the enone moiety via Wharton rearrangement resulted in tricyclic 
compound 2-94. Unfortunately, a domino Michael addition with methyl acrylate to get 
bicylo[2.2.2]octane derivative 2-189 failed as well as Diels-Alder reactions of the derived 
diene with different dienophiles. This way tricyclic enone 2-94 was prepared in 17.6% overall 
yield in the longest linear sequence of 15 steps. 
 
Scheme 94. Studies towards the synthesis of crotogoudin (2-1), utilizing a late stage 
bicyclo[2.2.2]octane formation. 
As a spin-off of this project, an effective total synthesis of the trinorditerpene moluccanic acid 
methyl ester (2-11) has been achieved from common intermediate 2-95 (Scheme 95). The 
synthesis features a CuBr2-mediated aromatization of enone 2-95 and Baeyer-Villiger 
oxidation of the A ring to finish the target molecule 2-11. The route to 2-11 proceeded in 
35.2% overall yield with a longest linear sequence of 14 steps from Wieland-Miescher ketone 
(2-14). Methyl ester 2-11 and its possible biosynthetic precursors were tested against different 
cancer cell lines and showed interesting activity.  
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Scheme 95. Synthesis of (±)-moluccanic acid methyl ester (2-11). 
Due to the challenges faced in the first approach towards crotogoudin (2-1), the 
bicyclo[2.2.2.]octane motif was constructed in the beginning of the synthesis via domino 
Michael reaction between a cyclohexenone, which was available from vinylogous ester 2-139, 
and methyl acrylate (Scheme 96). Ring B was introduced by intramolecular aldol 
condensation of 2-164. Reductive Stork alkylation of the dienolate, generated from 2-169 
furnished 2-179, where the stereochemistry of the newly formed stereocenter was opposite 
with respect to the one required for C-10 of crotogoudin (2-1). The route to 2-169 proceeded 
in 30% overall yield starting from vinylogous ester 2-139 with a longest linear sequence of 
seven steps utilizing a single protecting group (THP) and one oxidation reaction (from alcohol 
to aldehyde). 
 
Scheme 96. Synthesis of the tricyclic core structure of crotogoudin (2-1). 
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Experimental Section 
General Remarks 
 
Chemicals and Working Techniques 
 
Unless otherwise noted, all reactions were performed in oven-dried glassware. All solvents 
used in the reactions were purified before use. Dry diethyl ether, tetrahydrofuran, and toluene 
were distilled from sodium and benzophenone, whereas dry CH2Cl2, dimethylformamide, 
methanol, ethyl acetate, benzene, chloroform, pyridine, diisopropylamine and triethylamine 
were distilled from CaH2; acetone by distillation from phosphorus pentoxide. Petroleum ether 
with a boiling range of 40–60 °C was used. Reactions were generally run under nitrogen 
atmosphere. All commercially available compounds (Acros, Aldrich, Fluka, Merck, Avocado, 
Applichem and Strem) were used without purification.  
 
NMR Spectroscopy 
 
All spectra were measured on a Bruker Avance 400 spectrometer, which operates at 400 MHz 
for 
1
H and 100 MHz for 
13
C nuclei. The spectra were recorded at 295 K in CDCl3, C6D6, 
MeOD-d4 or in DMSO-d6; chemical shifts are calibrated to the residual proton and carbon 
resonance of the solvent: CDCl3 (
1
H 7.25, 
13
C 77.0 ppm), C6D6 (
1
H 7.16, 
13
C 128.1 ppm), 
MeOD-d4 (
1
H 3.31, 
13
C 49.0 ppm), DMSO (
1
H 2.50, 
13
C 39.5 ppm).
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Mass Spectrometry 
 
Mass spectra were recordered on a Bruker Daltonic APEX 2 with electron spray ionization 
(ESI). High resolution mass (HRMS) are reported as follows: (ESI): calcd mass, for the 
related compound followed by found mass. 
 
Chromatographic Methods 
 
Thin-layer chromatography (TLC) was performed on precoated with silica gel Machery-
Nagel Polygram Sil G/UV254. The compounds were visualized by UV254 light and the 
chromatography plates were developed with an aqueous solution of ceric ammonium 
molybdate or an aqueous solution of potassium permanganate (heating with hot gun). For 
preparation of the molybdate solution 20.0 g ammoinium molybdate [(NH4)6Mo7O24·4H2O] 
and 0.4 g Ce(SO4)2·4H2O were dissolved in 400 mL of 10% H2SO4. The potassium 
permanganate solution was prepared from 2.5 g KMnO4 and 12.5 g Na2CO3 in 250 mL water. 
 
Polarimetry 
 
Optical rotations were measured on a JASCO Polarimeter P-1020. They are reported as 
follows: [ ]
temperature
D (concentration, solvent). c = g per 100 mL. Anhydrous CH2Cl2, CHCl3 
or MeOH were used as solvents. For the measurement the sodium D line = 589 nm was used. 
 
Melting points 
 
Melting points were determined with a Büchi Melting Point B-540 apparatus. 
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Experimental Procedures 
All the experimental procedures are arranged to reflect the synthetic sequences shown in the 
schemes. 
 
 
(1R,4R,6R)-1-Methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-one (1-108a).
178
 A 
solution of H2O2 in water (30%, 160 mL, 1.42 mol) was added dropwise to a solution of (R)-
carvone (1-108) (70.0 g, 0.47 mol) in methanol (500 mL) at 0 °C over a period of 10 min. A 
solution of NaOH in water (2M, 120 mL, 0.24 mol) was added over a period of 30 min at the 
same temperature. The resulting mixture was stirred for 2 h at room temperature before it was 
treated with half-saturated Na2SO3 solution (500 mL) and extracted with diethyl ether (4 × 
300 mL). The combined organic layers were washed with water (2 × 300 mL) and saturated 
NaCl solution (200 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give epoxide 
1-108a (69.1 g, 89%) as a colorless oil. Rf = 0.38 (petroleum ether/EtOAc, 9:1). [ ]
20
D = –
77.6 (c 1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.33 (d, J = 3.2 Hz, 3H, 1-CH3), 
1.62 (s, 3H, H2C=C–CH3), 1.84 (ddd, J = 14.9, 12.0, 1.0 Hz, 1H, 5-H), 1.95 (ddd, J = 13.5, 
11.8, 2.8 Hz, 1H, 5-H), 2.25–2.34 (m, 1H, 4-H), 2.47–2.53 (m, 1H, 3-H), 2.62–2.68 (m, 1H, 
3-H), 3.37 (d, J = 2.1 Hz, 1H, 6-H), 4.65 (s, 1H, H2C=C–CH3), 4.71 (s, H2C=C–CH3); 
13
C 
NMR (100 MHz, CDCl3): [ppm] = 15.2 (1-CH3), 20.5 (H2C=C–CH3), 28.4 (C-5), 34.8 (C-
4), 41.7 (C-3), 58.5 (C-1), 61.1 (C-6), 110.4 (H2C=C–CH3), 146.1 (H2C=C–CH3), 205.1 (C-
2). 
 
 
(2S,3R,5R)-2-Chloro-3-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexenone (1-108b).
178
 
TFA (70 mL, 0.41 mol) was added dropwise to a mixture of epoxide 1-108a (50 g, 0.30 mol) 
and LiCl (130 g, 3.07 mol) in THF (900 mL) at 0 °C. The resulting mixture was stirred for 1 h 
at the same temperature before it was treated with saturated NaHCO3 solution (900 mL) at 0 
°C and stirred for additional 1 h at room temperature and extracted with diethyl ether (3 × 200 
mL). The combined organic layers were washed with water (2 × 200 mL) and saturated NaCl 
solution (200 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give ketone 1-108b 
(69.1 g, 89%) as a colorless oil. Rf = 0.29 (petroleum ether/EtOAc, 9:1); [ ]
20
D = –45.1 (c 
1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.66 (s, 3H, 2-CH3), 1.78 (s, 3H, 
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H2C=C–CH3), 1.82–1.91 (m, 1H, 5-H), 2.07 (br s, 1H, OH), 2.40–2.45 (m, 2H, 2 × 4-H), 
2.76–2.85 (m, 1H, 6-H), 3.03 (dd, J = 13.9, 13.1 Hz, 1H, 6-H), 4.25 (dd, J = 3.5, 2.9 Hz, 1H, 
3-H), 4.75–4.82 (m, 2H, H2C=C–CH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 20.2 
(H2C=C–CH3), 22.2 (2-CH3), 32.8 (C-4), 39.1 (C-5), 41.2 (C-6), 68.2 (C-3), 77.1 (C-2), 110.8 
(H2C=C–CH3), 146.6 (H2C=C–CH3), 204.7 (C-1). 
 
 
(2S,3R,5R)-2-Chloro-2-methyl-5-(prop-1-en-2-yl)-3-((tetrahydro-2H-pyran-2-
yl)oxy)cyclohexenone (1-109).
178
 PPTS (0.9 g, 3.6 mmol) was added to a stirred solution of 
alcohol 1-108b (61.0 g, 0.34 mol) and dihydropyran (110 mL, 1.21 mol) in CH2Cl2 (400 mL). 
The mixture was stirred for 2 d at room temperature before it was treated with saturated 
NaHCO3 solution (300 mL) and extracted with diethyl ether (3 × 200 mL). The combined 
organic layers were washed with water (200 mL) and saturated NaCl solution (200 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 30:1 to 15:1) to give ketone 1-109 (89.0 g, 92%) as 
a colorless oil. Rf = 0.44 (petroleum ether/EtOAc, 9:1); NMR: mixture (1:1) of two 
diastereomers on acetal carbon. 
 
 
(1R,2S,3R,5R)-Methyl 2-methyl-5-(prop-1-en-2-yl)-3-((tetrahydro-2H-pyran-2-
yl)oxy)cyclopentanecarboxylate (1-111).
178
 A solution of MeONa in methanol (1M, 220 mL, 
0.22 mol) was added dropwise to a solution of chloroketone 1-109 (40.0 g, 0.14 mol) in 
diethyl ether (400 mL) at 0 °C. The resulting mixture was stirred for 1 h at the same 
temperature before it was treated with saturated NH4Cl solution (100 mL) and stirred for 
additional 1 h at room temperature. The organic phase was separated and the aqueous phase 
was extracted with diethyl ether (3 × 100 mL). The combined organic layers were washed 
with water (200 mL) and saturated NaCl solution (200 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 15:1 to 9:1) to give carboxylate 1-111 (38.0 g, 96%) as a colorless oil. Rf = 0.36 
(petroleum ether/EtOAc, 9:1); NMR: mixture (1:1) of two diastereomers on acetal carbon. 
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(1R,2S,3R,5R)-Methyl 3-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentanecarboxylate 
(1-112).
178
 PPTS (0.9 g, 3.6 mmol) was added to a stirred solution of THP-protected alcohol 
1-111 (38.0 g, 0.14 mol) in methanol (500 mL). The resulting mixture was stirred for 20 h at 
room temperature before it was concentrated in vacuo to ca. 100 mL, treated with saturated 
NaHCO3 solution (300 mL), diluted with water (150 mL) and extracted with diethyl ether (3 × 
100 mL). The combined organic layers were washed with water (100 mL) and saturated NaCl 
solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 9:1 to 2:1) to give carboxylate 1-
112 (26.3 g, 98%) as a colorless oil. Rf = 0.08 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +5.0 (c 
1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.08 (d, J = 7.2 Hz, 3H, 2-CH3), 1.74 
(s, 3H, CCH3), 1.85 (ddd, J = 13.7, 7.1, 1.4 Hz, 1H, 4-H), 2.06 (ddd, J = 13.7, 10.9, 4.4 Hz, 
1H, 4-H), 2.46–1.54 (m, 1H, 2-H), 2.84 (dd, J = 10.3, 8.9 Hz, 1H, 1-H), 3.29 (ddd, J = 10.3, 
7.1, 6.4 Hz, 1H, 5-H), 3.63 (s, 3H, OCH3), 4.28 (dd, J = 4.5, 4.6 Hz, 1H, 3-H), 4.75 (s, 1H, 
H2C=C), 4.83 (br s, 1H, H2C=C); 
13
C NMR (100 MHz, CDCl3): [ppm] = 13.5 (2-CH3), 22.5 
(CCH3), 39.5 (C-4), 42.5 (C-5), 46.8 (C-2), 51.3 (C-1), 53.3 (OCH3), 75.1 (C-3), 111.4 
(H2C=C), 145.2 (H2C=C), 174.6 (ester). 
 
 
(1S,2R,5R)-Methyl 2-methyl-5-(prop-1-en-2-yl)cyclopentanecarboxylate (1-113). NaH 
(60% dispersion in oil, 22.0 g, 550 mmol) was added to a stirred solution of alcohol 1-112 
(11.2 g, 57.0 mmol) and imidazole (ca. 300 mg) in THF (200 mL) at 0 °C. The cooling bath 
was removed. After 15 min the reaction was recooled to 0 °C and CS2 (38 mL, 612 mmol) 
was added dropwise. The mixture was allowed to warm to ambient temperature and after 1 h 
recooled to 0 °C before MeI (40 mL, 600 mmol) was added dropwise. After 3 h the reaction 
was quenched by careful addition of water (200 mL) at 0 °C. The mixture was extracted with 
CH2Cl2 (3 × 100 mL). The combined organic layers were washed with water (2 × 200 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (5% ethyl acetate in petroleum ether) to give the titled xanthate (16.2 g, 
98%) as a yellow oil which was directly introduced to the next step. Rf = 0.43 (petroleum 
ether/EtOAc, 9:1).  
Tributylstannane (20.0 mL, 77.0 mmol) was added to a stirred solution of xanthate (16.2 g, 
56.0 mmol) in dry toluene (200 mL) under N2. The mixture was stirred for 5 min, and then 
AIBN (ca. 100 mg) was added. The resulting mixture was heated under reflux for 1 h and then 
the reaction was allowed to cool to ambient temperature, washed with water (3 × 100 mL) and 
saturated NaCl solution (100 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated in vacuo. The resulting colorless oil was distilled under reduced pressure (b.p. 
90–95 °C, 25 mbar) to afford the title compound 1-113 (6.9 g, 67%, over 2 steps) as a 
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colorless oil. Rf = 0.60 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +19.8 (c 1.00, diethyl ether); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.02 (d, J = 6.9 Hz, 3H, CHCH3), 1.16 (dddd, J = 
12.5, 10.5, 8.7, 7.8 Hz, 1H, 3-H), 1.71 (s, 3H, CH2=CCH3), 1.71–1.77 (m, 1H, 4-H), 1.83 
(dddd, J = 12.6, 10.2, 10.2, 7.6 Hz, 1H, 4-H), 2.02 (dddd, J = 12.5, 7.7, 7.7, 2.4 Hz, 1H, 3-H), 
2.41 (dddq, J = 14.2, 14.2, 6.6, 6.6 Hz, 1H, 2-H), 2.56 (dd, J = 8.9, 6.1 Hz, 1H, 1-H), 2.76 
(ddd, J = 9.4, 9.4, 6.7 Hz, 1H, 5-H), 3.55 (s, 3H, OCH3), 4.67 (br s, 1H, CH2=CCH3), 4.72 (br 
s, 1H, CH2=CCH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 21.2 (CHCH3), 22.6 
(CH2=CCH3), 29.7 (C-4), 33.7 (C-3), 36.9 (C-2), 49.7 (C-5), 51.0 (OCH3), 55.6 (C-1), 110.7 
(CH2=CCH3), 145.5 (CH2=CCH3), 175.1 (CO2CH3); HRMS (ESI): [M+Na]
+
 calcd for 
C11H18O2Na 205.11990, found 205.11972; The spectral data are identical to those previously 
reported.
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(1S,2R,5R)-2-Methyl-5-(prop-1-en-2-yl)cyclopentanecarbaldehyde (1-116). A solution of 
ester 1-113 (25.1 g, 0.14 mol) in diethyl ether (200 mL) was added dropwise to the suspension 
of lithium aluminium hydride (6.3 g, 0.17 mol) in diethyl ether (300 mL) at 0 °C. The mixture 
was stirred at room temperature for 2 d and then was carefully treated with 15% aqueous 
NaOH soultion (70 mL) and water (200 mL). Stirring was continued for 15 min, before 
MgSO4 was added, the mixture stirred for additional 15 min, and filtered to remove salts. 
Evaporation of the solvent yielded crude alcohol 1-114 (21.0 g), which was introduced to the 
next reaction without further purification. Rf = 0.25 (petroleum ether/EtOAc, 9:1).  
To a stirred solution of the foregoing alcohol 1-114 (21.0 g, 0.14 mol) in CH2Cl2 (700 mL) 
were added at room temperature Et3N (230 mL, 1.66 mol) and a solution of SO3×Py (125 g, 
0.78 mol) in DMSO (400 mL). The reaction mixture was stirred for 1 h before it was treated 
with water (300 mL) and extracted with ethyl acetate (3 × 200 mL). The combined organic 
layers were washed with water (200 mL), 1 N HCl (2 × 200 mL), water (2 × 200 mL), 
saturated NaCl solution (200 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was distilled at low pressure (b.p. 100–105 °C, 25 mbar) to give aldehyde 1-116 as a 
colorless oil (18.0 g, 87%, over 2 steps). Rf = 0.65 (petroleum ether/EtOAc, 9:1); The spectral 
data are identical to those previously reported.
180
 
 
 
(3aS,4R,6aR)-1,1,4-Trimethylhexahydro-1H-cyclopenta[c]furan (1-115). A solution of an 
alcohol 1-114 (100 mg, 0.65 mmol) in chloroform (3 mL) was stirred overnight at room 
temperature. The solvent was removed in vacuo to afford tetrahydrofuran 1-115 (100 mg, 
quant.) as a colorless oil. Rf = 0.55 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, 
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CDCl3): [ppm] = 0.97 (d, J = 6.8 Hz, 3H, CHCH3), 1.03–1.13 (m, 1H, 5-H), 1.11 (s, 3H, 
CCH3), 1.19 (s, 3H, CCH3), 1.38–1.48 (m, 1H, 4-H), 1.57–1.72 (m, 2H, 4-H, 6-H), 1.77 
(dddd, J = 11.9, 6.1, 6.0, 3.0 Hz, 1H, 5-H), 2.18–2.33 (m, 2H, 3a-H, 6a-H), 3.49 (dd, J = 9.1, 
3.0 Hz, 1H, 1-H), 3.86 (dd, J = 9.0, 7.4 Hz, 1H, 1-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
20.0 (6-CH3), 23.8 (3-CH3), 27.1 (3-CH3), 28.1 (C-4), 36.4 (C-5), 42.2 (C-6), 52.9 (C-3a), 
53.8 (C-6a), 71.3 (C-1), 81.8 (C-3); HRMS (ESI): [M+Na]
+
 calcd for C11H18O2Na 205.11990, 
found 205.11972; 
 
 
(1R,2R,5R)-2-Methyl-5-(prop-1-en-2-yl)cyclopentanecarbaldehyde (1-117). DBU (0.2 
mL) was added to a stirred solution of aldehyde 1-116 (17.0 g, 0.11 mol) in toluene (150 mL). 
The resulting mixture was stirred under reflux for 2 d. Then the solvent was carefully 
evaporated to afford a mixture of two stereoisomers 1-117/1-116 in a ratio of 2:1 (16.5 g, 
97%) [as determined by 
1
H NMR spectroscopy via integration of the aldehyde signals (1-116: 
9.48 ppm, 1-117: 9.72 ppm)]. 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.98 (d, J = 7.1 Hz, 3H, 
CHCH3), 1.13–1.34 (m, 2H), 1.43–1.54 (m, 1H), 1.84–2.02 (m, 1H), 1.63 (s, 3H, 
CH3C=CH2), 2.41–2.49 (m, 1H, 2-H), 2.62 (ddd, J = 8.7, 8.7, 3.4 Hz, 1H, 1-H), 2.98 (ddd, J = 
8.5, 8.5, 8.5 Hz, 1H, 5-H), 4.64 (br s, 1H, CH3C=CH2), 4.65 (br s, 1H, CH3C=CH2), 9.72 (d, J 
= 3.8 Hz, 1H, CH=O). 
 
 
(1R,2R,5R)-2-Acetyl-5-methylcyclopentanecarbaldehyde (1-118). Ozone was bubbled 
through a solution of aldehyde 1-117 (4.0 g, 27 mmol) in CH2Cl2 (40 ml) at –78 °C until a 
deep blue color was observed. Nitrogen was applied until no blue color remained. After the 
addition of PPh3 (10.5 g, 40 mmol) the reaction mixture was stirred overnight at room 
temperature. Rf ketoaldehyde 1-118 = 0.43 (petroleum ether/EtOAc, 4:1). This solution was 
used as such for the subsequent keto ester formation. An analytical sample was prepared after 
evaporation of the solvent followed by flash chromatography (petroleum ether/diethyl ether, 
9:1). [ ]
20
D = +25.5 (c 0.85, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.03 (d, J = 7.1 
Hz, 3H, CHCH3), 1.32 (ddd, J = 15.4, 12.5, 7.6 Hz, 1H, 4-H), 1.65 (ddd, J = 16.1, 12.8, 8.0 
Hz, 1H, 3-H), 1.88 (dddd, J = 12.6, 7.8, 6.4, 5.0 Hz, 1H, 4-H), 2.10 (dddd, J = 9.9, 7.5, 5.0, 
2.5 Hz, 1H, 3-H), 2.17 (s, 3H, CH3C=O), 2.56 (app dddq, J = 14.5, 14.5, 7.4, 7.1 Hz, 1H, 5-
H), 3.25 (ddd, J = 8.4, 7.0, 1.1 Hz, 1H, 1-H), 3.48 (ddd, J = 9.5, 7.6, 7.5 Hz, 1H, 2-H), 9.81 
(d, J = 0.8 Hz, 1H, CH=O); 
13
C NMR (100 MHz, CDCl3): [ppm] = 16.4 (CHCH3), 27.7 (C-
3), 29.1 (CH3C=O), 34.2 (C-4), 36.6 (C-5), 49.5 (C-2), 56.4 (C-1), 203.1 (CH=O), 209.0 
(CH3C=O); HRMS (ESI): [M+Na+MeOH]
+
 calcd for C10H18O3Na 209.11429, found 
209.11450. 
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Ethyl 3-((1’R,2’R,5’R)-2’-acetyl-5’-methylcyclopentyl)-3-oxopropanoate (1-119). 
Anhydrous tin (II) chloride
181
 (9.0 g, 47 mmol) was added, followed by dropwise addition of 
ethyl diazoacetate (8 mL, 73 mmol) to the foregoing solution of crude ketoaldehyde 1-118 in 
CH2Cl2 (40 mL) (the quenched ozonolysis solution). Stirring was continued for 2 h, and then 
the mixture was transferred to a separatory funnel, containing saturated NaCl (100 mL) and 
diethyl ether (200 mL). After separation of the layers, the aqueous phase was extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with water (100 mL), 
saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/diethyl ether, 4:1) to give β-
keto ester 1-119 (2.5 g, 66%, over 2 steps) as a colorless oil. Rf = 0.30 (petroleum 
ether/EtOAc, 4:1); [ ]
20
D = –11.7 (c 1.02, MeOH); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.83 (d, J = 7.3 Hz, 3H, CHCH3), 1.24 (dd, J = 7.3, 7.3 Hz, 3H, OCH2CH3), 1.42–1.50 (m, 
1H, 4’-H), 1.58–1.67 (m, 1H, 3’-H), 1.82–1.92 (m, 1H, 4’-H), 2.07–2.20 (m, 1H, 3’-H), 2.13 
(s, 3H, CH3C=O), 2.54 (app dddq, J = 13.7, 11.3, 7.0, 7.0 Hz, 1H, 5’-H), 3.40–3.48 (m, 2H, 
1’-H, 2’-H), 3.47 (s, 2H, 2-H), 4.11–4.30 (m, 2H, OCH2CH3); 
13
C NMR (100 MHz, CDCl3): 
[ppm] = 14.0 (OCH2CH3), 16.4 (CHCH3), 27.0 (C-3’), 29.3 (CH3C=O), 33.8 (C-4’), 37.0 (C-
5’), 49.8 (C-3), 51.2 (C-1’), 57.0 (C-2’), 61.3 (OCH2CH3), 166.8 (C-1), 203.3 (C-3), 209.2 
(CH3C=O); HRMS (ESI): [M+Na]
+
 calcd for C13H20O4Na 263.12538, found 263.12538. 
 
 
(3aR,6R,6aS)-Ethyl 3,6-dimethyl-1-oxo-1,3a,4,5,6,6a-hexahydropentalene-2-carboxylate 
(1-122). Anhydrous tin (II) chloride
181
 (160 mg, 0.83 mmol) was added, followed by dropwise 
addition of ethyl diazoacetate (0.27 mL, 2.5 mmol) to the solution of aldehyde 1-116 (200 mg, 
1.30 mmol) in CH2Cl2 (5 mL). Stirring was continued for 2 h, and then the mixture was 
transferred to a separatory funnel, containing saturated NaCl (100 mL) and diethyl ether (200 
mL). After separation of the layers, the aqueous phase was extracted with diethyl ether (3 × 
50 mL). The combined organic layers were washed with water (100 mL), saturated NaCl 
solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The obtained -
keto ester 1-116a (240 mg, 78%) was used in next step without further purification. Rf = 0.55 
(petroleum ether/EtOAc, 4:1); 
Ozone was bubbled through a solution of -keto ester 1-116a (240 mg, 1.01 mmol) in CH2Cl2 
(15 ml) at –78 °C until a deep blue color was observed. Nitrogen was applied until no blue 
color remained. After the addition of PPh3 (420 mg, 1.60 mmol) the reaction mixture was 
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stirred overnight at room temperature. The solvent was removed under reduced pressure. The 
residue was purified by flash chromatography (petroleum ether/diethyl ether, 9:1) to give -
keto ester 1-122 (173 mg, 52% over 2 steps). Rf = 0.53 (petroleum ether/EtOAc, 4:1); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 1.05 (d, J = 7.1 Hz, 3H, CHCH3), 1.29 (dd, J = 7.1, 7.1 
Hz, 3H, CH2CH3), 1.30–1.36 (m, 1H, 5-H), 1.48–1.61 (m, 2H, 4-H; 5-H), 1.98–2.06 (m, 1H, 
4-H), 2.13–2.19 (m, 1H, 6-H), 2.36 (dd, J = 6.3, 3.8 Hz, 1H, 6a-H), 3.16–3.21 (m, 1H, 3a-H), 
4.24 (ddd, J = 7.1, 7.1, 7.1 Hz, 2H, CH2CH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 14.1 
(CH2CH3), 17.1 (3-CH3), 20.0 (CHCH3), 27.2 (C-4), 33.2 (C-5), 37.1 (C-6), 49.4 (C-3a), 58.3 
(C-6a), 60.6 (CH2CH3), 131.3 (C-2), 163.3 (C-3), 185.7 (ester), 205.2 (C-1). 
 
 
Ethyl 3-((1’R,2’R,5’R)-2’-acetyl-5’-methylcyclopentyl)-2-diazo-3-oxopropanoate (1-121). 
Triethylamine (3.9 mL, 28.0 mmol) was added dropwise at 0 °C to a solution of β-keto ester 
1-119 (3.4 g, 14 mmol) and p-acetamidobenzenesulfonyl azide
182
 (p-ABSA, 1-120) (4.3 g, 18 
mmol) in acetonitrile (60 mL). The mixture was stirred for 2 h and treated with saturated 
NH4Cl solution (30 mL). The layers were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with water (100 mL) 
and saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (petroleum ether/EtOAc, 9:1) to give diazo 
compound 1-121 (2.7 g, 71%) as a yellow oil. Rf = 0.70 (petroleum ether/EtOAc, 2:1); [ ]
20
D 
= –39.2 (c 1.76, MeOH); 1H NMR (400 MHz, CDCl3): [ppm] = 0.80 (d, J = 7.1 Hz, 3H, 
CHCH3), 1.30 (dd, J = 7.2, 7.2 Hz, 3H, OCH2CH3), 1.39 (dddd, J = 12.8, 7.6, 7.4, 5.8 Hz, 1H, 
4’-H), 1.63 (dddd, J = 12.5, 8.9, 8.8, 8.2 Hz, 1H, 3’-H), 1.94 (dddd, J = 12.4, 8.6, 6.8, 5.0 Hz, 
1H, 4’-H), 2.07–2.13 (m,1H, 3’-H), 2.12 (s, 3H, CH3C=O), 2.61 (app dddq, J = 14.2, 14.2, 
6.9, 6.8 Hz, 1H, 5’-H), 3.56 (ddd, J = 18.7, 9.4, 9.4 Hz, 1H, 2’-H), 4.07 (dd, J = 8.6 Hz, 1H, 
1’-H), 4.23–4.31 (m, 2H, OCH2CH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 14.2 
(OCH2CH3), 16.8 (CHCH3), 27.4 (C-3’), 29.1 (CH3C=O), 34.0 (C-4’), 36.2 (C-5’), 52.6 (C-
2’), 53.1 (C-1’), 61.4 (OCH2CH3), 160.9 (C-1), 192.9 (C-3), 209.2 (CH3C=O); HRMS (ESI): 
[M+Na]
+
 calcd for C13H18O4N2Na 289.11588, found 289.11592. 
 
 
(1R,3aR,4R,7R,8aR)-5-Allyl 7-ethyl 1,4-dimethyl-8-oxo-1,2,3,3a,4,7,8,8a-octahydro-4,7-
epoxyazulene-5,7-dicarboxylate (1-125). Rh2(OAc)4 (30 mg, 1 mol%) was added to a 
mixture of diazo compound 1-121 (1.0 g, 3.8 mmol) and allyl propiolate
183
 (1-124) (2 mL) in 
toluene (50 mL) at room temperature. Then the closed Schlenk tube was transferred to a 
preheated oil bath (100 ºC) and kept with stirring at this temperature for 15 min. The mixture 
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was allowed to cool to room temperature and filtered through a pad of Celite, using diethyl 
ether as a rinse. The filtrate was concentrated in vacuo to afford crude cycloadduct 1-125 
(1.32 g) as a yellowish oil, which was used in the next step without further purification. Rf = 
0.50 (petroleum ether/EtOAc, 4:1); [ ]
20
D = +74.4 (c 1.84, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 0.95 (d, J = 6.9 Hz, 3H, CHCH3), 1.31 (dd, J = 7.1, 7.1Hz, 3H, OCH2CH3), 
1.69 (s, 3H, OCCH3), 3.28 (dd, J = 11.7, 6.4 Hz, 8a-H), 1.27–1.42 (m, 2H, OCH2CH3), 4.67 
(dd, J = 5.8, 5.8 Hz, 2H, OCH2CH=CH2), 5.26 (dd, J = 10.4, 1.0 Hz, 1H, OCH2CH=CH2), 
5.33 (dd, J = 17.0, 1.3 Hz, 1H, OCH2CH=CH2), 5.92 (dddd, J = 16.8, 10.9, 5.8, 5.5 Hz, 1H, 
OCH2CH=CH2), 6.93 (s, 1H, 6-H); further protons could not be assigned. 
13
C NMR (100 
MHz, CDCl3): [ppm] = 14.1 (OCH2CH3), 17.7 (OCCH3), 18.8 (CHCH3), 27.0 (C-3), 29.0 
(C-2), 29.8 (C-1), 47.1 (C-3a), 57.0 (C-8a), 62.5 (OCH2CH3), 65.6 (OCH2CH=CH2), 87.2 (C-
4), 93.2 (C-7), 118.9 (OCH2CH=CH2), 131.4 (OCH2CH=CH2), 137.2 (C-6), 146.0 (C-5), 
162.0 (CO2Allyl), 164.3 (CO2Et), 201.4 (C=O); HRMS (ESI): [M+Na]
+
 calcd for C19H24O6Na 
371.14651, found 371.14627.  
 
 
(1R,3aR,4R,7R,8S,8aR)-5-Allyl 7-ethyl 8-hydroxy-1,4-dimethyl-1,2,3,3a,4,7,8,8a-
octahydro-4,7-epoxyazulene-5,7-dicarboxylate (1-126). Cerium (III) chloride heptahydrate 
(3.5 g, 9.5 mmol) was added to the solution of crude ketone 1-125 (1.1 g, 3.2 mmol) in 
methanol (20 mL) and the mixture stirred for 30 min at room temperature, before it was 
cooled to –78 °C and sodium borohydride (240 mg, 6.4 mmol) was added in portions. Stirring 
was continued for 2 h at the same temperature. The reaction was quenched by slow addition 
of water, and most of methanol was removed in vacuo. Diethyl ether (100 mL) and water (100 
mL) were added, the layers separated, and the aqueous layer was extracted with diethyl ether 
(4 × 50 mL). The combined organic layers were washed with saturated NaCl solution, dried 
over MgSO4, filtered, and concentrated in vacuo to give crude alcohol 1-126 (1.1 g) as a 
yellowish oil, which was used in the next step without further purification. Rf = 0.20 
(petroleum ether/EtOAc, 4:1); An analytical sample was obtained by flash chromatography 
(petroleum ether/EtOAc, 9:1). [ ]
20
D = +17.0 (c 2.38, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 0.95 (d, J = 7.1 Hz, 3H, CHCH3), 0.98–1.03 (m, 1H, 2-H), 1.23–1.34 (m, 1H, 3-H), 
1.31 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 1.56 (s, 1H, OCCH3), 1.72–1.78 (m, 1H, 3-H), 1.87 
(ddd, J = 12.1, 12.1, 6.5 Hz, 1H, 3a-H), 1.94–2.02 (m, 2H, 2-H, OH), 2.17 (ddd, J = 12.5, 7.4, 
4.6 Hz, 1H, 8a-H), 2.25 (app dddq, J = 7.4, 7.4, 2.9 Hz, 1H, 1-H), 4.28 (2 app dq, J = 14.2, 
7.1, 2H, OCH2CH3), 4.51 (dd, J = 4.7, 4.7 Hz, 1H, 9-H), 4.66 (dd, J = 13.3, 5.7 Hz, 2H, 
OCH2CH=CH2), 5.24 (dd, J = 10.4, 1.0 Hz, 1H, OCH2CH=CH2), 5.33 (dd, J = 17.0, 1.3 Hz, 
1H, OCH2CH=CH2), 5.93 (dddd, J = 16.8, 10.9, 5.8, 5.5 Hz, 1H, OCH2CH=CH2), 7.02 (s, 
1H, 6-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 14.2 (OCH2CH3), 19.1 (OCCH3), 20.1 
(CHCH3), 25.8 (C-3), 31.1 (C-2), 32.5 (C-1), 35.7 (C-3a), 47.8 (C-8a), 61.9 (OCH2CH3), 65.3 
(OCH2CH=CH2), 73.5 (C-8), 87.2 (C-4), 88.4 (C-7), 118.5 (OCH2CH=CH2), 131.7 
(OCH2CH=CH2), 141.9 (C-6), 144.6 (C-5), 162.6 (CO2Allyl), 170.2 (CO2Et); HRMS (ESI): 
[M+Na]
+
 calcd for C19H26O6Na 373.16216, found 373.16217. 
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(1R,3aR,4R,7R,8R,8aR)-5-Allyl 7-ethyl 1,4-dimethyl-8-((triethylsilyl)oxy)-
1,2,3,3a,4,7,8,8a-octahydro-4,7-epoxyazulene-5,7-dicarboxylate (1-127). 2,6-Lutidine (0.2 
mL, 1.7 mmol) was added dropwise to a solution of alcohol 1-126 (150 mg, 0.43 mmol) in 
CH2Cl2 (5 mL) at –78 °C. Then TES-triflate (0.2 mL, 0.8 mmol) was added at the same 
temperature. The mixture was allowed to warm to room temperature, filtered through a pad of 
silica gel, washed with 50% solution of ethyl acetate in petroleum ether, and concentrated in 
vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 25:1) to 
give TES-ether 1-127 (118 mg, 59% over 3 steps) as a colorless oil. Rf = 0.53 (petroleum 
ether/EtOAc, 9:1); [ ]
20
D = +28.2 (c 2.36, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.61 (ddd, J = 15.8, 7.6, 7.6 Hz, 6H, Si(CH2CH3)3), 0.88 (d, J = 6.9 Hz, 3H, CHCH3), 0.93 
(dd, J = 7.9, 7.9 Hz, 9H, Si(CH2CH3)3), 0.97–1.05 (m, 1H, 2-H), 1.24–1.33 (m, 1H, 3-H), 1.33 
(dd, J = 7.4, 7.4 Hz, 3H, OCH2CH3), 1.54 (s, 3H, OCCH3), 1.68–1.75 (m, 1H, 3-H), 1.87–
1.96 (m, 2H, H-2, 3a-H), 2.07 (ddd, J = 12.5, 6.4, 4.3 Hz, 1H, 8a-H), 2.15–2.25 (m, 1H, 1-H), 
4.28 (2 app dq, J = 10.9, 7.4 Hz, 2H, OCH2CH3), 4.60–4.75 (m, 3H, 8-H, OCH2CH=CH2), 
5.24 (dd, J = 10.4, 0.8 Hz, 1H, OCH2CH=CH2), 5.33 (dd, J = 17.3, 1.3 Hz, 1H, 
OCH2CH=CH2), 5.93 (dddd, J = 16.8, 10.9, 5.8, 5.5 Hz, 1H, OCH2CH=CH2), 6.98 (s, 1H, 6-
H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 4.8 (Si(CH2CH3)3), 6.8 (Si(CH2CH3)3), 14.2 
(OCH2CH3), 19.4 (OCCH3), 19.6 (CHCH3), 24.8 (C-3), 31.1 (C-2), 32.9 (C-1), 35.2 (C-3a), 
48.3 (C-8a), 61.9 (OCH2CH3), 65.0 (OCH2CH=CH2), 73.3 (C-8), 86.8 (C-4), 89.2 (C-7), 
118.0 (OCH2CH=CH2), 132.0 (OCH2CH=CH2), 142.8 (C-6), 143.1 (C-5), 162.8 (CO2Allyl), 
170.1 (CO2Et); HRMS (ESI): [M+Na]
+
 calcd for C25H40O6SiNa 487.24864, found 487.24857. 
 
 
(1R,3aR,4R,7R,8R,8aR)-7-(Ethoxycarbonyl)-1,4-dimethyl-8-((triethylsilyl)oxy)-
1,2,3,3a,4,7,8,8a-octahydro-4,7-epoxyazulene-5-carboxylic acid (1-135). RhCl(PPh3)3 (10 
mg) was added to a solution of allyl ester 1-127 (42 mg, 0.09 mmol) in a mixture of 
water/ethanol (2 mL, 1:10). Then the closed flask was transferred to a preheated (100 °C) oil 
bath. The mixture was stirred for 1 h at this temperature, cooled, and then the solvents were 
removed in vacuo. The residue was purified by flash chromatography (petroleum ether/diethyl 
ether/AcOH (glac.), 4:1:0.01) to give carboxylic acid 1-135 (32 mg, 84%) as a colorless oil. 
Rf = 0.2 (petroleum ether/diethyl ether/AcOH (glac.), 4:1:0.01); [ ]
20
D = +50.6 (c 3.48, 
CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.62 (ddd, J = 15.9, 7.8, 7.8 Hz, 6H, 
Si(CH2CH3)3), 0.90 (d, J = 7.1 Hz, 3H, CHCH3), 0.94 (dd, J = 8.1, 8.1 Hz, 9H, Si(CH2CH3)3), 
0.99–1.07 (m, 1H, 2-H), 1.26–1.37 (m, 1H, 3-H), 1.33 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 
1.55 (s, 3H, OCCH3), 1.68–1.76 (m, 1H, 3-H), 1.88–1.96 (m, 2H, 3a-H, 2-H), 2.09 (ddd, J = 
12.4, 6.4, 4.4 Hz, 1H, 8a-H), 2.17–2.26 (m, 1H, 1-H), 4.29 (2 app dq, J = 10.9, 7.4 Hz, 2H, 
108  Experimental Section 
OCH2CH3), 4.67 (d, J = 4.3 Hz, 1H, 8-H), 7.14 (s, 1H, 6-H); 
13
C NMR (100 MHz, CDCl3): 
[ppm] = 4.8 (Si(CH2CH3)3), 6.9 (Si(CH2CH3)3), 14.1 (OCH2CH3), 19.4 (OCCH3), 19.6 
(CHCH3), 24.8 (C-3), 31.0 (C-2), 32.9 (C-1), 35.2 (C-3a), 48.4 (C-8a), 61.9 (OCH2CH3), 73.4 
(C-8), 86.7 (C-4), 89.2 (C-7), 142.8 (C-5), 145.7 (C-6), 168.2 (CO2Et), 169.9 (CO2H); HRMS 
(ESI): [M+Na]
+
 calcd for C22H36O6SiNa 447.21734, found 447.21730. 
 
 
(1R,3aR,4R,7R,8R,8aR)-Ethyl 5-(azidocarbonyl)-1,4-dimethyl-8-((triethylsilyl)oxy)-
1,2,3,3a,4,7,8,8a-octahydro-4,7-epoxyazulene-7-carboxylate (1-136). Trichloroacetonitrile 
(0.03 mL, 0.33 mmol) was added dropwise to a stirred solution of carboxylic acid 1-135 (70 
mg, 0.16 mmol), sodium azide (16 mg, 0.25 mmol), PPh3 (86 mg, 0.33 mmol) in acetone (2 
mL) at room temperature. After 30 min the solvent was removed by a flow of nitrogen and the 
residue was purified by flash chromatography (petroleum ether/EtOAc, 25:1) to give azide 1-
136 (66 mg, 90%) as a colorless oil. Rf = 0.37 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +40.1 (c 
1.63, MeOH); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.61 (ddd, J = 15.9, 7.8, 7.8 Hz, 6H, 
Si(CH2CH3)3), 0.88 (d, J = 7.1 Hz, 3H, CHCH3), 0.94 (dd, J = 8.1, 8.1 Hz, 9H, Si(CH2CH3)3), 
0.97–1.05 (m, 1H, 2-H), 1.25–1.37 (m, 1H, 3-H), 1.32 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 
1.54 (s, 3H, OCCH3), 1.68–1.76 (m, 1H, 3-H), 1.81–1.95 (m, 2H, 3a-H, 2-H), 2.06 (ddd, J = 
12.4, 6.4, 4.4 Hz, 1H, 8a-H), 2.15–2.25 (m, 1H, 1-H), 4.28 (2 app dq, J = 10.9, 7.4 Hz, 2H, 
OCH2CH3), 4.66 (d, J = 4.3 Hz, 1H, 8-H), 7.06 (s, 1H, 6-H); 
13
C NMR (100 MHz, CDCl3) 
[ppm] = 4.8 (Si(CH2CH3)3), 6.8 (Si(CH2CH3)3), 14.1 (OCH2CH3), 19.2 (OCCH3), 19.5 
(CHCH3), 24.7 (C-3), 31.0 (C-2), 32.9 (C-1), 35.2 (C-3a), 48.3 (C-8a), 62.0 (OCH2CH3), 73.4 
(C-8), 86.9 (C-4), 89.2 (C-7), 144.4 (C-5), 145.8 (C-6), 168.4 (CO2Et), 169.7 (CON3); HRMS 
(ESI): [M+Na]
+
 calcd for C22H35N3O5SiNa 472.22382, found 472.22384. 
 
 
(1R,3aR,4R,7R,8R,8aR)-Ethyl 1,4-dimethyl-5-oxo-8-((triethylsilyl)oxy)decahydro-4,7-
epoxyazulene-7-carboxylate (1-137). Azide 1-136 (66 mg, 0.15 mmol) was dissolved in 
toluene (2 mL) and stirred for 1 h at 100 °C. Then the solvent was removed in vacuo, the 
residue was dissolved in THF (2 mL) followed by the addition of 5% HCl (0.5 mL) and THF 
(0.5 mL). Stirring was continued for 15 min, then the reaction was quenched with 
triethylamine (0.5 mL) and the solvents were evaporated in vacuo. The residue was purified 
by flash chromatography (petroleum ether/EtOAc, 25:1) to give ketone 1-137 (48 mg, 83%) 
as a colorless oil. Rf = 0.53 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +0.5 (c 0.98, CH2Cl2); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 0.60 (dddd, J = 16.8, 9.9, 8.4, 1.8 Hz, 6H, Si(CH2CH3)3), 
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0.92 (d, J = 9.4 Hz, 3H, CHCH3), 0.93 (dd, J = 8.1, 8.1 Hz, 9H, Si(CH2CH3)3), 1.13–1.21 (m, 
1H, 2-H), 1.26 (s, 3H, OCCH3), 1.32 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 1.40 (ddd, J = 
10.9, 7.2, 1.3 Hz, 1H, 3-H), 1.60–1.68 (m, 1H, 3-H), 1.85 (ddd, J = 13.2, 10.7, 7.4 Hz, 1H, 3a-
H), 1.92–2.02 (m, 2H, 2-H, 8a-H), 2.22–2.31 (m, 1H, 1-H), 2.60 (d, J = 18.1 Hz, 1H, 6-H), 
3.10 (d, J = 18.1 Hz, 1H, 6-H), 4.28 (2 app dq, J = 10.8, 7.1 Hz, 2H, OCH2CH3), 4,73 (d, J = 
4.1 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 4.8 (Si(CH2CH3)3), 6.9 
(Si(CH2CH3)3), 14.1 (OCH2CH3), 16.5 (OCCH3), 19.2 (CHCH3), 24.0 (C-3), 32.4 (C-1), 32.6 
(C-2), 36.4 (C-3a), 38.8 (C-6), 45.2 (C-8a), 62.0 (OCH2CH3), 71.2 (C-8), 83.0 (C-4), 84.2 (C-
7), 171.4 (CO2Et), 214.6 (C=O); HRMS (ESI): [M+Na]
+
 calcd for C21H36O5SiNa 419.22242, 
found 419.22238. 
 
 
(1R,3aR,4R,5R,7R,8R,8aR)-Ethyl 5-hydroxy-1,4-dimethyl-8-((triethylsilyl)oxy)deca-
hydro-4,7-epoxyazulene-7-carboxylate (1-138). Sodium borohydride (21 mg, 0.55 mmol) 
was added in portions to a stirred solution of ketone 1-137 (150 mg, 0.38 mmol) in 
methanol/THF (6.6 mL, 1:10) at –10 °C. The mixture was allowed to warm to room 
temperature, and then carefully treated with water (5 mL). Most of the organic solvents were 
evaporated in vacuo, the residue was diluted with water (10 mL), and the mixture extracted 
with ethyl acetate (3 × 10 mL). The combined organic layers were dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 4:1) to give alcohol 1-138 (150 mg, 85%) as a colorless oil. Rf = 0.37 
(petroleum ether/EtOAc, 4:1); [ ]
20
D = +5.8 (c 2.46, CH2Cl2); 
1
H NMR (400 MHz, DMSO): 
[ppm] = 0.48–0.55 (m, 6H, Si(CH2CH3)3), 0.88 (dd, J = 8.1, 8.1 Hz, 9H, Si(CH2CH3)3), 0.96 
(d, J = 6.8 Hz, 3H, CHCH3), 1.09 (s, 3H, OCCH3), 1.10–1.35 (m, 2H, 2-H, 3-H), 1.21 (dd, J = 
7.1, 7.1 Hz, 3H, OCH2CH3), 1.47 (dddd, J = 12.4, 8.3, 8.3, 4.3 Hz, 1H, 3-H), 1.71 (ddd, J = 
13.8, 6.2, 6.1, 1H, 8a-H), 1.87–1.96 (m, 1H, 2-H), 2.14 (dd, J = 13.3, 8.0 Hz, 1H, 6-H), 2.19–
2.35 (m, 3H, 1-H, 3a-H, 6-H), 3.60 (ddd, J = 8.6, 8.6, 4.3 Hz, 1H, 5-H), 4.10 (2 app dq, J = 
10.9, 7.1 Hz, 2H, OCH2CH3), 4.63 (d, J = 6.1 Hz, 1H, 8-H), 5.20 (d, J = 4.3 Hz, 1H, OH); 
13
C 
NMR (100 MHz, CDCl3): [ppm] = 4.3 (SiCH2CH3), 6.7 (SiCH2CH3), 13.9 (OCH2CH3), 18.8 
(CHCH3), 19.9 (OCCH3), 23.8 (C-3), 32.0 (C-1), 32.7 (C-3a), 32.8 (C-6), 33.6 (C-2), 44.2 (C-
8a), 61.0 (OCH2CH3), 70.8 (C-8), 76.8 (C-5), 82.5 (C-4), 83.3 (C-7), 171.8 (CO2Et); HRMS 
(ESI): [M+Na]
+
 calcd for C21H38O5SiNa 421.23807, found 421.23845. 
 
 
(1R,3aR,4R,5R,7R,8R,8aR)-Ethyl 1,4-dimethyl-5,8-bis((triethylsilyl)oxy)decahydro-4,7-
epoxyazulene-7-carboxylate (1-139). 2,6-Lutidine (0.13 mL, 1.15 mmol) was added 
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dropwise to a solution of alcohol 1-138 (150 mg, 0.38 mmol) in CH2Cl2 (10 mL) at –78 °C. 
Then TES-triflate (0.13 mL, 0.58 mmol) was added at the same temperature. The mixture was 
allowed to warm to room temperature (ca 3 h), filtered through a pad of silica gel, the filter 
cake was washed with mixture of petroleum ether/EtOAc (1:1), and the filtrates concentrated 
in vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 25:1) to 
afford TES-ether 1-139 (159 mg, 82% over 2 steps). Rf = 0.55 (petroleum ether/EtOAc, 9:1); 
[ ]
20
D = +2.0 (c 6.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.51–0.61 (m, 12H, 
(Si(CH2CH3)3)2), 0.92 (dd, J = 7.9, 7.9 Hz, 9H, (Si(CH2CH3)3), 0.95 (dd, J = 8.1, 8.1 Hz, 9H, 
(Si(CH2CH3)3), 1.00 (d, J = 7.1 Hz, 3H, CHCH3), 1.18–1.26 (m, 1H, 2-H), 1.20 (s, 3H, 
OCCH3), 1.30 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 1.30–1.39 (m, 1H, 3-H), 1.53 (dddd, J = 
16.9, 8.8, 8.5, 4.7 Hz, 1H, 3-H), 1.81 (ddd, J = 14.0, 6.1, 6.1 Hz, 1H, 8a-H), 1.87–1.96 (m, 
1H, 2-H), 2.22–2.51 (m, 4H, 1-H, 3a-H, 6-H, 6-H), 3.77 (dd, J = 9.3, 7.5 Hz, 1H, 5-H), 4.21 
(2 app dq, J = 10.8, 7.1 Hz, 2H, OCH2CH3), 4.66 (d, J = 5.8 Hz, 1H, 8-H); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 4.8 (SiCH2CH3), 4.9 (SiCH2CH3), 6.7 (SiCH2CH3), 6.8 (SiCH2CH3), 
14.1 (OCH2CH3), 18.7 (CHCH3), 20.2 (OCCH3), 24.2 (C-3), 32.7 (C-1), 33.2 (C-3a), 34.1 (C-
6), 44.6 (C-2), 61.5 (OCH2CH3), 71.6 (C-8), 78.1 (C-5), 83.2 (C-4), 84.4 (C-7), 172.7 
(CO2Et); HRMS (ESI): [M+Na]
+
 calcd for C27H52O5Si2Na 535.32455, found 535.325022. 
 
 
2-((1R,3aR,4R,5R,7R,8R,8aR)-1,4-Dimethyl-5,8-bis((triethylsilyl)oxy)decahydro-4,7-
epoxyazulen-7-yl)propan-2-ol (1-140). Freshly prepared methylmagnesium iodide (0.12 mL, 
1M solution in diethyl ether, 0.12 mmol) was added dropwise to a stirred solution of ester 1-
139 (10 mg, 0.019 mmol) in THF (1 mL) at 0 °C. The reaction mixture was allowed to warm 
to room temperature and treated with saturated NH4Cl (0.5 mL), diluted with water (2 mL) 
and extracted with diethyl ether (3 × 5 mL). The combined organic layers were washed with 
saturated NaCl solution (2 × 10 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (petroleum ether/EtOAc, 25:1) to give 
tertiary alcohol 1-140 (9.7 mg, 100%) as a colorless oil. Rf = 0.48 (petroleum ether/EtOAc, 
9:1); [ ]
20
D = +3.4 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.57 (ddd, J = 
16.7, 8.6, 1.3 Hz, 6H, Si(CH2CH3)3), 0.65 (ddd, J = 15.9, 7.9, 2.3 Hz, 6H, Si(CH2CH3)3), 0.94 
(dd, J = 7.8, 7.8 Hz, 9H, Si(CH2CH3)3), 0.96 (dd, J = 8.1, 8.1 Hz, 9H, Si(CH2CH3)3), 1.00 (d, 
J = 7.1 Hz, 3H, CHCH3), 1.14 (s, 3H, OCCH3), 1.16 (s, 3H, C(CH3)2), 1.18 (s, 3H, C(CH3)2), 
1.22–1.28 (m, 1H, 2-H), 1.35 (dddd, J = 12.2, 10.3, 10.3, 6.2 Hz, 1H, 3-H), 1.49–1.58 (m, 1H, 
3-H), 1.69 (ddd, J = 13.6, 6.4, 4.7 Hz, 1H, 8a-H), 1.88 (dddd, J = 12.1, 10.5, 7.1, 4.9 Hz, 1H, 
2-H), 1.98 (dd, J = 13.0, 9.7 Hz, 1H, 6-H), 2.15–2.24 (m, 2H, 1-H, 6-H), 2.55 (ddd, J = 13.6, 
10.0, 9.0 Hz, 1H, 3a-H), 3.66 (dd, J = 9.6, 6.6 Hz, 1H, 5-H), 4.45 (d, J = 4.6 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 4.9 (SiCH2CH3), 5.9 (SiCH2CH3), 6.8 (SiCH2CH3), 
7.2 (SiCH2CH3), 18.6 (CHCH3), 21.2 (OCCH3), 24.0 (C-3), 24.8 (C(CH3)2), 24.8 (C(CH3)2), 
32.6 (C-1), 32.7 (C-6), 33.1 (C-3a), 34.9 (C-2), 45.9 (C-8a), 71.0 (C-8), 73.3 (C(CH3)2), 79.6 
(C-5), 81.4 (C-4), 89.1 (C-7); HRMS (ESI): [M+Na]
+
 calcd for C27H54O4Si2Na 521.34528, 
found 521.345436. 
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(((1R,3aR,4R,5R,7S,8R,8aR)-1,4-Dimethyl-7-(prop-1-en-2-yl)decahydro-4,7-
epoxyazulene-5,8-diyl)bis(oxy))bis(triethylsilane) (1-141). Burgess reagent (10 mg, 0.040 
mmol) was added to a stirred solution of alcohol 1-140 (5 mg, 0.010 mmol) in toluene (1 mL) 
and the mixture stirred at 110 °C for 5 min. Then the solvent was evaporated and the residue 
purified by flash chromatography (petroleum ether/EtOAc, 30:1) to afford the tittled alkene 1-
141 (3.4 mg, 71%) as a colorless oil. Rf = 0.31 (petroleum ether/EtOAc, 33:1); [ ]
20
D = +4.8 
(c 0.31, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.50–0.60 (m, 12H, 
(Si(CH2CH3)3)2), 0.92 (dd, J = 7.8, 7.8 Hz, 9H, Si(CH2CH3)3), 0.95 (dd, J = 8.1, 8.1 Hz, 9H, 
Si(CH2CH3)3), 1.00 (d, J = 6.8 Hz, 3H, CHCH3), 1.16 (s, 3H, OCCH3), 1.21–1.27 (m, 1H, 2-
H), 1.30–1.39 (m, 1H, 3-H), 1.49–1.58 (m, 1H, 3-H), 1.73 (ddd, J = 14.0, 5.9, 5.8 Hz, 1H, 8a-
H), 1.77 (s, 3H, CH2=CCH3), 1.84–1.93 (m, 1H, 2-H), 2.04 (dd, J = 13.0, 9.2 Hz, 1H, 6-H), 
2.19–2.24 (m, 1H, 1-H), 2.29 (dd, J = 13.1, 7.3 Hz, 1H, 6-H), 2.49 (ddd, J = 14.0, 10.1, 8.7 
Hz, 1H, 3a-H), 3.68 (dd, J = 9.3, 7.3 Hz, 1H, 5-H), 4.25 (d, J = 6.1 Hz, 1H, 8-H), 4.88 (dd, J = 
1.4, 1.4 Hz, 1H, C=CH2), 4.91 (br.s, 1H, C=CH2); 
13
C NMR (100 MHz, CDCl3): [ppm] = 5.0 
(SiCH2CH3), 5.4 (SiCH2CH3), 6.8 (SiCH2CH3), 7.0 (SiCH2CH3), 18.4 (CH3C=CH2), 18.6 
(CHCH3), 20.7 (OCCH3), 23.9 (C-3), 32.8 (C-3a), 32.9 (C-1), 34.0 (C-2), 35.0 (C-6), 45.7 (C-
8a), 72.4 (C-8), 78.7 (C-5), 80.9 (C-4), 85.9 (C-7), 112.1 (CH3C=CH2), 147.0 (CH3C=CH2); 
HRMS (ESI): [M+Na]
+
 calcd for C27H52O3Si2Na 503.33472, found 503.33510. 
 
 
(((1R,3aR,4R,5R,7S,8R,8aR)-1,4-Dimethyl-7-(prop-2-yl)decahydro-4,7-epoxyazulene-5,8-
diyl)bis(oxy))bis(triethylsilane) (1-143). A 5 mL round-bottom flask was charged with 
alkene 1-141 (3.40 mg, 0.007 mmol) and a stirring bar. Ethyl acetate (1 mL) and Pd/C 10% 
(4.00 mg) were added with stirring. The reaction was placed under H2 atmosphere and stirred 
for 2 h at room temperature. The reaction mixture was filtered through a pad of celite and the 
filtrate was concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 100:1) to afford the title compound 1-143 (2.5 mg, 72%) as a 
colorless oil. Rf = 0.60 (petroleum ether/ EtOAc, 60:1); [ ]
20
D = +2.7 (c 0.55, CH2Cl2); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 0.52–0.64 (m, 12H, (Si(CH2CH3)3)2), 0.92–1.01 (m, 27H, 
(Si(CH2CH3)3)2, (CHCH3)3, 1.12 (s, 3H, OCCH3), 1.17–1.35 (m, 2H, 2-H, 3-H), 1.47–1.52 
(m, 1H, 3-H), 1.60–1.74 (m, 3H, 8a-H, 6-H CH(CH3)2), 1.85–1.94 (m, 1H, 2-H), 2.17–2.24 
(m, 2H, 6-H, 1-H), 2.40 (ddd, J = 13.8, 10.4, 8.6 Hz, 1H, 3a-H), 3.52 (dd, J = 8.6, 8.6 Hz, 1H, 
5-H), 4.36 (d, J = 6.1 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 5.0 (SiCH2CH3), 
5.3 (SiCH2CH3), 6.8 (SiCH2CH3), 7.0 (SiCH2CH3), 16.6 (CH(CH3)2), 16.8 (CH(CH3)2), 18.9 
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(CHCH3), 20.4 (OCCH3), 24.0 (CH(CH3)2), 31.6 (C-3), 32.6 (C-3a), 33.6 (C-1), 34.1 (C-2), 
34.7 (C-6), 46.0 (C-8a), 71.3 (C-8), 78.9 (C-5), 80.6 (C-4), 85.4 (C-7); HRMS (ESI): 
[M+Na]
+
 calcd for C27H54O3SiNa 505.35037, found 505.35007. 
 
 
(1R,3aR,4R,5R,7S,8R,8aR)-1,4-Dimethyl-7-(prop-1-en-2-yl)decahydro-4,7-epoxyazulene-
5,8-diol (1-142). TBAF × 3H2O (38.5 mg, 0.120 mmol) was added in one portion to a stirred 
solution of silyl ether 1-141 (6.9 mg, 0.012 mmol) in anhydrous THF (1 mL) at 0 °C. Then 
the cooling bath was removed and the mixture stirred overnight at room temperature. The 
solvent was evaporated in vacuo and the residue purified by flash chromatography (petroleum 
ether/EtOAc, 2:1) to give alcohol 1-142 (2.0 mg, 65%) as white crystals. Rf = 0.32 (petroleum 
ether/EtOAc, 2:1); [ ]
20
D = +2.5 (c 0.2, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.08 
(d, J = 7.3 Hz, 3H, CHCH3), 1.19–1.27 (m, 1H, 2-H), 1.27 (s, 3H, OCCH3), 1.36 (dddd, J = 
11.6, 11.6, 9.2, 9.1 Hz, 1H, 3-H), 1.58–1.65 (m, 1H, 3-H), 1.75 (dd, J = 1.4, 0.9 Hz, 3H, 
CH3C=CH2), 1.86 (ddd, J = 13.6, 8.0, 4.2 Hz, 1H, 8a-H), 1.97 (dd, J = 13.4, 9.6 Hz, 1H, 6-H), 
2.07–2.15 (m, 1H, 2-H), 2.24–2.37 (m, 3H, 1-H, 3a-H, 6-H), 3.91 (dd, J = 9.6, 4.8 Hz, 1H, 5-
H), 4.17 (d, J = 4.3 Hz, 1H, 8-H), 4.70 (ddd, J = 3.2, 1.5, 1.4 Hz, 1H, CH3C=CH2), 4.93 (dd, J 
= 1.9, 0.9 Hz, 1H, CH3C=CH2); 
13
C NMR (100 MHz, CDCl3): [ppm] = 18.5 (CH3C=CH2), 
20.4 (CHCH3), 21.5 (OCCH3), 26.0 (C-3), 31.4 (C-3a), 33.8 (C-1), 34.4 (C-2), 38.4 (C-6), 
44.8 (C-8a), 73.8 (C-8), 78.9 (C-5), 81.7 (C-4), 86.0 (C-7), 107.9 (CH3C=CH2), 148.4 
(CH3C=CH2); HRMS (ESI): [M+Na]
+
 calcd for C15H24O3Na 275.16177, found 275.16169. 
 
 
2-Methyl-1-(5-methylfuran-2-yl)propan-1-ol (1-148). Preparation of isopropylmagnesium 
bromide. A solution of isopropyl bromide (35.7 mL, 0.38 mol) in THF (200 mL) was added 
dropwise to a stirred mixture of Mg (9.7 g, 0.40 mmol) in THF (40 mL) maintaining a 
temperature 45 °C. The resulting mixture was stirred for 1 h at the same temperature. The 
concentration was found to be 1.7M in THF by titration of a THF solution of menthol in 
presence of 1,10-phenantroline.  
General procedure for the titration of Grignard reagents. A Grignard reagent solution was 
added dropwise to a stirred solution of menthol (312 mg, 2.00 mmol) and 1,10-phenantroline 
(4 mg, 0.02 mmol) in THF (15 mL) at room temperature until a distinct violet color persisted 
for longer than one minute. C[RMgX] in M = mmol of menthol/volume of RMgX in mL.
184
 
Grignard reaction. Isopropylmagnesium bromide (200 mL, 0.35 mol) was added dropwise to 
a stirred solution of 5-methylfurfural (1-147) (15.0 g, 0.14 mol) in THF (200 mL) at –78 °C. 
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The resulting mixture was allowed to warm to room temperature, then again cooled to –78 °C 
and treated with saturated NH4Cl solution (50 mL), diluted with water (200 mL), and 
extracted with diethyl ether (3 × 100 mL). The combined organic layers were washed with 
saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 9:1) to give alcohol 1-
148 (17.0 g, 81%) as a colorless oil. Rf = 0.60 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 0.82 (d, J = 6.9 Hz, 3H, iPr), 0.99 (d, J = 6.6 Hz, 3H, iPr), 2.02–2.10 
(m, 2H, OH, iPr), 2.24 (s, 3H, CCH3), 4.24 (dd, J = 6.9, 1.8 Hz, 1H, CHOH), 5.85–5.87 (m, 
1H, 3-H), 6.05 (d, J = 3.0 Hz, 1H, 4-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 13.4 (5-
CH3), 18.3 (iPr), 18.8 (iPr), 33.1 (iPr), 73.5 (CHOH), 105.8 (C-4), 107.2 (C-3), 151.2 (C-5), 
154.3 (C-2); HRMS (ESI): [M+Na]
+
 calcd for C9H14O2Na 177.08860, found 177.088595. 
 
 
6-Hydroxy-2-isopropyl-6-methyl-2H-pyran-3(6H)-one (1-149).
70
 An aqueous solution of 
H2O2 (30%, 5 mL, 38 mmol) was added dropwise to a stirred solution of alcohol 1-148 (3.0 g, 
19 mmol) and pTSA (1.4 g, 7.6 mmol) in dimethoxyethane (190 mL) at room temperature. 
The resulting mixture was stirred overnight before it was treated with Me2S (5.5 mL, 76 
mmol), stirred for additional 1 h, diluted with diethyl ether (100 mL), washed with saturated 
NaCl solution (3 × 100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 9:1) to give 
hydroxypyranone 1-149 (2.0 g, 62%) as a colorless oil. Rf = 0.25 (petroleum ether/EtOAc, 
4:1); 
1
H NMR (400 MHz, CDCl3):
185
 [ppm] = 0.84 (d, J = 6.9, 3H, iPr), 1.02 (d, J = 7.1 Hz, 
3H, iPr), 1.62 (s, 3H, CCH3), 2.38–2.44 (m, 1H, iPr), 2.61 (s, 1H, OH), 4.34 (d, J = 2.8 Hz, 
1H, 2-H), 6.00 (d, J = 10.2 Hz, 1H, 4-H), 6.80 (d, J = 10.2 Hz, 1H, 5-H); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 16.0 (iPr), 19.0 (iPr), 28.6 (iPr), 28.8 (6-CH3), 78.3 (C-2), 92.6 (C-
6), 127.1 (C-4), 147.8 (C-5), 196.9 (C-6); HRMS (ESI): [M+Na]
+
 calcd for C9H14O3Na 
193.08352, found 193.083436. 
 
 
(Z)-2-Methyl-4,7-dioxooct-5-en-3-yl acetate (1-150). Acetyl chloride (0.28 mL, 3.9 mmol) 
was added dropwise to a stirred solution of hydroxypyranone 1-149 (330 mg, 2.0 mmol), 
DMAP (50 mg, 0.4 mmol) and pyridine (0.5 mL) in CH2Cl2 (2.5 mL) at –10 °C. The resulting 
mixture was allowed to warm to room temperature and stirred for 2 h before it was treated 
with water (10 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were washed with 1M HCl solution (2 × 30 mL), saturated NaCl solution (2 × 30 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
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chromatography (petroleum ether/EtOAc, 9:1) to give acetate 1-150 (350 mg, 82%) as a 
colorless oil. Rf = 0.27 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.89 (d, J = 6.8, 3H, iPr), 0.97 (d, J = 6.8 Hz, 3H, iPr), 2.11 (s, 3H, acetate), 2.18–2.23 (m, 
1H, iPr) 2.32 (s, 3H, 7-CH3), 4.96 (d, J = 5.0 Hz, 1H, 3-H), 6.94 (br s, 2H, 5-H, 6-H); 
13
C 
NMR (100 MHz, CDCl3): [ppm] = 16.9 (iPr), 18.9 (iPr), 20.4 (CH3COO), 28.8 (iPr), 29.4 
(C-8), 82.1 (C-3), 132.7 (C-5), 137.6 (C-6), 170.6 (CH3COO), 196.4 (C-4), 197.5 (C-7); 
HRMS (ESI): [M+Na]
+
 calcd for C11H16O4Na 235.23211, found 235.23203. 
 
 
(1S,5S)-Allyl 1-isopropyl-5-methyl-2-oxo-8-oxabicyclo[3.2.1]octa-3,6-diene-6-carboxylate 
(1-155). Allyl propiolate (1-124) (320 mg, 2.9 mmol), acetic anhydride (0.22 mL, 2.36 
mmol), hydroxypyranone 1-149 (100 mg, 0.59 mmol) and one drop of glacial acid were 
dissolved in toluene (5 mL). The mixture was stirred for 10 h at 110 °C in a closed Schlenk 
tube before the solvent was removed under reduced pressure. The residue was purified by 
flash chromatography (petroleum ether/EtOAc, 15:1) to give enone 1-155 (30 mg, 20%) as a 
colorless oil. Rf = 0.78 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.96 (d, J = 6.9, 3H, iPr), 0.97 (d, J = 7.1 Hz, 3H, iPr), 1.71 (s, 3H, 5-CH3), 2.50 (ddd, J = 
13.7, 6.9, 6.9 Hz, 1H, iPr), 4.61–4.71 (m, 2H, CH2CH=CH2), 5.25–5.35 (m, 2H, 
CH2CH=CH2), 5.49 (d, J = 9.9 Hz, 1H, 3-H), 5.88–5.97 (m, 1H, CH2CH=CH2), 6.93 (s, 1H, 
7-H), 7.25 (d, J = 9.7 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): [ppm] = 16.4 (C-5), 16.9 
(iPr), 20.2 (iPr), 28.5 (iPr), 65.6 (CH2CH=CH2), 84.7 (C-1), 97.6 (C-5), 118.9 (CH2CH=CH2), 
122.9 (C-3), 131.6 (CH2CH=CH2), 144.0 (C-7), 147.8 (C-6), 154.5 (C-4), 162.5 (ester), 194.3 
(C-2); HRMS (ESI): [M+Na]
+
 calcd for C15H18O4Na 285.29079, found 285.29081. 
 
 
1-Methoxycyclohexa-1,4-diene (1-162).
73
 A 1-liter, three-necked flask, equipped with an 
inlet tube and mechanic stirrer was charged with anisol (1-161) (15.0 g, 0.17 mol), THF (45 
mL), tert-butanol (75 mL) and liquid ammonia (ca. 500 mL). The resulting mixture was 
carefully treated with lithium (5.0 g, 0.71 mol) in small portions at –78 °C. When the addition 
was complete, the mixture was allowed to warm to room temperature and stirred overnight 
before it was carefully treated with methanol (45 mL) and water (250 mL) and extracted with 
diethyl ether (3 × 100 mL). The combined organic layers were washed with water (2 × 100 
mL) saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo 
(40 °C, 800 mbar). The residue was distilled at low pressure (b.p. 45–50 °C, 26 mbar) to give 
diene 1-162 as a colorless oil (11.6 g, 76%). 
1
H NMR (400 MHz, CDCl3): [ppm] = 2.47–
2.56 (m, 2H, 2 × 5-H), 2.81–2.93 (m, 2H, 2 × 2H), 3.46 (s, 3H, OCH3), 4.52 (m, 1H, 6-H), 
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5.67 (m, 2H, 3-H, 4-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 26.3 (C-5), 28.4 (C-2), 53.6 
(OCH3), 90.5 (C-6), 123.1 (C-4), 124.5 (C-3), 152.8 (C-1). 
 
 
Cyclohex-3-enone (1-163).
74
 Perchloric acid (60%, 5 drops) was added to a stirred 
suspension of diene 1-162 (22.5 g, 0.21 mol) in CCl4 (55 mL) and water (140 mL). The two 
phase system was stirred vigorously for 20 h at room temperature, before the organic layer 
was separated. The aqueous phase was extracted with CH2Cl2 (2 × 100 mL). The combined 
organic layers were washed with saturated NaCl solution (100 mL), dried over MgSO4, 
filtered, and concentrated in vacuo (30 °C, 600 mbar) to afford enone 1-163 (20.1 g, 99%) as 
a colorless oil, which was used in the next step without further purification. 
 
 
4-Hydroxycyclohex-2-enone (1-160).
76
 A solution of mCPBA (70%, 34.3 g, 0.140 mol) in 
CH2Cl2 (200 mL) was added dropwise to a stirred solution of enone 1-163 (12.2 g, 0.127 mol) 
in CH2Cl2 (200 mL). The resulting mixture was stirred for 15 h at room temperature before it 
was filtered and treated with Na2S2O3 solution (10%, 250 mL). After additional stirring for 1 
h, the organic phase was separated and washed with saturated NaHCO3 solution (200 mL), 
water (100 mL), saturated NaCl solution (100 mL), dried over MgSO4 and concentrated in 
vacuo. 
The residue was dissolved in CH2Cl2/diethyl ether mixture (1:1, 250 mL) and stirred for 1 h 
with basic alumina (17 g). The resulting mixture was filtered from alumina, solvents were 
removed under reduced pressure. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 1:2) to give allylic alcohol 1-160 (6.5 g, 46%) as a colorless oil. Rf = 
0.40 (petroleum ether/EtOAc, 1:2). 
1
H NMR (400 MHz, CDCl3): [ppm] = 2.04 (ddd, J = 
12.5, 9.1, 4.2 Hz, 1H, 5-H), 2.32–2.44 (m, 2H, 5-H, 6-H), 2.57 (ddd, J = 15.9, 4.2, 1.0 Hz, 1H, 
6-H), 4.51 (dddd, J = 9.1, 4.3, 2.0, 1.7 Hz, 1H, 4-H), 5.95 (ddd, J = 10.3, 2.2, 1.0 Hz, 1H, 2-
H), 6.91 (ddd, J = 10.4, 2.2, 1.3 Hz, 1H, 3-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 32.5 
(C-5), 35.9 (C-6), 69.3 (C-4), 129.1 (C-2), 154.5 (C-3), 199.5 (C-1). 
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4-((tert-Butyldimethylsilyl)oxy)cyclohex-2-enone (1-164).
76
 DBU (9.5 mL, 64 mmol) was 
added dropwise to a stirred solution of allylic alcohol 1-160 (6.5 g, 58 mmol) and TBSCl (9.2 
g, 61 mmol) in benzene (120 mL). The resulting solution was stirred for 2 h at room 
temperature before it was diluted with diethyl ether (200 mL), washed with water (100 mL), 
0.1M HCl solution (2 × 100 mL), saturated NaHCO3 solution (100 mL), water (100 mL) and 
saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 15:1) to give allylic 
alcohol 1-164 (11.5 g, 88%) as a colorless oil. Rf = 0.95 (petroleum ether/EtOAc, 1:2); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 0.11 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3), 0.93 (s, 9H, 
SiC(CH3)3), 2.01 (ddd, J = 12.8, 4.2, 1.9 Hz, 1H, 5-H), 2.20 (ddd, J = 12.8, 4.2, 1.9 Hz, 1H, 5-
H), 2.34 (ddd, J = 15.9, 12.8, 4.2, 1H, 6-H), 2.62 (ddd, J = 15.9, 4.2, 1.0 Hz, 1H, 6-H), 4.51 
(dddd, J = 9.3, 4.2, 2.2, 2.1 Hz, 1H, 4-H), 5.91 (ddd, J = 10.3, 2.2, 1.0 Hz, 1H, 2-H), 6.82 
(ddd, J = 10.4, 2.2, 1.3 Hz, 1H, 3-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –4.8 (SiCH3), –
4.3 (SiCH3), 18.0 (SiC(CH3)3), 25.7 (SiC(CH3)3), 32.1 (C-5), 35.4 (C-6), 66.9 (C-4), 128.6 
(C-2), 153.8 (C-3), 198.8 (C-1). 
 
 
(((3S,4S)-3-(But-3-en-1-yl)-4-((tert-butyldimethylsilyl)oxy)cyclohex-1-en-1-
yl)oxy)trimethylsilane (1-165).
71
 A solution of CuBr·SMe2 (1.0 g, 0.005 mol) in HMPA (21 
mL) was added to a THF solution (80 mL) of 3-butenylmagnesium bromide, prepared from 3-
butenyl bromide (10.5 g, 0.077 mol) and magnesium (2.1 g, 0.085 mol), over 5 min at –78 °C. 
The mixture was stirred for additional 30 min at –78 °C and a THF solution (50 mL) of enone 
1-164 (11.5 g, 0.051 mol) and TMSCl (10.9 g, 0.100 mol) was added dropwise over 30 min at 
–78 °C. The mixture was stirred for 1 h before it was treated with triethylamine (6.4 mL), 
followed by addition of hexane (100 mL) and pH 7 phosphate buffer solution (100 mL). The 
resulting mixture was filtered through a celite pad and the filtrate was extracted with diethyl 
ether (100 mL). The organic layer was separated and washed with water (2 × 100 mL) and 
saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 30:1, + 0.5% Et3N) to 
give silyl enol ether 1-165 (15.1 g, 88%) as a colorless oil. Rf = 0.45 (petroleum ether/EtOAc, 
30:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.06 (s, 6H, Si(CH3)2), 0.19 (s, 9H, Si(CH3)3), 
0.90 (s, 9H, SiC(CH3)3), 1.25–1.33 (m, 1H, 7-H), 1.54–1.62 (m, 1H, 7-H), 1.64–1.68 (m, 1H, 
6-H), 1.72–1.77 (m, 1H, 6-H), 1.97–2.05 (m, 2H, 2 × 5-H), 2.06–2.13 (m, 3H, 3-H, 2 × 8-H), 
3.55 (ddd, J = 9.2, 6.1, 2.8 Hz, 1H, 4-H), 4.70 (s, 1H, 2-H), 4.95 (d, J = 10.8 Hz, 1H, 10-H), 
5.02 (d, J = 17.7 Hz, 1H, 10-H), 5.81 (dddd, J = 17.7, 13.2, 10.8, 6.1 Hz, 1H, 9-H); 
13
C NMR 
(100 MHz, CDCl3): [ppm] = –4.8 (Si(CH3)2), –4.3 (Si(CH3)2), 0.2 (Si(CH3)3), 18.1 
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(SiC(CH3)3), 25.9 (SiC(CH3)3), 27.5 (C-8), 29.8 (C-6), 30.9 (C-5), 32.9 (C-7), 42.3 (C-3), 
70.8 (C-4), 106.0 (C-2), 114.4 (C-10), 139.0 (C-9), 149.7 (C-1). 
 
 
(4S,5S)-5-(But-3-en-1-yl)-4-(tert-butyldimethylsilyl)oxy)bicyclo[4.1.0]heptane-1-ol (1-
159).
71
 A hexane solution of diethyl zinc (1M, 22 mL, 22.0 mmol) was added to a stirred 
solution of silyl enol ether 1-165 (5.2 g, 15.4 mmol) in diethyl ether (50 mL), followed by 
slow addition of diiodomethane (2.7 mL, 33.2 mmol). The resulting mixture was stirred under 
reflux for 13 h before it was cooled to 0 °C, treated with saturated NH4Cl solution (50 mL) 
and extracted with diethyl ether (3 × 50 mL). The combined organic layers were washed with 
saturated NaCl solution (2 × 100 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The crude product was used in the next step without further purification. 
A solution of previously prepared cyclopropane in methanol (60 mL) was treated with 
potassium carbonate (80 mg). The mixture was stirred for 1 h at room temperature before it 
was treated with pH 7 phosphate buffer solution (50 mL). After most of the methanol was 
removed under reduced pressure, the residue was extracted with diethyl ether (3 × 50 mL). 
The combined organic layers were washed with saturated NaCl solution (2 × 100 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 6:1) to give cyclopropanol 1-159 (4.2 g, 91% over 
2 steps) as a colorless oil. Rf = 0.2 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 0.03 (s, 3H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2), 0.47 (dd, J = 5.4, 5.7 Hz, 
1H, 11-H), 0.86 (s, 9H, SiC(CH3)3), 0.93–0.98 (m, 1H, 11-H), 1.05–1.11 (m, 1H, 6-H), 1.22–
1.31 (m, 2H, 2 × 7-H), 1.61–1.67 (m, 1H, 2-H), 1.81–1.86 (m, 2H, 2-H, 3-H), 1.93–2.02 (m, 
1H, 3-H), 2.06–2.12 (m, 1H, 5-H), 2.22–2.32 (m, 2H, 2 × 8-H), 3.28 (ddd, J = 11.0, 8.9, 3.3 
Hz, 1H, 4-H), 4.92 (d, J = 10.8 Hz, 1H, 10-H), 5.06 (d, J = 17.8 Hz, 1H, 10-H), 5.81 (dddd, J 
= 17.8, 13.0, 10.8, 6.4 Hz, 1H, 9-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –4.8 (Si(CH3)2), 
–4.0 (Si(CH3)2), 18.0 (SiC(CH3)3), 19.4 (C-11), 23.6 (C-6), 25.9 (SiC(CH3)3), 30.4 (C-3), 30.5 
(C-7), 30.8 (C-8), 33.1 (C-2), 45.6 (C-5), 55.4 (C-1), 73.2 (C-4), 114.2 (C-10), 138.8 (C-9). 
 
 
(3R,3aR,8R,8aR)-8-((tert-Butyldimethylsilyl)oxy)-3-methyloctahydroazulen-5(1H)-one 
(1-157).
71
 AgNO3 (240 mg, 1.41 mmol) and (NH4)2S2O8 (4.9 g, 21 mmol) were added to a 
solution of cyclopropanol 1-159 (4.2 g, 14.2 mmol), pyridine (2.3 mL, 28 mmol) and 1,4-
cyclohexadiene (4.1 mL, 43 mmol) in dimethylformamide (120 mL) at 0 °C. The result ing 
mixture was stirred for 4 h at room temperature before it was carefully treated with saturated 
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NaHCO3 solution (100 mL) and extracted with diethyl ether (3 × 100 mL). The combined 
organic layers were washed with saturated NaCl solution (2 × 100 mL), dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 15:1) to give ketone 1-157 (2.9 g, 69%) as a colorless oil. Rf = 0.78 
(petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.05 (s, 3H, Si(CH3)2), 
0.06 (s, 3H, Si(CH3)2), 0.83 (d, J = 7.2 Hz, 3H, 3-CH3), 0.87 (s, 9H, SiC(CH3)3), 1.24–1.33 
(m, 1H, H-2), 1.33–1.42 (m, 1H, H-2), 1.69–1.92 (m, 4H, 2 × 1-H, 2 × 7-H), 1.92–1.98 (m, 
1H, 3a-H), 2.06 (dddd, J = 19.0, 8.5, 5.5, 5.5 Hz, 1H, 3-H), 2.18 (ddd, J = 10.3, 7.7, 3.9 Hz, 
1H, 8a-H), 2.37–2.59 (m, 4H, 2 × 4-H, 2 × 6-H), 3.44 (ddd, J = 9.9, 9.9, 3.7 Hz, 1H, 8-H); 13C 
NMR (100 MHz, CDCl3): [ppm] = –4.7 (Si(CH3)2), –4.1 (Si(CH3)2), 15.8 (3-CH3), 18.1 
(SiC(CH3)3), 25.8 (SiC(CH3)3), 30.4 (C-1), 31.9 (C-7), 33.8 (C-2), 37.8 (C-3a), 39.0 (C-6), 
40.3 (C-4), 44.7 (C-3), 53.0 (C-8a), 78.5 (C-8), 213.8 (C-5). 
 
 
Isopulegone (1-174).
186
 (–)-Isopulegol (1-173) (50 g, 0.32 mol) was added dropwise to a 
stirred solution of PCC (110 g, 0.51 mol) in CH2Cl2 (1300 mL) at room temperature. The 
resulting mixture was stirred overnight before it was filtered through a silica-Celite pad, 
which was then washed with CH2Cl2. The solvent was removed under reduced pressure. The 
residue was distilled at low pressure (b.p. 40–42 °C, 1 × 10–2 mbar) to give isopulegone (1-
174) as a colorless oil (48.6 g, 100%). Rf = 0.57 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 1.01 (d, J = 6.3 Hz, 3H, 5-CH3), 1.42 (m, 1H, 4-H), 1.72 (s, 3H, 
CCH3), 1.75–2.06 (m, 5H, 2 × 3H, 4-H, 5-H, 6-H), 2.38 (ddd, J = 13.2, 3.6, 2.0 Hz, 1H, 6-H), 
2.93 (dd, J = 12.0, 3.5 Hz, 1H, 2-H), 4.69 (s, 1H, C=CH2), 4.91 (s, 1H, C=CH2); 
13
C NMR 
(100 MHz, CDCl3): [ppm] = 21.3 (CCH3), 22.3 (5-CH3), 31.2 (C-3), 33.8 (C-4), 35.3 (C-5), 
50.5 (C-6), 57.7 (C-2), 112.8 (C=CH2), 143.4 (C=CH2), 210.2 (C-1). 
 
 
Vinylmagnesium bromide. 1,2-Dibromoethane (72 mL, 0.80 mol) was added dropwise (1 h) 
to a stirred solution of KOH (60 g, 1.05 mol) in ethanol (400 mL) at 40 °C. The resulting 
vinyl bromide was distilled from the reaction mixture (b.p. 16 °C) through a Vigreux column 
(30 cm) and collected in a nitrogen cooled flask. Distillation over CaCl2 (2 times) gave vinyl 
bromide (60 g, 70%) as a colorless liquid. Vinyl bromide should be stored at –20 °C and 
handled in a well ventilated hood. A solution of vinyl bromide (12.9 g, 121 mmol) in THF (50 
mL) was added dropwise to a suspension of magnesium turnings (2.9 g, 130 mmol) in THF 
(10 mL), activated with a single iodine crystal, maintaining the temperature at 38 °C. After 
complete addition of vinyl bromide, the reaction mixture was stirred for 1 h at the same 
temperature. The concentration was found to be 1.7M in THF by titration of a THF solution of 
menthol in presence of 1,10-phenantroline. For the exact procedure, see titration of 
isopropylmagnesium bromide, described earlier. 
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(1R,2S,5R)-5-Methyl-2-(prop-1-en-2-yl)-1-vinylcyclohexanol (1-172). Freshly prepared 
vinylmagnesium bromide (250 mL, 1.7M solution in THF, 0.42 mol) was added dropwise to a 
stirred solution of ketone 1-174 (47.0 g, 0.33 mol) in THF (300 mL) at –80 °C. The reaction 
mixture was allowed to warm to room temperature within 1 h and treated with saturated 
NH4Cl solution (50 mL), diluted with water (200 mL), and extracted with diethyl ether (3 × 
100 mL). The combined organic layers were washed with saturated NaCl solution (2 × 100 
mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was distilled at low 
pressure (b.p. 45–50 °C, 6 × 10–3 mbar) to give alcohol 1-172 as a colorless oil (55.7 g, 92%). 
Rf = 0.69 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +17.2 (c 2.49, MeOH); 
1
H NMR (400 MHz, 
CDCl3): = 0.86 (d, J = 6.6 Hz, 3H, 5-CH3), 0.90–1.01 (m, 1H, 4-H), 1.10 (ddd, J = 14.0, 
12.2, 2.0 Hz, 1H, 6-H), 1.47 (ddd, J = 13.2, 6.4, 3.6 Hz, 1H, 3-H), 1.61 (ddd, J = 13.7, 3.3, 2.3 
Hz, 1H, 6-H), 1.74 (s, 3H, 2’-CH3), 1.76–1.83 (m, 4H, 3-H, 4-H, 5-H, OH), 1.98 (dd, J = 
13.0, 3.3 Hz, 1H, 2-H), 4.73 (s, 1H, 1’-H), 4.87 (s, 1H, 1’-H), 4.96 (dd, J = 10.7, 1.3 Hz, 1H, 
CH2 vinyl), 5.16 (dd, J = 17.2, 1.1 Hz, 1H, CH2 vinyl), 5.86 (dd, J = 17.0, 10.7 Hz, 1H, CH 
vinyl); 
13
C NMR (100 MHz, CDCl3): = 22.2 (5-CH3), 25.7 (2’-CH3), 27.4 (C-5, C-3), 34.8 
(C-4), 46.5 (C-6), 52.0 (C-2), 73.2 (C-1), 110.6 (CH2 vinyl), 111.7 (C-1’), 146.2 (CH vinyl), 
148.1 (C-2’); HRMS (ESI): [M+Na]+ calcd for C12H20ONa 203.14064, found 203.140504. 
 
 
(9R,E)-5,9-Dimethylcyclodec-5-enone (1-171). A solution of alcohol 1-172 (26.7 g, 0.15 
mol) and 18-crown-6 ether (3.9 g, 0.015 mol) in abs. THF (100 mL) was added to a stirred 
suspension of KH (17.8 g, 0.45 mol) in THF (250 mL). The resulting mixture was stirred 
under reflux for 12 h. Then the reaction mixture was treated with ethanol (30 mL) at –78 °C, 
diluted with water (300 mL) and extracted with diethyl ether (3 × 100 mL). The combined 
organic layers were washed with saturated NaCl solution (2 × 100 mL), dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was distilled at low pressure (55−60 °C, 10–2 
mbar) to give ketone 1-171 as a colorless oil (23.9 g, 89%). Rf = 0.59 (petroleum 
ether/EtOAc, 9:1); [ ]
20
D = +2.9 (c 1.0, MeOH); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.92 
(d, J = 6.8 Hz, 3H, 9-CH3), 1.17–1.23 (m, 1H), 1.43 (s, 3H, 5-CH3), 1.60–1.68 (m, 2H), 1.80–
1.85 (m, 1H), 1.95–2.15 (m, 6H), 2.20–2.35 (m, 2H), 2.57–2.63 (m, 1H), 5.12–5.14 (m, 1H, 
6-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 15.9 (5-CH3), 24.8 (9-CH3), 25.8, 27.3 (CH2), 
28.8 (C-9), 37.3, 41.3, 43.1, 53.3 (CH2), 126.4 (C-6), 138.0 (C-5), 208.7 (C=O); HRMS 
(ESI): [M+Na]
+
 calcd for C12H20ONa 203.14064, found 203.140461. 
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(1R,7R,10R)-1,7-Dimethyl-11-oxa-bicyclo[8.1.0]undecan-5-one (1-176). mCPBA (11.5 g, 
47.0 mmol, 70–75%) was added to a stirred solution of ketone 1-171 (7.0 g, 39 mmol) in abs. 
CH2Cl2 (400 mL) and the mixture stirred overnight at ambient temperature. The reaction 
mixture was treated with saturated Na2S2O3 solution (100 mL) and stirred for additional 1 h. 
The organic layer was separated and washed with saturated NaHCO3 solution (2 × 100 mL), 
water (100 mL), saturated NaCl solution (100 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 15:1) to give epoxide 1-176 (6.3 g, 83%) as white crystals (m.p. 66–67.5 °C). Rf 
= 0.24 (petroleum ether/EtOAc, 9:1); [ ]
20
D = –0.4 (c 1.29, MeOH); 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 0.84–0.92 (ddd, J = 13.7, 13.7, 3.3 Hz, 1H, 2-H), 0.96 (d, J = 7.4 Hz, 3H, 
7-CH3), 1.15 (s, 3H, 1-CH3), 1.25–1.45 (m, 2H, 8-H, 9-H), 1.55–1.65 (m, 1H, 3-H), 1.79–1.85 
(m, 2H, 8-H, 9-H), 2.10–2.20 (m, 2H, 2-H, 3-H), 2.24–2.43 (m, 4H, 4-H, 4-H, 6-H, 7-H), 2.56 
(dd, J = 17.5, 10.3 Hz, 1H, 6-H), 2.63 (dd, J = 7.5, 0.9 Hz, 1H, 10-H); 
13
C-NMR (100 MHz, 
CDCl3): [ppm] = 16.1 (1-CH3), 20.2 (C-3), 23.4 (7-CH3), 26.4 (C-9), 28.8 (C-7), 35.9 (C-8), 
40.5 (C-2), 43.2 (C-4), 52.3 (C-6), 61.5 (C-1), 63.2 (C-10), 210.3 (C=O); HRMS (ESI): 
[M+Na]
+
 calcd for C12H20O2Na 219.13555, found 219.135501. 
 
 
(1R,3aR,4R,8aS)-4-Hydroxy-1,4-dimethyl-octahydroazulen-4(2H)-one (1-177) and 
(1R,3aR,4R,8S,8aS)-1,4-dimethyldecahydro-4,8-epoxyazulen-8-ol (1-178). A solution of 
epoxy ketone 1-176 (7.0 g, 35.7 mmol) in THF (50 mL) was added to the suspension of NaH 
(6.0 g, 150.0 mmol, 60% dispersed in mineral oil) in THF (200 mL) and stirred under reflux 
for 1 h. Then the reaction mixture was cooled to –10 °C and carefully treated with saturated 
NH4Cl solution (50 mL). The mixture was diluted with water (100 mL) and extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with 1M HCl solution 
(50 mL), water (50 mL), saturated NaCl solution (50 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 9:1) to give an inseparable mixture of ketone 1-177 and hemiketal 1-178 (1-
177/1-178 = 30:70) which was introduced in the next step without further purification (6.0 g, 
90%). 
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(1S,3aR,6R,8aR)-1-Hydroxy-1,6-dimethyl-octahydroazulen-4(1H)-one (14). A freshly 
prepared solution of LDA in THF (1.0 mL, 0.5M, 0.50 mmol) was added dropwise to a 
solution of epoxy ketone 1-176 (25 mg, 0.13 mmol) in THF (1 mL) at –80 °C followed by 
stirring of the mixture for 24 h at the same temperature. The reaction mixture was treated with 
saturated NH4Cl solution (10 mL) and extracted with diethyl ether (3 × 10 mL). The 
combined organic layers were washed with water (10 mL), saturated NaCl solution (10 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 9:1) to give a mixture of ketone 1-177/hemiketal 1-
178 (4 mg, 20%) and ketone 1-179 (21 mg, 80%). Rf = 0.18 (petroleum ether/EtOAc, 4:1); 
[ ]
20
D = –16.8 (c 0.28, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.83 (dddd, J = 13.1, 
13.1, 12.0, 1.3 Hz, 1H, 8-H), 0.97 (d, J = 6.6 Hz, 3H, 6-H), 1.12–1.20 (m, 1H, 7-H), 1.45–
1.54 (m, 1H, 2-H), 1.59–1.68 (m, 3H, 2-H, 6-H, OH), 1.70–1.80 (m, 2H, 3-H, 8-H), 1.87–1.93 
(m, 1H, 7-H), 2.09–2.20 (m, 2H, 3-H, 8a-H), 2.32 (ddd, J = 10.2, 2.8, 1.8 Hz, 1H, 5-H), 2.42 
(dd, J = 11.4, 10.2 Hz, 1H, 5-H), 3.42 (ddd, J = 9.4, 9.4, 7.4 Hz, 1H, 3a-H); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 21.8 (C-3), 23.6 (4-CH3), 24.1 (1-CH3), 27.5 (C-8), 34.4 (C-6), 38.6 
(C-2), 38.6 (C-7), 52.2 (C-5), 52.3 (C-8a), 55.4 (C-3a), 82.4 (C-1), 213.2 (C-4); HRMS (ESI): 
[M+Na]
+
 calcd for C12H20O2Na 219.13555, found 219.135579. 
 
 
(1R,3aR,4R,8R,8aS)-1,4-Dimethyldecahydroazulene-4,8-diol (1-180). NaBH4 (50 mg, 1.30 
mmol) was added to a solution of ketone 1-177 (170 mg, 0.87 mmol) in a THF/MeOH 
mixture (10 mL/1 mL) at –78 °C. The resulting mixture was allowed to warm to ambient 
temperature and stirred for 1 h at room temperature. Then the reaction mixture was cooled to 
0 °C and carefully treated with water (10 mL). The mixture was extracted with diethyl ether 
(3 × 20 mL). The combined organic layers were washed with water (20 mL), saturated NaCl 
solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 1:1) to give diol 1-180 (155 mg, 
91%) as a colorless oil. Rf = 0.34 (petroleum ether/EtOAc, 1:1); [ ]
20
D = –14.0 (c 2.35, 
MeOH); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.99 (d, J = 6.3 Hz, 3H, 1-CH3), 1.05 (ddd, J 
= 12.3, 5.8 Hz, 1H, 2-H), 1.17 (s, 3H, 4-CH3), 1.20–1.30 (m, 1H, 3-H), 1.40 (dddd, J = 14.7, 
7.6, 3.8, 3.7 Hz, 1H, 6-H), 1.46–1.60 (m, 3H, 1-H, 5-H, 7-H), 1.65–1.94 (m, 6H, 2-H, 3-H, 5-
H, 6-H, 7-H, 8a-H), 2.32 (ddd, J = 11.2, 11.2, 7.1 Hz, 1H, 3a-H), 3.91 (dd, J = 6.6, 3.0 Hz, 
1H, 8-H), 4.64 (br s, 1H, OH); 
13
C NMR (100 MHz, CDCl3): [ppm] = 17.4 (C-6), 19.5 (1-
CH3), 30.2 (C-7), 31.1 (C-3), 32.2 (4-CH3), 34.6 (C-2), 36.7 (C-5), 39.7 (C-1), 54.1 (C-3a, C-
8a), 71.7 (C-8), 75.5 (C-4); HRMS (ESI): [M+Na]
+
 calcd for C12H22O2Na 221.115120, found 
221.151057. 
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(3R,3aS,4S,8R,8aR)-3,8-Dimethyl-4-((triethylsilyl)oxy)-decahydro-4,8-epoxyazulen (1-
184). A freshly prepared LDA solution (0.5M in THF, 1.0 mL, 0.50 mmol) was added drowise 
to a stirred solution of 1-177 and 1-178 (25 mg, 0.13 mmol) in THF (1 mL) at –78 °C. The 
resulting mixture was stirred for 1 h at the same temperature before it was treated with 
TESOTf (86 µL, 0.38 mmol). After being stirred overnight, the reaction mixture was diluted 
with petroleum ether/EtOAc mixture (1:1, 3 mL) and filtered through a pad of silica (eluent 
petroleum ether/EtOAc 1:1). Solvents were removed under reduced pressure to afford acetal 
1-184 (39 mg, 96%) as a colorless oil. Rf = 0.78 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 0.56–0.67 (m, 6H, Si(CH2CH3)3); 0.94 (dd, J = 7.8, 7.8 Hz, 12H, 
Si(CH2CH3)3); 0.98 (d, J = 6.1 Hz, 3H, 3-CH3), 1.17 (s, 3H, 8-CH3), 1.36–1.53 (m, 5H, 2 × 2-
H, 2 × 5-H, 6-H), 1.57–1.67 (m, 2H, 1-H, 6-H), 1.78–1.93 (2 × 7-H), 2.03–2.13 (m, 2H, 1-H, 
3-H), 2.21 (dd, J = 13.6, 8.6 Hz, 1H, 3a-H), 2.65 (ddd, J = 13.8, 9.1, 9.1 Hz, 1H, 8a-H); 
13
C 
NMR (100 MHz, CDCl3): [ppm] = 6.3 (Si(CH2CH3)3), 7.0 (Si(CH2CH3)3), 18.5 (3-CH3), 
20.5 (C-6), 25.3 (8-CH3), 28.1 (C-1), 31.8 (C-2), 33.4 (C-7), 33.7 (C-3), 41.2 (C-5), 54.4 (C-
3a), 64.5 (C-8a), 80.9 (C-8), 105.2 (C-4); HRMS (ESI): [M+Na]
+
 calcd for C18H34O2SiNa 
333.22203, found 333.222230. 
 
 
(1R,3aR,4R,8aS)-1,4-Dimethyl-8-oxo-decahydroazulen-4-yl-pivalate (1-185) and 
(3R,3aS,4R,8R,8aR)-3,8-Dimethyldecahydro-4,8-epoxyazulen-4-yl pivalate (1-186). 
Pivalic anhydride (16 ml, 79.1 mmol) was added dropwise to a stirred solution of 1-177 and 
1-178 mixture (4.3 g, 21.9 mmol) in dry acetonitrile (90 mL) at –10 °C, followed by addition 
of Sc(OTf)3 (0.1 g, 0.2 mmol) dissolved in acetonitrile (1 mL) at the same temperature. The 
resulting mixture was stirred overnight at 0 °C, treated with saturated NaHCO3 solution (50 
mL) and extracted with diethyl ether (3 × 50 mL). The combined organic extracts were 
washed with saturated NaCl solution (50 mL), dried over MgSO4, filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 25:1) to 
give pivalic ketone 1-185 (3.7 g, 61%) and protected hemiketal 1-186 (2.3 g, 37%) as 
colorless oils. 
Pivalic ketone 1-185: Rf = 0.65 (petroleum ether/EtOAc, 4:1); [ ]
20
D = +22.5 (c 1.0, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.01 (d, J = 6.4 Hz, 3H, 1-CH3), 1.08 (s, 9H, (CH3)3), 
1.16–1.26 (m, 1H, 2-H), 1.41 (s, 3H, 4-CH3), 1.50–1.86 (m, 5H, 2 × 3-H, 5-H, 2 × 6-H), 1.93–
2.07 (m, 2H, 1-H, 2-H), 2.28–2.39 (m, 3H, 5-H, 7-H, 8a-H), 2.57 (ddd, J = 11.7, 11.7, 3.3 Hz, 
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1H, 7-H), 2.95 (ddd, J = 11.2, 11.2, 7.1 Hz, 1H, 3a-H); 
13
C NMR (100 MHz, CDCl3): [ppm] 
= 19.9 (1-CH3), 21.2 (C-6), 26.2 (4-CH3), 27.1 (CO(CH3)3), 29.4 (C-3), 35.3 (C-5), 35.4 (C-
2), 39.2 (C-1), 39.6 (CO(CH3)3), 41.5 (C-7), 49.4 (C-3a), 61.3 (C-8a), 86.1 (C-4), 177.7 (C=O 
ester), 212.4 (C=O ketone). HRMS (ESI): [M+Na]
+
 calcd for C17H28O3Na 303.19307, found 
303.192921. 
Hemiketal pivalate 1-186: Rf = 0.75 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 0.99 (d, J = 6.1 Hz, 3H, 1-CH3), 1.15 (s, 9H, CO(CH3)3), 1.26 (s, 3H, 4-
CH3), 1.40–1.68 (m, 7H, 5-H, 2-H), 1.88–1.99 (m, 2H), 2.14–2.22 (m, 2H, 3-H), 2.31–2.35 
(ddd, J = 11.9, 11.7, 6.2 Hz, 1H), 2.46 (dd, J = 13.8, 8.2 Hz, 1H, 3a-H), 2.79 (ddd, J = 13.6, 
8.6, 8.6 Hz, 1H, 8a-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 17.9 (1-CH3), 20.9 (C-6), 
25.0 (4-CH3), 27.0 (CO(CH3)3), 27.9 (C-3), 28.9 (C-5), 31.8 (C-2), 33.7 (C-1), 38.5 
(CO(CH3)3), 39.0 (C-7), 41.1 (C-3a), 54.5 (C-8a), 62.5 (C-3a), 82.1 (C-4), 110.0 (C-8), 176.0 
(CO(CH3)3); HRMS (ESI): [M+Na]
+
 calcd for C17H28O3Na 303.19307, found 303.193064. 
Recycling of 1-177+1-178 via pivalic ester cleavage: K2CO3 (4.20 g, 30.4 mmol) was added 
to a stirred solution of ester 1-186 (2.85 g, 10.2 mmol) in methanol (70 mL). The resulting 
mixture was stirred for 10 h at 60 °C, treated with water (100 mL) and extracted with diethyl 
ether (3 × 100 mL). The combined organic layers were washed with saturated NaCl solution 
(2 × 100 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified 
by flash chromatography (petroleum ether/EtOAc, 5:1) to give a mixture 1-177+1-178 (1.83 
g, 92%) as a colorless oil. 
 
 
(1R,3aS,4R,8aR)-8a-Bromo-1,4-dimethyl-8-oxodecahydroazulen-4-yl pivalate (1-187). 
Phenyltrimethylammonium tribromide (PTT)
89
 (48 mg, 0.13 mmol) was added to a stirred 
solution of ketone 1-185 (30 mg, 0.11 mmol) in THF (1 mL) at –10 °C. The resulting mixture 
was allowed to warm to 0 °C and stirred for 30 min before it was filtered through a pad of 
silica (3 cm) using a mixture of petroleum ether/EtOAc (5:1, 20 mL) as a rinse. The solvents 
were removed under reduced pressure to give bromide 1-187 (31 mg, 80%) as white crystals. 
Rf = 0.45 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.08 (d, J = 
5.8 Hz, 1H, 1-CH3), 1.12 (s, 9H, C(CH3)3), 1.13 (s, 3H, 4-CH3), 1.58–2.01 (m, 8H, 2 × 2-H, 2 
× 3-H, 5-H, 2 × 6-H, 7-H), 2.45–2.53 (m, 2H, 5-H, 7-H), 3.38 (ddd, J = 12.1, 12.1, 3.3 Hz, 
1H, 1-H), 4.00 (dd, J = 9.4, 6.4 Hz, 1H, 3a-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 18.0 
(1-CH3), 19.8 (C-6), 22.7 (C-3), 24.6 (4-CH3), 27.1 (C(CH3)3), 31.7 (C-2), 39.1 (C-5), 39.4 
(C(CH3)3), 40.8 (C-7), 43.6 (C-1), 58.4 (C-3a), 84.2 (C-4), 86.4 (C-8a), 177.2 (ester), 204.4 
(C-8). 
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(3R,3aR,6R,6aS)-3-((E)-5,5-Dimethyl-4-oxohex-2-enyl)-3,6-dimethylhexahydro-1H-
cyclopenta[c]furan-1-one (1-189). n-BuLi (0.20 mL, 2.5M in THF) was added to a flask 
containing abs. THF (1.0 mL). The resulting solution was cooled to –20 °C and then DIPA 
(0.07 mL, 0.40 mmol) was added. The resulting LDA solution was stirred at –20 °C for 1 h. 
Then a solution of ketone 1-185 (30.0 mg, 0.11 mmol) in abs. THF (1.0 mL) was added at –20 
°C. The resulting solution was warmed to –5 °C and stirred for 40 min. After this time, the 
reaction mixture was recooled to –78 °C and a solution of PhSeCl (57.4 mg, 0.33 mmol) in 
THF (0.5 mL) was added dropwise. The resulting yellow solution was allowed to stir 
overnight at –40 °C and then treated with saturated NH4Cl solution (5 mL). The layers were 
separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined organics 
were washed with saturated NaCl solution, dried over MgSO4, filtered, and concentrated in 
vacuo. The residue was dissolved in THF (1 mL) and H2O2 (0.1 mL, 1.1 mmol, 30% in water) 
was added in one portion. The resulting solution was stirred overnight and then diluted with 
water (5 mL). The layers were separated and the aqueous phase extracted with EtOAc (3 × 10 
mL). The combined organics were washed with saturated Na2S2O3 solution (2 × 10 mL), 
saturated NaCl solution (20 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 20:1) to give enone 1-
189 (15 mg, 50%) as a colorless oil. Rf = 0.42 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +10.7 (c 
1.5, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.13–1.14 (m, 12H, 5’-(CH3)3, 6-CH3), 
1.17–1.25 (m, 1H, 5-H), 1.35 (s, 3H, 3-CH3), 1.52–1.57 (m, 1H, 5-H), 1.80–1.96 (m, 2H, 4-
H), 2.33–2.40 (m, 1H, 6-H), 2.53–2.69 (m, 3H, 1’-H, 3a-H), 2.76 (dd, J = 8.6, 4.1 Hz, 1H, 6a-
H), 6.60 (app d, J = 15.2 Hz, 1H, 3’-H), 6.83 (ddd, J = 15.2, 7.6, 7.6, 1H, 2’-H); 13C NMR 
(100 MHz, CDCl3): [ppm] = 21.3 (6-CH3), 26.0 (5-(CH3)3), 27.0 (3-CH3), 27.6 (C-4), 35.4 
(C-5), 37.7 (C-6), 40.0 (C-1’), 42.9 (C-5’), 49.8 (C-3a), 53.5 (C-6a), 84.7 (C-3), 128.2 (C-3’), 
140.2 (C-2’), 179.3 (C=O ester), 203.7 (C=O ketone); HRMS (ESI): [M+Na]+ calcd for 
C17H26O3Na 301.17742, found 301.177335. 
 
 
 (2R,5R)-5-Methyl-2-(prop-1-en-2-yl)-1-((trimethylsilyl)ethynyl)cyclohexanol (1-174a). n-
BuLi (2.5M in hexane, 5.8 mL, 14.5 mmol) was added dropwise to a stirred solution of mono-
TMS-acetylene (1.6 mL, 14.5 mmol) in THF (100 mL) at –78 °C over 15 min. The resulting 
solution was stirred for 15 min before a solution of isopulegone (1-174) (2.0 g, 13.2 mmol) in 
THF (20 mL) was added dropwise and stirring continued for additional 1 h at the same 
temperature. The reaction was treated with saturated NH4Cl solution (50 mL) and extracted 
with diethyl ether (3 × 50 mL). The combined organic layers were washed with saturated 
NaCl solution (50 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, 15:1) to give a diastereomeric 
Experimental Section  125 
mixture of two alcohols 1-174a (2.4 g, 73%, dr 1.2:1) as a colorless oil, which was used in 
next step without separation. Rf = 0.58, 0.68 (petroleum ether/EtOAc, 9:1); HRMS (ESI): 
[M+Na]
+
 calcd for C15H26OSiNa 273.164513, found 273.164250. 
 
 
(2R,5R)-1-Ethynyl-5-methyl-2-(prop-1-en-2-yl)cyclohexanol (1-201). The diastereomeric 
mixture of alcohols 1-174a (1.2:1, 70 mg, 0.28 mmol) was dissolved in methanol (1 mL) and 
treated with K2CO3 (58 mg, 0.42 mmol) at room temperature. The resulting mixture was 
stirred for 2 h before it was diluted with diethyl ether (10 mL), treated with water (10 mL) and 
extracted with diethyl ether (3 × 10 mL).The combined organic layers were washed with 
saturated NaCl solution (10 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 15:1) to give alcohols 
1-201 (47 mg, 96%, dr 1.2:1) as colorless oils.  
Rf = 0.53 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.88 (d, J = 
6.6 Hz, 3H, 5-CH3), 0.85–0.99 (m, 2H, 3-H, 4-H), 1.24–1.39 (m, 2H, 3-H, 4-H), 1.45–1.50 
(m, 1H, 5-H), 1.66–1.82 (m, 2H, 2-H, 6-H), 1.98 (s, 3H, CH2=CCH3), 2.11–2.18 (m, 1H, 6-
H), 2.22 (br s, 1H, OH), 2.41 (s, C≡CH), 4.84 (br s, CH2=CCH3), 5.00 (dd, J = 1.5, 1.5 Hz, 
1H, CH2=CCH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 21.8 (CH2=CCH3), 25.9 (5-CH3), 
26.6 (C-3), 26.7 (C-5), 34.4 (C-4), 48.0 (C-6), 52.1 (C-2), 67.4 (C-1), 71.2 (C≡CH), 88.6 
(C≡CH), 112.4 (CH2=CCH3), 148.0 (CH2=CCH3). 
Rf = 0.63 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.94 (d, J = 
6.8 Hz, 3H, 5-CH3), 0.88–1.02 (m, 1H, 3-H), 1.17–1.28 (m, 1H, 4-H), 1.60–1.90 (m, 4H, 6-H, 
5-H, 3-H, 4-H), 1.87 (s, 3H, CH2=CCH3), 2.04–2.11 (m, 2H, 6-H, 2-H), 2.47 (s, 1H, OH), 
2.71 (s, C≡CH), 4.92 (s, CH2=CCH3), 4.99 (dd, J = 1.5, 1.5 Hz, 1H, CH2=CCH3); 
13
C NMR 
(100 MHz, CDCl3): [ppm] = 20.9 (CH2=CCH3), 21.8 (5-CH3), 28.0 (C-3), 30.2 (C-5), 34.3 
(C-4), 48.6 (C-6), 55.7 (C-2), 69.6 (C-1), 74.2 (C≡CH), 86.2 (C≡CH), 115.1 (CH2=CCH3), 
145.3 (CH2=CCH3); HRMS (ESI): [M+Na]
+
 calcd for C12H18ONa 201.124986, found 
201.124935. 
 
 
(1R,3aR,4R,8aS)-1,4-Dimethyl-8-oxo-1,2,3,3a,4,5,8,8a-octahydroazulen-4-yl pivalate (1-
190). TBS enol ether formation. n-BuLi (0.43 mL, 2.5M in THF) was added to a flask 
containing THF (1.5 mL). The resulting solution was cooled to –20 °C and then DIPA (0.17 
mL, 1.18 mmol) was added. The resulting LDA solution was stirred at –20 °C for 1 h and 
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recooled to –40 °C. A solution of ketone 1-185 (100 mg, 0.36 mmol) in abs. THF (1.0 mL) 
was introduced dropwise at –40 °C. The resulting solution was stirred at the same temperature 
for 2 h and then a solution of TBSCl (217 mg, 1.44 mmol) in abs. THF (1.0 mL) was added 
followed by HMPA (0.1 mL, 0.54 mmol). The reaction mixture was allowed to warm to room 
temperature. After being stirred overnight, water (10 mL) was added. The organic layer was 
separated and the water phase extracted with diethyl ether (3 × 20 mL). The combined organic 
layers were washed with saturated NaCl solution (2 × 20 mL), dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc/Et3N, 40:1:0.12) to give TBS enol ether (131 mg, 93%) as a colorless oil. Rf = 
0.37 (petroleum ether/EtOAc, 33:1). The compound was directly introduced to the next step. 
Saegusa-Ito oxidation. To a solution of TBS enol ether obtained above in dry DMSO (3.0 
mL) was added Pd(OAc)2 (11.2 mg, 0.05 mmol). The reaction mixture was placed under 
oxygen (balloon) and stirred at 50 °C for 24 h. After this time, the reaction mixture was 
diluted with diethyl ether (10 mL) followed by water addition (5 mL). The layers were 
separated and the aqueous phase extracted with diethyl ether (3 × 10 mL). The combined 
organic extracts were washed with saturated NaCl solution (2 × 10 mL), dried over MgSO4, 
filtered, and concentrated in vacuo.The residue was purified via flash chromatography 
(petroleum ether/EtOAc, 9:1) to give enone 1-190 (76 mg, 83%) as a colorless oil. Rf = 0.42 
(petroleum ether/EtOAc, 9:1); [ ]
20
D = –21.3 (c 0.39, MeOH); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 0.97 (d, J = 5.8 Hz, 3H, 1-CH3), 1.06 (s, 9H, tBu), 1.15–1.24 (m, 2H, CH2), 1.46 (s, 
3H, 4-CH3), 1.86–2.03 (m, 2H, 3a-H, CH2), 2.50 (dd, J = 10.6, 10.6 Hz, 1H, CH2), 2.61–2.67 
(m, 1H, 5-H), 2.80–2.87 (m, 1H, 8a-H), 3.26–3.32 (m, 1H, 5-H), 5.90 (dd, J = 12.1, 2.9 Hz, 
1H, 7-H), 6.10 (ddd, J = 12.1, 6.7, 2.7 Hz 1H, 6-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
18.2 (1-CH3), 25.0 (4-CH3), 27.0 (C(CH3)3), 28.5 (CH2), 34.8 (CH2), 36.9 (C-1), 39.4 
(C(CH3)3), 40.8 (C-5), 50.6 (C-3a), 63.7 (C-8a), 85.0 (C-4), 130.9 (C-7), 137.0 (C-6), 177.9 
(C=O ester), 204.2 (C=O ketone). HRMS (ESI): [M+Na]
+
 calcd for C17H26O3Na 301.17742, 
found 301.177335. 
 
 
(1R,3aR,4RS,8aS)-1,4-Dimethyl-1,2,3,3a,4,5,8,8a-octahydroazulene-4,8-diol (1-204). A 
solution of pivalate 1-190 (20 mg, 0.072 mmol) in THF (1.5 mL) was added to a stirred 
suspension of LiAlH4 (27 mg, 0.72 mmol) in THF (1 mL) at 0 °C. The mixture was allowed 
to warm to room temperature and stirred for 2 h before it was carefully treated with water (10 
mL) and extracted with diethyl ether (3 × 10 mL). The combined organic layers were washed 
with saturated NaCl solution (20 mL), dried over MgSO4, filtered and concentrated in vacuo. 
The residue was purified by flash chromatography (petroleum ether/EtOAc, 1:1) to give the 
corresponding diol (12 mg, 86%) as a colorless oil. Rf = 0.32 (petroleum ether/EtOAc, 1:2). 
The crude diol (12 mg, 0.061 mmol) was dissolved in CH2Cl2 (2 mL) and treated with Dess-
Martin periodinane (30 mg, 0.070 mmol) at 0 °C. The mixture was allowed to warm to room 
temperature and stirred for 2 h before it was carefully treated with water (10 mL) and 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were washed with 
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saturated NaCl solution (10 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 1:1) to give the enone 
1-169 (9 mg, 75%) as a colorless oil. Rf = 0.46 (petroleum ether/EtOAc, 2:1). 
The crude enone 1-169 (9 mg, 0.046 mmol) was dissolved in CCl4 (1 mL) and treated with 
NBS (9 mg, 0.50 mmol) and AIBN (cat.) at room temperature. The resulting mixture was 
stirred for 3 h under reflux before the solvent was removed. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 7:1) to give bromide 1-204 (9 mg, 69%) as a 
colorless oil. Rf = 0.55 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.98 (d, J = 6.4 Hz, 3H, 1-CH3), 1.23–1.33 (m, 2H, 2-H, 3-H), 1.37 (s, 3H, 4-CH3), 1.59–1.76 
(m, 2H, 1-H, 3-H), 1.91–1.97 (m, 1H, 2-H), 2.66 (dd, J = 11.7, 9.7 Hz, 1H, 8a-H), 2.90 (ddd, 
J = 11.8, 8.3, 8.1 Hz, 1H, 3a-H), 3.75 (s, 1H, OH), 4.71 (d, J = 4.3 Hz, 1H, 7-H), 5.84 (d, J = 
9.4 Hz, 1H, 5-H), 6.06 (dd, J = 9.4, 4.3 Hz, 1H, 6-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
19.9 (1-CH3), 23.1 (4-CH3), 24.7 (C-3), 36.0 (C-1), 40.1 (C-2), 56.7 (C-7), 58.2 (C-3a), 61.5 
(C-8a), 83.5 (C-4), 100.7 (C-8), 126.9 (C-6), 138.0 (C-5).  
 
 
(1R,3aR,4R,7S,8aS)-7-(2-Hydroxypropan-2-yl)-1,4-dimethyl-8-oxodecahydroazulen-4-yl 
pivalate (1-207). A solution of ketone 1-185 (200 mg, 0.71 mmol) in THF (6 mL) was added 
dropwise to freshly prepared LDA (4.7 mL, 2.14 mmol, 0.45M solution in THF) at –45 °C. 
The resulting mixture was stirred for 1 h before ZnCl2 (0.85 mL, 0.85 mmol, 1M solution in 
diethyl ether) was added dropwise at –78 °C, followed by addition of acetone (0.6 mL, 8.17 
mmol). After 30 min the reaction mixture was treated with saturated NH4Cl solution (5 mL), 
diluted with water (15 mL) and extracted with diethyl ether (3 × 20 mL). The combined 
organic layers were washed with saturated NaCl solution (20 mL), dried over MgSO4, filtered 
and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 5:1) to give aldol product 1-207 (193 mg, 83%) as a colorless oil. Rf = 0.53 
(petroleum ether/EtOAc, 2:1); [ ]
20
D = +50.4 (c 0.76, MeOH); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.06 (d, J = 6.6 Hz, 3H, 1-CH3), 1.12 (s, 9H, COC(CH3)3), 1.21 (s, 6H, 2 × 2’-CH3), 
1.26−1.36 (m, 1H, CH2), 1.46−1.89 (m, 7H, 4-CH3, 2 × CH2), 2.02−2.08 (m, 1H, CH2), 
2.12−2.23 (m, 1H, 1-H), 2.39−2.44 (m, 2H, 8a-H, CH2), 2.58 (dd, J = 12.1, 2.0 Hz, 1H, 7-H), 
2.95 (ddd, J = 12.8, 11.3, 6.4 Hz, 1H, 3a-H), 3.87 (br. s, 1H, 2’-OH); 13C NMR (100 MHz, 
CDCl3): [ppm] = 19.8 (1-CH3), 22.9 (CH2), 27.1 (COC(CH3)3), 27.1 (2’-CH3), 27.6 (4-CH3), 
29.0 (2’-CH3), 30.2 (CH2), 34.1, 35.7 (CH2), 39.0 (C-1), 39.6 (COC(CH3)3), 50.1 (C-3a), 56.9 
(C-7), 62.5 (C-8a), 71.9 (C-2’), 85.3 (C-4), 177.7 (C=O ester), 217.1 (C=O ketone); HRMS 
(ESI): [M+Na]
+
 calcd for C20H34O4Na 361.23493, found 361.235157. 
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(1R,3aR,4R,7R,8aS)-1,4-Dimethyl-8-oxo-7-(prop-1-en-2-yl)decahydroazulen-4-yl pivalate 
(20). Burgess reagent (42 mg, 0.177 mmol) was added to a stirred solution of alcohol 1-207 
(15 mg, 0.044 mmol) in abs. toluene (3 mL) and the mixture stirred at 110 °C for 5 min. After 
cooling, the solvent was evaporated and the residue purified by flash chromatography 
(petroleum ether/EtOAc, 15:1) providing alkene 1-209 (14 mg, quant.) as a colorless oil. Rf = 
0.56 (petroleum ether/EtOAc, 9:1); [ ]
20
D = +89.5 (c 12.7, MeOH); 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 1.05 (d, J = 6.5 Hz, 3H, 1-CH3), 1.11 (s, 9H, COC(CH3)3), 1.27−1.35 (m, 
1H, 2-H), 1.54 (s, 3H, 4-CH3), 1.59−1.87 (m, 8H, 2’-CH3, 2 × 3-H, 5-H, 2 × 6-H), 2.04−2.07 
(m, 1H, 2-H), 2.17−2.23 (m, 1H, 1-H), 2.42−2.52 (m, 2H, 5-H, 8a-H), 2.92 (ddd, J = 12.5, 
11.1, 6.6 Hz, 1H, 3a-H), 3.31 (dd, J = 12.2, 2.3 Hz, 1H, 7-H), 4.78 (s, 1H, 1’-H), 4.93 (s, 1H, 
1’-H); 13C NMR (100 MHz, CDCl3): [ppm] = 19.7 (1-CH3), 22.3 (2’-CH3), 25.7 (CH2), 27.1 
(COC(CH3)3), 27.1 (4-CH3), 30.0 (CH2), 33.9 (CH2), 35.5 (CH2), 39.3 (C-1), 39.6 
(COC(CH3)3), 50.1 (C-3a), 55.7 (C-7), 61.5 (C-8a), 85.5 (C-4), 111.9 (C-1’), 144.2 (C-2’), 
177.8 (C=O ester), 210.9 (C=O ketone); HRMS (ESI): [M+Na]
+
 calcd for C20H32O3Na 
343.22437, found 343.224348.  
 
 
(1R,3aR,4R,8aR)-1,4-Dimethyl-8-oxo-7-(propan-2-ylidene)decahydroazulen-4-yl pivalate 
(1-210). K2CO3 (18 mg, 0.131 mmol) was added to a stirred solution of ketone 1-209 (14 mg, 
0.044 mmol) in methanol (2 mL). The resulting mixture was stirred at 70 °C for 4 h, treated 
with water (10 mL) and extracted with diethyl ether (3 × 20 mL). The combined organic 
layers were washed with water (10 mL), saturated NaCl solution (10 mL), dried over MgSO4, 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 15:1) to give enone 1-210 (7 mg, 50%) as a colorless oil and enone 
epi-1-210 (7 mg, 50%), which was introduced again in this step without further purification.  
1-210: Rf = 0.33 (petroleum ether/EtOAc, 9:1); [ ]
20
D = –99.2 (c 0.39, CH2Cl2); 
1
H NMR 
(400 MHz, CDCl3): [ppm] = 0.86 (d, J = 6.9 Hz, 3H, 1-CH3), 1.16 (s, 9H, COC(CH3)3), 
1.40−1.45 (m, 1H, 2-H), 1.43 (s, 3H, 4-CH3), 1.62−1.75 (m, 2H, 2-H, 3-H),1.74 (s, 3H, 2’-
CH3), 1.83 (s, 3H, 2’-CH3), 1.86−1.95 (m, 2H, 3-H, 6-H), 2.03 (ddd, J = 13.9, 8.8, 1.6 Hz, 1H, 
5-H), 2.41 (ddd, J = 13.6, 11.2, 1.9 Hz, 1H, 5-H), 2.48−2.55 (m, 1H, 6-H), 2.54 (dd, J = 11.9, 
6.6 Hz, 1H, 8a-H), 2.62−2.69 (m, 1H, 1-H), 2.93 (ddd, J = 11.2, 11.2, 5.8 Hz, 1H, 3a-H); 13C 
NMR (100 MHz, CDCl3): [ppm] = 15.9 (1-CH3),18.4 (4-CH3), 20.8 (2’-CH3), 21.9 (2’-CH3), 
23.9 (C-6), 24.6 (C-3), 27.2 (COC(CH3)3), 32.6 (C-2), 36.7 (C-5), 37.4 (C-1), 39.5 
(COC(CH3)3), 44.6 (C-3a), 56.5 (C-8a), 86.5 (C-4), 136.8 (C-2’), 137.9 (C-7), 177.6 (C=O 
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ester), 209.6 (C=O ketone); HRMS (ESI): [M+Na]
+
 calcd for C20H32O3Na 343.22437, found 
343.224401. 
epi-1-210
187
: Rf = 0.45 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
1.05 (d, J = 6.6 Hz, 3H, 1-CH3), 1.13 (s, 9H, COC(CH3)3), 1.20−2.44 (m, 9H), 1.43 (s, 3H, 4-
CH3), 1.71 (s, 3H, 2’-CH3), 1.73 (s, 3H, 2’-CH3), 2.56 (dd, J = 10.0, 7.0 Hz, 1H, 8a-H), 2.91 
(ddd, J = 12.0, 10.1, 6.9 Hz, 1H, 3a-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 20.3, 20.8, 
22.3, 24.1, 25.3, 27.1, 28.1, 33.7, 34.4, 36.9, 49.6 44.6 (C-3a), 61.4 (C-8a), 85.6 (C-4), 132.6 
(C-2’), 136.1 (C-7), 177.6 (C=O ester), 210.0 (C=O ketone); HRMS (ESI): [M+Na]+ calcd for 
C20H32O3Na 343.22437, found 343.224399. 
 
 
(1R,3aR,4R,8R,8aR)-1,4-Dimethyl-7-(propan-2-ylidene)decahydroazulene-4,8-diol (1-
211). A solution of ketone 1-210 (20 mg, 0.062 mmol) in THF (1 mL) was added dropwise to 
a stirred suspension of LiAlH4 (30 mg, 0.789 mmol) in THF (1 mL) at –10 °C. The resulting 
mixture was allowed to warm to ambient temperature during 2 h and then carefully treated 
with 20% aqueous NaOH solution (0.5 mL) and water (10 mL). Stirring was continued for 15 
min, before the mixture was extracted with diethyl ether (3 × 15 mL). The combined organic 
layers were washed with water (10 mL), saturated NaCl solution (10 mL), dried over MgSO4, 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 3:1) to give diol 1-211 (25 mg, 69%) and diol epi-1-211 (8 mg, 
22%) as white crystals. epi-1-211: Rf = 0.54 (petroleum ether/EtOAc, 2:3). 1-211: Rf = 0.48 
(petroleum ether/EtOAc, 2:3); [ ]
20
D = –29.1 (c 0.35, MeOH); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.09 (d, J = 7.3 Hz, 3H, 1-CH3), 1.11 (s, 3H, 4-CH3), 1.24−1.30 (m, 1H, 2-H), 
1.41−1.56 (m, 3H, 3-H, 5-H, 8a-H), 1.65 (s, 3H, 2’-CH3), 1.68−1.82 (m, 2H, 2-H, 3-H), 1.76 
(s, 3H, 2’-CH3), 1.93 (ddd, J = 14.3, 10.0, 1.8 Hz, 1H, 5-H),2.02−2.13 (m, 1H, 1-H), 2.21 
(app dd, J = 10.1, 15.4 Hz, 1H, 6-H), 2.38 (app dd, J = 9.1, 15.7 Hz, 1H, 6-H), 2.66 (ddd, J = 
10.0, 10.0, 8.0 Hz, 1H, 3a-H), 4.89 (br.s, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
16.3 (1-CH3), 20.4 (2’-CH3), 20.7 (2’-CH3), 22.3 (C-6), 22.7 (4-CH3) 25.9 (C-3), 34.4 (C-2), 
38.1 (C-1), 43.4 (C-5), 46.3 (C-3a), 46.5 (C-8a), 68.6 (C-8), 74.6 (C-4), 126.8 (C-2’), 136.4 
(C-7); HRMS (ESI): [M+Na]
+
 calcd for C15H26O2Na 261.18250, found 261.182581. 
 
 
(1R,3aR,4R,7R,8R,8aR)-7-Isopropyl-1,4-dimethyldecahydro-4,7-epoxyazulen-8-ol (1-
212). Mercury (II) trifluoroacete (90 mg, 0.21 mmol) was added in one portion to a stirred 
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solution of alkenediol 1-211 (40 mg, 0.17 mmol) in CH2Cl2/MeOH (5 mL / 10 L) at –78 °C. 
The mixture was stirred overnight at the same temperature, treated with water (20 mL) and 
extracted with diethyl ether (3 × 15 mL). The combined organic layers were washed with 
water (10 mL), saturated NaCl solution (10 mL), dried over MgSO4, filtered and concentrated 
in vacuo. The residue was dissolved in MeOH (5 mL), cooled to –78 °C and NaBH4 (120 mg, 
3.16 mmol) was added in one portion. The resulting mixture was allowed to warm to ambient 
temperature within 3 h, treated with water (20 mL) and extracted with ethyl acetate (3 × 15 
mL). The combined organic layers were washed with saturated NaCl solution (10 mL), dried 
over MgSO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 15:1) to give epoxyazulene 1-212 (38 mg, 95%) as 
white crystals. Rf = 0.66 (petroleum ether/EtOAc, 4:1); [ ]
20
D = –36.7 (c 0.55, MeOH); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 0.83 (d, J = 6.8 Hz, 3H, 2’-CH3), 0.89 (d, J = 6.8 Hz, 3H, 
2’-CH3), 0.92−0.96 (m, 1H, 3-H), 1.00 (d, J = 7.3 Hz, 3H, 1-CH3), 1.13 (dddd, J = 13.2, 8.3, 
8.3, 2.8 Hz, 1H, 2-H), 1.25 (s, 3H, 4-CH3), 1.24−1.36 (m, 2H, 5-H, 6-H), 1.42 (ddd, J = 13.5, 
7.2, 2.8 Hz, 1H, 8a-H), 1.60−1.67 (m, 1H, 3-H), 1.70−1.86 (m, 4H, 3a-H, 5-H, 6-H, 8-OH), 
1.93 (dddd, J = 13.4, 10.8, 8.2, 2.8 Hz, 1H, 2-H), 2.23 (app ddd, J = 15.0, 7.4, 2.6 Hz, 1H, 1-
H), 2.34 (app. sept, J = 6.8 Hz, 1H, 2’-H), 3.80 (br s, 1H, 8-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = 15.9 (2’-CH3), 17.8 (2’-CH3), 19.8 (1-CH3), 24.5 (C-3), 24.6 (4-CH3), 27.6 (C-6), 
28.2 (C-9), 30.1 (C-5), 32.5 (C-2), 33.8 (C-1), 44.3 (C-3a), 44.5 (C-8a), 70.5 (C-8), 84.0 (C-
4), 88.9 (C-7); HRMS (ESI): [M+Na]
+
 calcd for C15H26O2Na 261.18250, found 261.182896. 
 
 
(1R,3aR,4R,7R,8aR)-7-Isopropyl-1,4-dimethyloctahydro-4,7-epoxyazulen-8(2H)-one (1-
213). Dess-Martin periodinane (19.8 mg, 0.047 mmol) was added to a stirred solution of 
alcohol 1-212 (10.0 mg, 0.042 mmol) in CH2Cl2 (2 mL) at 0 °C. The resulting mixture was 
stirred for 2 h at room temperature and then saturated Na2S2O3 solution (1 mL) was added, 
followed by addition of saturated NaHCO3 solution (1 mL) after 15 min. The resulting 
mixture was stirred for additional 15 min, the organic layer was separated and the aqueous 
layer extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were washed with 
water (10 mL), saturated NaCl solution (10 mL), dried over MgSO4, filtered and concentrated 
in vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 33:1) to 
give ketone 1-213 (8.8 mg, 89%) as white crystals. Rf = 0.50 (petroleum ether/EtOAc, 9:1); 
[ ]
20
D = –94.8 (c 0.92, MeOH); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.94 (d, J = 6.9 Hz, 
6H, 2 × 2’-CH3), 0.99 (d, J = 7.1 Hz, 3H, 1-CH3), 1.11−1.24 (m, 2H, 2-H, 3-H), 1.36 (s, 3H, 
4-CH3), 1.57−1.70 (m, 3H, 3-H, 5-H, 6-H), 1.91−2.07 (m, 3H, 2-H, 5-H, 6-H), 2.17−2.25 (m, 
3H, 3a-H, 8a-H, 9-H), 2.37 (app ddd, J = 13.3, 13.3, 6.5 Hz, 1H, 1-H); 
13
C NMR (100 MHz, 
CDCl3): [ppm] = 16.6 (1-CH3), 17.6 (2’-CH3), 18.4 (2’-CH3), 23.9 (4-CH3), 25.5 (C-3), 29.3 
(C-2`), 30.1 (C-1), 30.5 (C-5), 31.0 (C-2), 31.5 (C-6), 52.1 (C-8a), 54.2 (C-3a), 83.8 (C-4), 
89.8 (C-7); 207.6 (C-8); HRMS (ESI): [M+Na]
+
 calcd for C15H24O2Na 236.34991, found 
236.34987. 
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(1R,3aR,4R,7R,8S,8aR)-7-Isopropyl-1,4-dimethyldecahydro-4,7-epoxyazulen-8-yl 
cinnamate (9-deoxy-englerin) (1-205). TiCl4 (5 L, 46 mol) was added to a stirred solution 
of triethylsilane (24 µL, 152 µmol) and ketone 1-213 (8.8 mg, 38 mol) in CH2Cl2 (2 mL) at 
–78 °C. The mixture was stirred for 30 min at this temperature, before it was treated with 
saturated NaHCO3 solution (2 mL). The aqueous layer was extracted with diethyl ether (3 × 
15 mL). The combined organic layers were washed with water (10 mL), saturated NaCl 
solution (10 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc 4:1) to give alcohol 1-214 (6.4 mg, 
72%) as white crystals. 
Triethylamine (11 µL, 81 µmol) and 2,4,6-trichlorobenzoyl chloride (10 µL, 67 µmol) were 
added successively to a stirred solution of alcohol 1-214 (6.4 mg, 27 µmol) and cinnamic acid 
(8.0 mg, 54 µmol) in dry toluene (1 mL), followed by addition of 4-DMAP (0.2 mg, cat. 
amounts) after 10 min. The reaction mixture was stirred for 12 h, diluted with diethyl ether 
(10 mg), and the organic phase was extracted with 1M HCl solution (5 mL), saturated 
NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), before it was dried over MgSO4, 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc 33:1) to give 9-deoxy-englerin (1-205) (8.5 mg, 63% over 2 steps) as 
a colorless oil. Rf = 0.61 (petroleum ether/EtOAc, 9:1); [ ]
20
D = –20.6 (c 0.32, MeOH); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 0.94 (d, J = 7.1 Hz, 3H, 1-CH3), 0.95 (d, J = 6.9 Hz, 3H, 
2’-CH3), 1.00 (d, J = 6.6 Hz, 3H, 2’-CH3), 1.00−1.10 m (1H, 3-H), 1.18−1.23 (m, 1H, 2-H), 
1.27 (s, 3H, 4-CH3), 1.42−1.50 (m, 1H, 5-H), 1.59−1.68 (m, 2H, 6-H, 8a-H), 1.75−1.86 (m, 
4H, 3a-H, 5-H, 6-H, 2’-H), 1.93 (dddd, J = 13.4, 10.8, 8.2, 2.8 Hz, 1H, 2-H), 1.99−2.12 (m, 
2H, 1-H, 3-H), 5.17 (d, J = 10.4 Hz, 1H, 8-H); 6.40 (d, J = 16.0 Hz, 1H, 4’-H); 7.35−7.39 (m, 
3H, 2 × meta-, para); 7.51−7.53 (m, 2H, 2 × ortho), 7.65 (d, J = 15.8 Hz, 1H, 5’-H); 13C NMR 
(100 MHz, CDCl3): [ppm] = 17.3 (1-CH3), 17.6 (2’-CH3), 18.4 (2’-CH3), 24.4 (4-CH3), 25.0 
(C-3), 30.4 (C-6), 31.1 (C-5), 31.2 (C-2), 31.5 (C-1), 33.3 (C-2’), 47.5 (C-8a), 49.0 (C-3a), 
72.6 (C-8), 83.2 (C-4), 86.0 (C-7), 118.4 (C-4’), 128.1 (2 × orto), 128.8 (2 × meta), 130.2 
(para), 134. 4 (C-6’), 144.7 (C-5’), 165.8 (C=O ester); HRMS (ESI): [M+Na]+ calcd for 
C24H32O3 391.22437, found 391.224232. 
 
 
2-Methylcyclohexane-1,3-dione (2-98).
138
 Cyclohexa-1,3-dione (2-97) (42.0 g, 0.38 mol) 
was dissolved in a solution of NaOH (14 g, 0.35 mol) in water (70 mL). Methyl iodide (46 
mL, 0.74 mmol) was added in one portion and the resulting solution was stirred for 20 h at 65 
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°C before it was cooled to 0 °C. The precipitate was filtered and washed with cold petroleum 
ether (50 mL) and cold water (40 mL) to give diketone (29.8, 63%) 2-98 as white crystals 
(m.p. 198–201 °C (lit.188 204–205 °C)). 1H NMR (400 MHz, DMSO-d6; 100% enol 
tautomer): [ppm] = 1.52 (s, 3H, CH3), 1.80 (m, 2H, 2 × 5-H), 2.29 (dd, J = 6.5, 6.5 Hz, 4H, 2 
× 4-H, 2 × 6-H); 
13
C NMR (100 MHz, DMSO-d6): [ppm] = 7.7 (CH3), 21.0 (C-5), 33.0 (C-
4, C-6), 110.0 (C-1, C-3) C-2 was not observed. 
 
 
8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (2-14).
139
 A solution of 
diketone 2-98 (42.0 g, 0.33 mol), methyl vinyl ketone (35.0 g, 0.50 mol) and potassium 
hydroxide (0.4 g, 0.01 mmol) in methanol (160 mL) was stirred for 3 h under reflux. The 
volatiles were removed under reduced pressure and the residue was dissolved in benzene (650 
mL) and treated with pyrrolidine (2 mL). The resulting mixture was stirred under reflux with 
a Dean-Stark condenser for 1 h before it was cooled to room temperature, diluted with diethyl 
ether (200 mL), washed with 1M HCl solution (200 mL), saturated NaCl solution (200 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was crystallized from 
petroleum ether/diethyl ether (1:1, 300 mL) to give Wieland-Miescher ketone (2-14) (35.6 g, 
60%) as white crystals (m.p. 46–49.5 °C (lit.139 48.6–50 °C)). Rf = 0.22 (petroleum 
ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3) [ppm] = 1.42 (s, 3H, CH3), 1.67 (qt, J = 13.3, 
4.4 Hz, 1H, 3-H), 2.05–2.13 (m, 3H, 3-H, 2 × 8-H), 2.41–2.49 (m, 4H, 2-H, 4-H, 2 × 7-H), 
2.62–2.71 (m, 2H, 2-H, 4-H), 5.82 (s, 1H, 5-H); 13C NMR (100 MHz, CDCl3) [ppm] = 23.0 
(C-3), 23.3 (CH3), 29.7 (C-8), 31.8 (C-4), 33.7 (C-7), 37.7 (C-2),50.7 (C-8a), 126.9 (C-5), 
166.0 (C-4a), 198.4 (C-6), 211.1 (C-1). 
 
 
8a'-Methyl-3',4',8',8a'-tetrahydro-2'H-spiro[[1,3]dioxolane-2,1'-naphthalen]-6'(7'H)-one 
(2-99).
141
 pTSA (115.3 g, 0.61 mol) was added to a stirred mixture of diketone 2-14 (107.8 g, 
0.60 mol) and molecular sieves (4Å, 200 g) in ethylene glycol (2.7 L) at room temperature. 
After stirring for 23 min the reaction mixture was poured into a saturated NaHCO3 solution (3 
L) and extracted with ethyl acetate (3 × 500 mL). The combined organic layers were washed 
with water (500 mL), saturated NaCl solution (300 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was crystallized from petroleum ether/diethyl ether (20:1, 
600 mL) to give enone 2-99 (108.5 g, 81%) as white crystals (m.p. 50–51.5 °C (lit.141 51–52 
°C)). Rf = 0.34 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.34 (s, 
3H, CH3), 1.64–1.93 (m, 4H, 2 × 3-H, 8-H, 2 × 2-H), 2.24–2.28 (m, 2H, 8-H, 4-H), 2.34–2.46 
(m, 3H, 4-H, 2 × 7-H), 3.93–4.08 (m, 4H, (CH2O)2), 5.80 (s, 1H, 5-H); 
13
C NMR (100 MHz, 
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CDCl3): [ppm] = 20.6 (C-3), 21.9 (CH3), 27.0 (C-8), 30.2 (C-4), 31.6 (C-7), 34.0 (C-2), 45.2 
(C-8a), 65.2 ((CH2O)2), 65.5 ((CH2O)2), 112.5 (C-1), 125.8 (C-5), 167.9 (C-4a), 199.4 (C-6). 
 
 
8a'-Methyl-5'-((phenylthio)methyl)-3',4',8',8a'-tetrahydro-2'H-spiro[[1,3]dioxolane-2,1'-
naphthalen]-6'(7'H)-one (2-100).
144
 Enone 2-99 (103.0 g, 0.45 mmol), thiophenol (76.6 g, 
0.70 mol), formaline (57 mL, 0.74 mol) and triethylamine (84 mL, 0.60 mol) were dissolved 
in propan-1-ol (350 mL). The resulting mixture was stirred for 24 h under reflux, before it 
was cooled down to ambient temperature and filtered. The mother liquor was treated with an 
aqueous solution of KOH (5%, 1 L) and extracted with diethyl ether (3 × 500 mL). The 
combined organic layers were washed with KOH solution (5%, 3 × 250 mL), saturated NaCl 
solution (300 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give enone 2-100 (153.0 g, 
96%) as a colorless oil. Rf = 0.37 (petroleum ether/ EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.31 (s, 3H, CH3), 1.49–1.60 (m, 1H, 3-H), 1.63–1.78 (m, 3H, 2-H, 3-H, 8-H), 1.85 
(ddd, J = 13.5, 13.5, 4.6 Hz, 1H, 2-H), 1.98–2.07 (m, 1H, 4-H), 2.24 (ddd, J = 13.5, 13.5, 4.8 
Hz, 1H, 8-H), 2.37 (ddd, J = 14.9, 14.9, 5.1 Hz, 1H, 7-H), 2.49 (ddd, J = 15.9, 15.9, 4.4 Hz, 
1H, 7-H), 2.66 (d, J = 15.5 Hz, 1H, 4-H), 3.76 (d, J = 11.6 Hz, 1H, CH2S), 3.90–3.99 (m, 5H, 
(CH2O)2, CH2S), 7.19–7.28 (m, 3H, 2 × HAr-m, HAr-p), 7.35–7.43 (m, 2H, HAr-o); 
13
C NMR 
(100 MHz, CDCl3): [ppm] = 21.4 (CH3), 21.7 (C-3), 26.5 (C-8), 27.1 (C-4), 29.4 (CH2S), 
29.8 (C-2), 33.9 (C-7), 45.8 (C-8a), 65.2 ((CH2O)2), 65.4 ((CH2O)2), 112.8 (C-1), 126.7 (CAr-
p), 128.8 (CAr-m), 130.4 (C-5), 131.5 (CAr-o), 136.4 (CAr-ipso), 164.3 (C-4a), 197.0 (C-6). 
 
 
(4a'S,8a'S)-5',5',8a'-trimethylhexahydro-2'H-spiro[[1,3]dioxolane-2,1'-naphthalen]-
6'(7'H)-one (2-101).
144
 Lithium (13.1 g, 1.88 mol) was added to liquid ammonia (2 L) at –78 
°C in small portions. The resulting blue solution was stirred for 1 h, before it was treated with 
a solution of enone 2-100 (108.0 g, 0.31 mol) and tert-butanol (58 mL, 0.61 mol) in THF (1 
L) at –78 °C over a period of 2 h. The reaction mixture was stirred for additional 1 h and then 
methyl iodide (196 mL, 3.14 mol) was added at the same temperature. The result ing mixture 
was allowed to warm to room temperature, stirred overnight, carefully treated with water (1 
L) and extracted with diethyl ether (3 × 250 mL). The combined organic layers were washed 
with saturated NaCl solution (3 × 200 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to 
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give ketone 2-101 (69.1 g, 87%) as a colorless oil. Rf = 0.62 (petroleum ether/ EtOAc 2:1); 
1
H 
NMR (400 MHz, CDCl3): [ppm] = 1.03 (s, 3H, 5-CH3), 1.06 (s, 3H, 5-CH3), 1.22 (s, 3H, 8a-
CH3), 1.44–1.55 (m, 4H, 2-H, 3-H, 2 × 4-H), 1.62–1.74 (m, 3H, 2-H, 3-H, 8-H), 1.81–1.89 
(m, 1H, 4a-H), 1.93 (ddd, J = 13.4, 13.4, 5.3 Hz, 1H, 8-H), 2.28–2.36 (m, 1H, 7-H), 2.57–2.63 
(m, 1H, 7-H), 3.82–3.93 (m, 4H, (CH2O)2); 
13
C NMR (100 MHz, CDCl3): [ppm] = 16.2 (8a-
CH3), 21.8 (5-CH3), 21.9 (C-4), 23.0 (C-3), 25.6 (5-CH3), 30.0 (C-2), 30.4 (C-8), 34.6 (C-7), 
42.8 (C-8a), 47.8 (C-5), 49.3 (C-4a), 65.0 (CH2O)2), 65.3 (CH2O)2), 113.0 (C-1), 216.8 (C-6). 
 
 
(4a'S,6'S,8a'S)-5',5',8a'-Trimethyloctahydro-2'H-spiro[[1,3]dioxolane-2,1'-naphthalen]-
6'-ol (2-103). Sodium borohydride (0.12 g, 3.2 mmol) was added in one portion to a stirred 
solution of ketone 2-101 (0.81 g, 3.2 mmol) in ethanol (10 mL) at –78 °C. The resulting 
mixture was allowed to warm to 0 °C and stirred for 0.5 h before it was carefully treated with 
water (10 mL) and extracted with diethyl ether (3 × 50 mL). The combined organic layers 
were washed with saturated NaCl solution (50 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was crystallized from petroleum ether/ethyl acetate (9:1, 
10 mL) to give desired diastereomer 2-103 (0.74 g, 91%) as white crystals. Rf = 0.68 
(petroleum ether/ EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.79 (s, 3H, 8a-CH3), 
0.98 (s, 3H, 5-CH3), 1.05 (s, 3H, 5-CH3), 1.25–1.72 (m, 11H, 2 × 2-H, 2 × 3-H, 2 × 4-H, 4a-
H, 2 × 7-H, 2 × 8-H), 3.24 (dd, J = 11.1, 4.3 Hz, 1H, 6-H), 3.79–3.94 (m, 4H, (CH2O)2); 
13
C 
NMR (100 MHz, CDCl3): [ppm] = 15.4 (5-CH3), 16.5 (8a-CH3), 20.6 (5-CH3), 23.1 (C-4), 
27.1 (C-3), 28.0 (C-2), 28.7 (C-7), 30.4 (C-8), 38.8 (C-5), 43.1 (C-8a), 48.2 (C-4a), 64.8 
(CH2O)2), 65.3 (CH2O)2), 78.7 (C-6), 113.3 (C-1). 
Recycling of ketone XX from the mother liquor. The mother liqior after filtration was 
concentrated in vacuo to give a diastereomeric mixture of alcohols 2-103/2-102 in a ratio 1:7 
(55 mg, 0.22 mmol). A CH2Cl2 solution (2 mL) of these alcohols was treated with Dess-
Martin reagent (101 mg, 0.24 mmol) and the resulting solution was stirred for 2 h at room 
temperature before it was treated with saturated Na2S2O3 solution (1 mL) and stirred for 
additional 15 min. The resulting mixture was washed with saturated NaHCO3 solution (10 
mL). The organic phase was separated and the aqueous phase was extracted with CH2Cl2 (3 × 
10 mL).The combined organic layers were washed with saturated NaCl solution (10 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 1:1) to give ketone 2-101 (48 mg, 87%) as white 
crystals. 
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(4aS,6S,8aS)-6-Hydroxy-5,5,8a-trimethyloctahydronaphthalen-1(2H)-one (2-96).
189
 
pTSA monohydrate (0.61 g, 3.2 mmol) was added to a stirred solution of acetal 2-103 (0.82 g, 
3.2 mmol) in an acetone/water mixture (1:1, 20 mL). The resulting mixture was stirred 
overnight before it was treated with saturated NaHCO3 solution (20 mL) and extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with saturated NaCl 
solution (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
crystallized from petroleum ether/ethyl acetate (9:1, 10 mL) to give ketone 2-96 (0.66 g, 97%) 
as white crystals. Rf = 0.37 (petroleum ether/ EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 0.87 (s, 3H, 5-CH3), 0.99 (s, 3H, 8a-CH3), 1.12 (s, 3H, 5-CH3), 1.42–1.79 (m, 8H, 
H-4a, 2 × 4-H, 2 × 3-H, 7-H, 2 × 8-H), 2.02–2.10 (m, 1H, 7-H), 2.10–2.18 (m, 1H, 2-H), 2.54 
(ddd, J = 14.0, 14.0, 7.0 Hz, 1H, 2-H), 3.16–3.20 (m, 1H, 6-H); 13C NMR (100 MHz, CDCl3): 
[ppm] = 15.8 (C-4), 18.6 (5-CH3), 20.7 (8a-CH3), 26.2 (5-CH3), 26.9 (C-3), 27.8 (C-7), 30.9 
(C-8), 31.2 (C-2), 37.4 (C-5), 48.6 (C-8a), 52.6 (C-4a), 78.1 (C-6), 215.4 (C-1). 
 
 
(4aS,6S,8aS)-6-((tert-Butyldimethylsilyl)oxy)-5,5,8a-trimethyloctahydronaphthalen-
1(2H)-one (2-106). TBSCl (7.9 g, 52.4 mmol) was added in one portion to a stirred solution 
of alcohol 2-96 (10.0 g, 47.6 mmol) and imidazole (7.1 g, 104.8 mmol) in DMF (100 mL) at 0 
°C. The resulting solution was allowed to warm to room temperature and stirred overnight, 
treated with water (200 mL) and extracted with diethyl ether (3 × 100 mL). The combined 
organic layers were washed with water (200 mL), saturated NaCl solution (100 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give ketone 2-106 (15.0 g, 97%) as 
white crystals. Rf = 0.68 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] 
= 0.03 (s, 3H, Si(CH3)2), 0.05 (s, 3H, Si(CH3)2), 0.86 (s, 3H, 5-CH3), 0.89 (s, 9H, SiC(CH3)3), 
0.92 (s, 3H, 8a-CH3), 1.14 (s, 3H, 5-CH3), 1.47–1.80 (m, 8H, H-4a, 2 × 4-H, 2 × 3-H, 7-H, 2 × 
8-H), 2.03–2.09 (m, 1H, 7-H), 2.11–2.22 (m, 1H, 2-H), 2.56 (ddd, J = 14.0, 14.0, 7.0 Hz, 1H, 
2-H), 3.15 (m, 1H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –5.0 (Si(CH3)2), –3.8 (Si(CH3)2), 
16.3 (C-4), 18.1 (SiC(CH3)3), 18.7 (5-CH3), 21.0 (8a-CH3), 25.9 (SiC(CH3)3), 26.4 (5-CH3), 
27.3 (C-3), 28.4 (C-7), 31.1 (C-8), 37.5 (C-2), 40.3 (C-5), 48.6 (C-8a), 52.7 (C-4a), 78.7 (C-
6), 215.5 (C-1). 
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(4bS,7S,8aR,10aS)-7-((tert-Butyldimethylsilyl)oxy)-4b,8,8-trimethyl-
1,4b,5,6,7,8,8a,9,10,10a-decahydrophenanthren-3(2H)-one (2-95). NaH (60% suspension 
in mineral oil; 3.2 g, 80.0 mmol) was added portionwise to a stirred solution of ketone 2-106 
(20.0 g, 61.5 mmol) in a THF/toluene (200 mL/80 mL) mixture at 0 °C. The resulting 
suspension was stirred 30 min at the same temperature followed by addition of ethyl formate 
(10 mL). The resulting mixture was allowed to warm to room temperature, stirred overnight 
and carefully treated with water (200 mL) at 0 °C. The organic phase was separated and the 
aqueous phase was extracted with diethyl ether (3 × 100 mL). The combined organic layers 
were washed with saturated NaCl solution (2 × 100 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. 
The obtained formylketone 2-107 was dissolved in CH2Cl2 (100 mL) and treated with 
triethylamine (17.2 mL, 123.0 mmol) and methyl vinyl ketone (15.4 mL, 215.2 mmol) at 0 
°C. The resulting solution was stirred for 2 h at room temperature, and then diluted with water 
(200 mL). The organic phase was separated and the aqueous layer extracted with diethyl ether 
(3 × 100 mL). The combined organic layers were washed with saturated NaCl solution (100 
mL), dried over MgSO4, filtered, and concentrated in vacuo.  
This residue was dissolved in methanol (100 mL) and treated with MeONa (16.6 g, 307.5 
mmol). The resulting solution was stirred under reflux for 1 h, treated with water and 
concentrated in vacuo. Additional 200 mL of water was added and the mixture extracted with 
diethyl ether (3 × 100 mL). The combined organic layers were washed with saturated NaCl 
solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give tricyclic enone 
2-95 (18.1 g, 78%) as white crystals. Rf = 0.37 (petroleum ether/ EtOAc 9:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 0.03 (s, 3H, Si-CH3), 0.05 (s, 3H, Si-CH3), 0.82 (s, 3H, 8-CH3), 0.88 
(s, 9H, SiC(CH3)3), 0.91 (s, 3H, 8-CH3), 1.02 (dd, J = 12.1, 2.8 Hz, 1H, 8a-H), 1.11 (s, 3H, 
4b-CH3), 1.14–1.21 (m, 1H, 10-H), 1.49–1.77 (m, 7H, 1-H, 2 × 5-H, 2 × 6-H, 2 × 9-H), 1.98–
2.11 (m, 2H, H-1, H-10), 2.23 (ddd, J = 16.4, 12.7, 5.0 Hz, 1H, 2-H), 2.36 (ddd, J = 16.4, 5.0, 
5.0 Hz, 1H, 2-H), 2.49–2.58 (m, 1H, 10a-H), 3.17 (dd, J = 10.2, 4.9 Hz, 1H, 7-H), 5.80 (d, J = 
1.8 Hz, 1H, 4-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –5.0 (Si-CH3), –3.8 (Si-CH3), 16.1 
(8-CH3), 18.1 (Si-C), 21.3 (4b-CH3, C-9), 25.9 (C(CH3)3), 27.7 (C-6), 28.5 (8-CH3), 29.3 (C-
1), 34.2 (C-10a), 34.7 (C-5), 35.1 (C-10), 35.9 (C-2), 40.1 (C-8), 40.6 (C-4b), 52.2 (C-8a), 
78.8 (C-7), 119.8 (C-4), 176.0 (C-4a), 201.3 (C-3); HRMS (ESI): [M+Na]
+
 calcd for 
C23H40O2SiNa 399.268978, found 399.268854. 
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(2S,4aS,4bR,5S,8aS,10aS)-2-((tert-Butyldimethylsilyl)oxy)-1,1,4a-trimethyldecahydro-
1H-phenanthro[4,4a-b]oxiren-6(5aH)-one (2-109). Hydrogen peroxide (30% aqueous 
solution; 10 mL, 88.2 mmol) was added to a stirred solution of enone 2-95 (5.8 g, 15.4 mmol) 
in methanol at –40 °C followed by addition of NaOH (10% aqueous solution; 6 mL, 15.0 
mmol) at the same temperature. The resulting mixture was stirred overnight, treated with 
saturated Na2S2O3 solution (50 mL) and extracted with diethyl ether (3 × 50 mL). The 
combined organic layers were washed with saturated NaCl solution (50 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give epoxide 2-109 (4.2 g, 70%) as 
white crystals. Rf = 0.60 (petroleum ether/ EtOAc 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] 
= 0.00 (s, 3H, Si(CH3)2), 0.00 (s, 3H, Si(CH3)2), 0.75 (s, 3H, 1-CH3), 0.85 (s, 9H, C(CH3)3), 
0.89 (s, 3H, 1-CH3), 1.04 (ddd, J = 12.9, 3.4, 3.4 Hz, 1H, 4-H), 1.10 (s, 3H, 4a-CH3), 1.19 
(dd, J = 12.4, 2.5 Hz, 1H, 10a-H), 1.23–1.39 (m, 2H, 4-H, 9-H), 1.45–1.86 (m, 5H, 2 × 3-H, 2 
× 8-H, 10-H), 1.70–1.77 (m, 1H, 10-H), 1.89 (ddd, J = 12.8, 7.6, 3.5 Hz, 1H, 9-H), 2.00–2.18 
(m, 2H, 7-H, 8a-H), 2.40 (ddd, J = 19.0, 5.1, 1.6 Hz, 1H, 7-H), 3.14 (dd, J = 10.9, 4.8 Hz, 1H, 
2-H), 3.18 (s, 1H, 5-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –5.0 (Si(CH3)2), –3.9 
(Si(CH3)2), 15.8 (1-CH3), 18.0 (C(CH3)3), 19.5 (4a-CH3), 21.2 (C-10), 23.6 (C-8), 25.8 
(C(CH3)3), 26.8 (C-3), 28.0 (1-CH3), 28.6 (C-4), 32.0 (C-8a, C-9), 36.2 (C-7), 37.6 (C-4a), 
39.6 (C-1), 50.0 (C-10a), 57.6 (C-5), 71.1 (C-4b), 78.2 (C-2), 206.7 (C-6); HRMS (ESI): 
[M+Na]
+
 calcd for C23H40O3SiNa 415.263893, found 415.264016. 
 
 
(4aS,4bS,7S,8aS,10aR)-7-((tert-Butyldimethylsilyl)oxy)-4b,8,8-trimethyl-
1,2,4a,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-4a-ol (2-112). Hydrazine 
monohydrochloride (1.3 g, 19.1 mmol) and triethylamine (4 mL, 28.5 mmol) were sonicated 
in CH2Cl2 (20 mL) for 0.5 h before a solution of ketone 2-109 (2.5 g, 6.4 mmol) in 
dichlormethane (10 mL) was added at room temperature. The resulting solution was stirred 
for 2 h, then the solvent was removed in vacuo and the residue was purified by flash 
chromatography (petroleum ether/EtOAc, 15:1 to 9:1) to give allylic alcohol 2-112 (2.2 g, 
86%) as a colorless oil. Rf = 0.66 (petroleum ether/ EtOAc 9:1); 
1
H NMR (400 MHz, C6D6): 
[ppm] = 0.07 (s, 3H, Si(CH3)2), 0.10 (s, 3H, Si(CH3)2), 0.88 (s, 3H, 4b-CH3), 0.94 (s, 3H, 8-
CH3), 1.02 (br s, 12H, SiC(CH3)3, 8-CH3), 1.15–1.20 (m, 1H, 1-H), 1.26–1.40 (m, 4H, 1-H, 5-
H, 9-H, 10-H), 1.50 (ddd, J = 12.2, 12.2, 2.9 Hz, 1H, 10a-H), 1.55–1.97 (m, 8H, 2 × 2-H, 5-H, 
2 × 6-H, 8a-H, 9-H, 10-H), 3.30 (dd, J = 11.1, 4.8 Hz, 1H, 7-H), 5.61 (ddd, J = 6.6, 6.6, 3.3 
Hz, 1H, 3-H), 5.73 (d, J = 10.1 Hz, 1H, 4-H); 
13
C NMR (100 MHz, C6D6): [ppm] = –4.7 
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(Si(CH3)2), –3.7 (Si(CH3)2), 16.1 (8-CH3), 17.4 (4b-CH3), 18.4 (SiC(CH3)3), 21.9 (C-10), 25.3 
(C-1), 26.1 (C-2), 26.2 (SiC(CH3)3), 28.2 (C-6), 28.7 (8-CH3), 29.2 (C-5, C-9), 37.1 (C-10a), 
39.8 (C-8), 40.5 (C-4b), 44.6 (C-8a), 73.7 (C-4a), 79.5 (C-7), 130.3 (C-4), 131.7 (C-3). 
 
 
(2S,4aS,10aR)-2-((tert-Butyldimethylsilyl)oxy)-1,1,4a-trimethyl-1,2,3,4,4a,7,8,9,10,10a-
decahydrophenanthrene (2-113). Molecular sieves (4Å, 0.2 g) were added to a stirred 
solution of allylic alcohol 2-112 (500 mg, 1.28 mmol) in benzene (15 mL) followed by 
addition of pTSA monohydrate (10 mg). Then the flask was transferred to a preheated oil bath 
(100 °C) and stirred there for 1 minute. The resulting mixture was concentrated in vacuo and 
the residue was purified by flash chromatography (petroleum ether/EtOAc, 33:1) to give a 
mixture of dienes 2-113 and 2-114 (490 mg, 1.27 mmol) as a colorless oil. Rf = 0.69 
(petroleum ether/ EtOAc 33:1). 
 
 
(1aR,3aS,5aS,7S,9aS,9bS,9cR)-7-((tert-Butyldimethylsilyl)oxy)-6,6,9a-
trimethyltetradecahydrophenanthro[3,4-b]oxiren-9b-ol (2-118). mCPBA (70%, 500 mg, 
2.90 mmol) was added to a stirred suspension of NaHCO3 (100 mg) and alcohol 2-112 (650 
mg, 1.72 mmol) in CH2Cl2 (6 mL) at room temperature. The resulting mixture was stirred for 
5 h before it was treated with saturated Na2S2O3 solution (10 mL) and stirred for additional 1 
h. The organic layer was separated and washed with saturated NaHCO3 solution (2 × 10 mL), 
water (10 mL), saturated NaCl solution (10 mL), dried over MgSO4, filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 15:1) to 
give epoxide 2-118 (660 mg, 97%) as a colorless oil. Rf = 0.64 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.06 (s, 3H, Si(CH3)2), 0.10 (s, 3H, Si(CH3)2), 0.77 (s, 
3H, 9a-CH3), 0.71–0.84 (m, 1H, 3-H), 0.93 (s, 3H, 6-CH3), 0.99 (s, 3H, 6-CH3), 1.02 (s, 9H, 
SiC(CH3)3), 0.95–1.00 (m, 1H, 3a-H), 1.12–1.38 (m, 5H, 2-H, 3-H, 4-H, 5-H, 9-H), 1.55–1.71 
(m, 5H, 4-H, 5-H, 2 × 8-H), 1.80 (ddd, J = 14.3, 2.0, 2.0 Hz, 1H, 2-H), 1.87 (dd, J = 12.5, 2.4 
Hz, 1H, 5a-H), 2.14 (ddd, J = 12.9, 12.9, 5.3 Hz, 1H, 9-H), 2.59 (s, OH), 2.87–2.92 (m, 1H, 
1a-H), 2.96 (d, J = 3.8 Hz, 1H, 9c-H), 3.30 (dd, J = 10.6, 5.3 Hz, 1H, 7-H); 
13
C-NMR (100 
MHz, CDCl3): [ppm] = –4.7 (Si(CH3)2), –3.7 (Si(CH3)2), 16.2 (6-CH3), 16.4 (4a-CH3), 18.4 
(SiC(CH3)3), 20.9 (C-3), 21.8 (C-5), 25.4 (C-2), 26.2 (SiC(CH3)3), 28.0 (C-4, C-8), 28.5 (6-
CH3), 28.9 (C-9), 37.6 (C-3a), 39.7 (C-6), 40.6 (C-9a), 45.2 (C-5a), 56.0 (C-1a, C-9c), 71.5 
(C-9b), 79.3 (C-7); HRMS (ESI): [M+Na]
+
 calcd for C23H42O3SiNa 417.279543, found 
417.279957. 
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(4R,4aS,4bS,7S,8aS,10aR)-7-((tert-Butyldimethylsilyl)oxy)-4b,8,8-
trimethyltetradecahydrophenanthrene-4,4a-diol (2-119). A solution of epoxide 2-118 (660 
mg, 1.68 mmol) in diethyl ether (10 mL) was added dropwise to a stirred suspension of 
LiAlH4 (76 mg, 2.0 mmol) in diethyl ether (20 mL) at –78 °C. The resulting mixture was 
allowed to warm to room temperature, stirred for 2 h before it was treated with isopropanol (1 
mL) and water (50 mL). The aqueous phase was separated and extracted with diethyl ether (3 
× 10 mL). ). The combined organic layers were washed with saturated NaCl solution (50 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 9:1) to give diol 2-119 (610 mg, 92%) as a 
colorless oil. Rf = 0.21 (petroleum ether/ EtOAc 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.06 (s, 6H, Si(CH3)2), 0.79 (s, 3H, 8-CH3), 0.90 (s, 9H, SiC(CH3)3), 0.93 (s, 3H, 8-CH3), 1.05 
(s, 3H, 4b-CH3), 1.09–1.72 (m, 15H, 2 × 1-H, 2 × 2-H, 2 × 3-H, 5-H, 2 × 6-H, 8a-H, 2 × 9-H, 
2 × 10-H, 10a-H), 1.98–2.04 (m, 1H, 5-H), 2.85 (s, 1H, 4a-OH), 3.20–3.24 (m, 1H, 7-H), 3.37 
(d, J = 5.0 Hz, 1H, 4-OH), 3.71 (ddd, J = 10.2, 5.2, 5.2 Hz, 1H, 4-H); 
13
C-NMR (100 MHz, 
CDCl3): [ppm] = –4.7 (Si(CH3)2), –3.5 (Si(CH3)2), 16.6 (8-CH3), 17.0 (4b-CH3), 18.8 
(SiC(CH3)3), 22.7 (C-9), 24.7 (C-2), 26.4 (SiC(CH3)3), 29.1 (C-6), 29.5 (8-CH3), 30.1 (C-1), 
30.8 (C-10), 33.6 (C-5), 34.1 (C-3), 39.5 (C-10a), 40.5 (C-8), 44.0 (C-4b), 46.8 (C-8a), 71.4 
(C-4), 77.6 (C-4a), 80.2 (C-7); HRMS (ESI): [M+Na]
+
 calcd for C23H44O3SiNa 419.295193, 
found 419.295294. 
 
 
4-((2R,4aS,6S,8aS)-6-((tert-Butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-
oxodecahydronaphthalen-2-yl)butanal (2-121). Dess-Martin reagent
58
 (43 mg, 0.103 mol) 
was added in one portion to a stirred suspension of diol 2-119 (37 mg, 0.093 mol) and 
NaHCO3 (50 mg, 0.595 mmol) in CH2Cl2 (10 mL) at room temperature. The mixture was 
stirred for 2 h before it was treated with saturated Na2S2O3 solution (5 mL) and stirred for 
additional 15 minutes. The resulting suspension was washed with saturated NaHCO3 solution 
(10 mL). The organic phase was separated and the aqueous phase was extracted with CH2Cl2 
(3 × 10 mL). The combined organic layers were washed with saturated NaCl solution (10 
mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 9:1) to give ketone 2-121 (34 mg, 92%) as a 
colorless oil. Rf = 0.27 (petroleum ether/ EtOAc 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.06 (s, 6H, Si(CH3)2), 0.79–0.89 (m, 3H, 3-H, 4a-H, 1’-H), 0.84 (s, 3H, 5-CH3), 0.86 (br s, 
6H, 5-CH3, 8a-CH3), 1.00 (s, 9H, C(CH3)3), 1.33–1.92 (m, 10H, 3-H, 2 × 4-H, 2 × 7-H, 1’-H, 
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2 × 2’-H, 2 × 3’-H), 2.16 (ddd, J = 12.8, 12.8, 6.2 Hz, 1H, 2-H), 3.02 (dd, J = 11.0, 4.4 Hz, 
1H, 6-H), 9.36 (dd, J = 1.5, 1.5 Hz, 1H, 4’-H); 13C NMR (100 MHz, CDCl3): [ppm] = –4.8 
(Si(CH3)2), –3.7 (Si(CH3)2), 16.4 (5-CH3), 18.3 (SiC(CH3)3), 18.6 (8a-CH3), 20.1 (C-2), 21.3 
(C-4), 26.1 (SiC(CH3)3), 27.7 (C-7), 28.3 (5-CH3), 29.7 (C-1’), 31.6 (C-8), 33.7 (C-3), 40.4 
(C-5), 44.1 (C-3’), 45.0 (C-4a), 48.4 (C-8a), 53.2 (C-2), 79.0 (C-6), 200.7 (C-4’), 213.5 (C-1).  
 
 
(4aS,4bS,7S,8aS,10aR)-7-((tert-Butyldimethylsilyl)oxy)-4a-hydroxy-4b,8,8-
trimethyldodecahydrophenanthren-4(4aH)-one (2-120). To a stirred solution of diol 2-119 
(600 mg, 1.51 mmol) in CH2Cl2 (20 mL) were added at room temperature Et3N (2.1 mL, 15.1 
mmol) and a solution of SO3·Py (1.2 g, 7.55 mmol) in DMSO (20 mL). The reaction mixture 
was stirred for 1 h before it was treated with water (100 mL) and extracted with diethyl ether 
(3 × 50 mL). The combined organic layers were washed with water (100 mL), 1 N HCl (2 × 
100 mL), water (2 × 100 mL), saturated NaCl solution (100 mL), dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 15:1)  to give ketone 2-120 as a colorless oil (430 mg, 73%). Rf = 0.32 
(petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.10 (s, 6H, Si(CH3)2), 
0.92 (s, 3H, 8-CH3), 0.99 (s, 3H, 8-CH3), 1.02 (s, 9H, SiC(CH3)3), 1.11 (s, 3H, 4b-CH3), 1.18–
1.57 (m, 11H, 2 × 1-H, 2 × 2-H, 5-H, 6-H, 8a-H, 2 × 9-H, 2 × 10-H), 1.61–1.77 (m, 2H, 6-H, 
10a-H), 2.06–2.12 (m, 3-H), 2.21 (ddd, J = 13.4, 3.5, 3.5 Hz, 1H, 5-H), 2.62 (ddd, J = 12.7, 
11.7, 6.2 Hz, 1H, 3-H), 3.17 (dd, J = 11.5, 4.4 Hz, 1H, 7-H); 
13
C-NMR (100 MHz, CDCl3): 
[ppm] = –4.7 (Si(CH3)2), –3.6 (Si(CH3)2), 16.4 (8-CH3), 16.5 (4b-CH3), 18.4 (SiC(CH3)3), 
21.4 (C-9), 24.9 (C-2), 26.2 (SiC(CH3)3), 27.2 (C-1), 28.0 (C-6), 28.5 (C-10), 28.9 (8-CH3), 
29.8 (C-5), 39.5 (C-3), 39.9 (C-8), 40.4 (C-10a), 41.0 (C-4b), 46.2 (C-8a), 79.5 (C-7), 81.4 
(C-4a), 210.9 (C-4); HRMS (ESI): [M+Na]
+
 calcd for C23H42O3SiNa 417.279543, found 
417.279653. 
 
 
(4bS,7S,8aR)-7-((tert-Butyldimethylsilyl)oxy)-4b,8,8-trimethyl-2,3,4b,5,6,7,8,8a,9,10-
decahydrophenanthren-4(1H)-one (2-94). Thionyl chloride (0.23 mL, 3.17 mmol) was 
added dropwise to a stirred solution of alcohol 2-120 (230 mg, 0.58 mmol) in pyridine (5 mL) 
at 0 °C. The resulting mixture was allowed to warm to room temperature and stirred for 20 
min before it was concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 15:1) to give enone 2-94 as a colorless oil (220 mg, 100%). Rf = 
0.52 (petroleum ether/EtOAc, 9:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.09 (s, 3H, 
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Si(CH3)2), 0.11 (s, 3H, Si(CH3)2), 0.84 (dd, J = 12.2, 1.6 Hz, 1H, 8a-H), 0.94 (s, 3H, 8-CH3), 
1.00 (s, 3H, 8-CH3), 1.03 (s, 9H, SiC(CH3)3), 1.03–1.08 (m, 1H, 5-H),1.23–1.49 (m, 4H, 2 × 
2-H, 2 × 9-H), 1.39 (s, 3H, 4b-CH3), 1.58–1.69 (m, 3H, 2 × 1-H, 6-H), 1.75–1.86 (m, 3H, 6-
H, 2 × 10-H), 2.06 (ddd, J = 16.2, 9.3, 7.1 Hz, 1H, 3-H), 2.27–2.34 (m, 1H, 3-H), 3.19–3.28 
(m, 2H, 5-H, 7-H); 
13
C-NMR (100 MHz, CDCl3): [ppm] = –4.8 (Si(CH3)2), –3.6 (Si(CH3)2), 
16.6 (8-CH3), 18.3 (C-9), 18.4 (SiC(CH3)3), 19.6 (4b-CH3), 22.3 (C-2), 26.2 (SiC(CH3)3), 
28.7 (C-6), 28.9 (8-CH3), 31.8 (C-1), 34.6 (C-10), 34.7 (C-5), 37.8 (C-4b), 39.8 (C-8), 40.0 
(C-3), 51.8 (C-8a), 79.8 (C-7), 142.8 (C-4a), 154.8 (C-10a), 196.7 (C-4); HRMS (ESI): 
[M+Na]
+
 calcd for C23H40O2SiNa 377.287034, found 377.286828. 
 
 
(2S,4aS,10aR)-1,1,4a-Trimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-2,6-diol (2-
129). To a solution of enone 2-95 (1.00 g, 2.65 mmol) in acetonitrile (50 mL) was added a 
solution of CuBr2 (1.00 g, 4.48 mmol) in acetonitrile (50 mL) added dropwise over 2 h at 
room temperature. The resulting mixture was stirred for additional 1 h, treated with phosphate 
buffer (pH = 7; 200 mL) and extracted with diethyl ether (3 × 100 mL). The combined 
organic layers were washed with saturated NaCl solution (100 mL), dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 4:1 to 1:1) to give phenol 2-129 (690 mg, quant.) as yellowish 
crystals. Rf = 0.45 (petroleum ether/ EtOAc 1:1); 
1
H NMR (400 MHz, CD3OD): [ppm] = 
0.86 (s, 3H, 1-CH3), 1.03 (s, 3H, 1-CH3), 1.15 (s, 3H, 4a-CH3), 1.19–1.25 (m, 1H, 10a-H), 
1.35 (ddd, J = 12.9, 12.9, 4.4 Hz, 1H, 4-H), 1.63–1.87 (m, 4H, 2 × 3-H, 2 × 10-H), 2.22 (ddd, 
J = 13.0, 13.5, 3.4 Hz, 1H, 4-H), 2.64–2.84 (m, 2H, 2 × 9-H), 3.20 (dd, J = 11.1, 5.0 Hz, 1H, 
2-H), 6.47 (dd, J = 8.1, 2.5 Hz, 1H, 7-H), 6.65 (d, J = 2.5 Hz, 1H, 5-H), 6.79 (d, J = 8.1 Hz, 
1H, 8-H); 
13
C NMR (100 MHz, CD3OD): [ppm] = 16.1 (1-CH3), 20.2 (C-10), 25.3 (4a-CH3), 
28.8 (C-3, 1-CH3), 31.0 (C-9), 38.5 (C-4), 39.1 (C-4a), 40.1 (C-1), 51.5 (C-10a), 79.4 (C-2), 
111.8 (C-5), 113.9 (C-7), 126.9 (C-8a), 130.7 (C-8), 151.7 (C-4b), 156.1 (C-6); HRMS (ESI): 
[M–H]– calcd for C17H23O2 259.170354, found 259.170369. 
 
 
(2S,4aS,10aR)-6-((tert-Butyldimethylsilyl)oxy)-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a-
octahydrophenanthren-2-ol (2-130). TBSCl (140 mg, 0.93 mmol) was added in one portion 
to a stirred solution of phenol 2-129 (220 mg, 0.85 mmol) and imidazole (125 mg, 1.86 
mmol) in THF (10 mL) at 0 °C. The resulting mixture was allowed to warm to room 
142  Experimental Section 
temperature and stirred overnight, diluted with water (20 mL) and extracted with diethyl ether 
(3 × 20 mL). The combined organic layers were washed with saturated NaCl solution (10 
mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 9:1 to 4:1) to give mono-TBS-protected compound 
2-130 (290 mg, 91%) as a colorless oil. Rf = 0.43 (petroleum ether/EtOAc, 4:1); 
1
H NMR 
(400 MHz, CD3OD): [ppm] = 0.15 (2 × s, 6H, Si(CH3)2), 0.87 (s, 3H, 1-CH3), 0.96 (s, 9H, 
C(CH3)3), 1.05 (s, 3H, 1-CH3), 1.16 (s, 3H, 4a-CH3), 1.25 (dd, J = 12.2, 2.1 Hz, 1H, 10a-H), 
1.45 (ddd, J = 12.8, 12.8, 4.7 Hz, 1H, 4-H), 1.69–1.90 (m, 4H, 2 × 3-H, 2 × 10-H), 2.22 (ddd, 
J = 12.9, 12.9, 3.5 Hz, 1H, 4-H), 2.67–2.88 (m, 2H, 2 × 9-H), 3.21 (dd, J = 11.0, 5.2 Hz, 1H, 
2-H), 6.53 (dd, J = 8.3, 2.5 Hz, 1H, 7-H), 6.67 (d, J = 2.3 Hz, 1H, 5-H), 6.84 (d, J = 8.3 Hz, 
1H, 8-H); 
13
C NMR (100 MHz, CD3OD): [ppm] = –4.2 (Si(CH3)2), 16.1 (1-CH3), 19.1 (SiC), 
20.2 (C-10), 25.4 (4a-CH3), 26.3 (C(CH3)3), 28.8 (C-3, 1-CH3), 31.1 (C-9), 38.4 (C-4), 38.7 
(C-4a), 40.1 (C-1), 51.4 (C-10a), 79.4 (C-2), 116.8 (C-5), 118.6 (C-7), 129.0 (C-8a), 130.8 
(C-8), 151.7 (C-4b), 154.8 (C-6); HRMS (ESI): [M+H]
+
 calcd for C23H39O2Si 375.271383, 
found 375.271019. 
 
 
(4aS,10aR)-6-((tert-Butyldimethylsilyl)oxy)-1,1,4a-trimethyl-1,4,4a,9,10,10a-
hexahydrophenanthren-2(3H)-one (2-131). Dess-Martin reagent (500 mg, 1.17 mmol) was 
added to a stirred suspension of alcohol 2-130 (400 mg, 1.07 mmol) and Na2CO3 (400 mg) in 
CH2Cl2 (10 mL) at 0 °C. The reaction mixture was stirred for 2 h at room temperature, treated 
with saturated Na2S2O3 (5 mL) followed by addition of saturated NaHCO3 (20 mL) solution. 
The organic phase was separated and the aqueous phase extracted with diethyl ether (3 × 30 
mL). The combined organic layers were washed with saturated NaCl solution (20 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 12:1 to 6:1) to give ketone 2-131 (400 mg, quant.) 
as a colorless oil. Rf = 0.77 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CD3OD): 
[ppm] = 0.15 (s, 6H, Si(CH3)2), 0.96 (s, 9H, Si(CH3)3), 1.11 (s, 3H, 1-CH3), 1.14 (s, 3H, 1-
CH3), 1.25 (s, 3H, 4a-CH3), 1.72–1.93 (m, 4H, 3-H, 10a-H, 2 × 10-H), 2.41 (m, 1H, 3-H), 
2.57–2.87 (m, 4H, 2 × 4-H, 2 × 9-H), 6.57 (dd, J = 8.1, 2.5 Hz, 1H, 7-H), 6.70 (d, J = 2.5 Hz, 
1H, 5-H), 6.89 (d, J = 8.1 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CD3OD): [ppm] = –4.2 
(Si(CH3)2), 19.1 (SiC), 21.4 (1-CH3, C-10), 25.0 (4a-CH3), 26.2 (C(CH3)3), 27.4 (1-CH3), 
31.1 (C-9), 35.5 (C-4), 38.5 (C-4a), 38.7 (C-3), 48.4 (C-1), 51.9 (C-10a), 117.8 (C-5), 119.1 
(C-7), 129.0 (C-8a), 130.9 (C-8), 149.7 (C-4b), 155.0 (C-6), 219.9 (C-2); HRMS (ESI): 
[M+Na]
+
 calcd for C23H36O2SiNa 395.237678, found 395.237858. 
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(4aS,10aR)-6-Hydroxy-1,1,4a-trimethyl-1,4,4a,9,10,10a-hexahydrophenanthren-2(3H)-
one (5). pTsOH monohydrate (23 mg, 0.12 mmol) was added to a stirred solution of ketone 2-
131 (30 mg, 0.08 mmol) in methanol (2 mL) at room temperature. The resulting solution was 
stirred overnight at the same temperature, poured into water (20 mL) and extracted with ethyl 
acetate (3 × 20 mL). The combined organic layers were washed with saturated NaCl solution 
(20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
flash chromatography (petroleum ether/EtOAc, 6:1 to 2:1) to give phenol 2-128 (20 mg, 
quant.) as a colorless oil. Rf = 0.19 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, 
CD3OD): [ppm] = 1.12 (s, 3H, 1-CH3), 1.14 (s, 3H, 1-CH3), 1.25 (s, 3H, 4a-CH3), 1.65–1.93 
(m, 4H, 10a-H, 3-H, 2 × 10-H), 2.34 (ddd, J = 13.1, 7.8, 4.3 Hz, 1H, 3-H), 2.55–2.86 (m, 4H, 
2 × 4-H, 2 × 9-H), 6.52 (dd, J = 8.3, 2.5 Hz, 1H, 7-H), 6.69 (d, J = 2.5 Hz, 1H, 5-H), 6.79 (d, 
J = 8.3 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CD3OD): [ppm] = 21.5 (1-CH3, C-10), 25.0 (4a-
CH3), 27.4 (1-CH3), 31.1 (C-9), 35.6 (C-4), 38.7 (C-4a), 38.7 (C-3), 48.9 (C-1), 52.0 (C-10a), 
112.7 (C-5), 114.4 (C-7), 126.9 (C-8a), 130.8 (C-8), 149.6 (C-4b), 156.4 (C-6), 220.2 (C-2); 
HRMS (ESI): [M–H]– calcd for C17H21O2 257.154703, found 257.154736. 
 
 
(5aR,11bS)-10-((tert-Butyldimethylsilyl)oxy)-5,5,11b-trimethyl-1,5,5a,6,7,11b-
hexahydronaphtho[2,1-c]oxepin-3(2H)-one (2-132). mCPBA (70%; 790 mg, 3.22 mmol) 
was added to a stirred suspension of ketone 2-131 (600 mg, 1.61 mmol) and NaHCO3 (135 
mg, 1.61 mmol) in CH2Cl2 (10 mL) at room temperature. The resulting mixture was stirred 
overnight, treated with saturated Na2S2O3 (5 mL) followed by addition of saturated NaHCO3 
(30 mL) solution. The organic phase was separated and the aqueous phase extracted with 
ethyl acetate (3 × 20 mL). The combined organic layers were washed with saturated NaCl 
solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 12:1 to 6:1) to give lactone 2-132 
(580 mg, 93%) as a colorless oil. Rf = 0.37 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 0.16 (s, 6H, Si(CH3)2), 0.96 (s, 9H, C(CH3)3), 1.46 (s, 3H, 5-CH3), 
1.47 (s, 3H, 11b-CH3), 1.56 (s, 3H, 5-CH3), 1.70–1.76 (m, 2H, 2 × 6-H), 1.96 (ddd, J = 14.2, 
6.0, 3.8 Hz, 1H, 1-H), 2.22–2.34 (m, 2H, 1-H, 5a-H), 2.53–2.80 (m, 4H, 2 × 2-H, 2 × 7-H), 
6.58 (dd, J = 8.3, 2.5 Hz, 1H, 9-H), 6.66 (d, J = 2.3 Hz, 1H, 11-H), 6.84 (d, J = 8.3 Hz, 1H, 8-
H); 
13
C NMR (100 MHz, CDCl3): [ppm] = –4.4 (Si(CH3)2), 18.9 (SiC), 24.8 (C-6), 25.7 
(C(CH3)3), 26.4 (5-CH3), 26.5 (11b-CH3), 30.1 (C-7), 30.2 (5-CH3), 32.7 (C-2), 39.0 (C-1), 
39.5 (C-11b), 49.3 (C-5a), 85.8 (C-5), 117.9 (C-9), 118.1 (C-11), 126.5 (C-7a), 129.1 (C-8), 
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149.4 (C-11a), 154.1 (C-11b), 174.1 (C-3); HRMS (ESI): [M+H]
+
 calcd for C23H37O3Si 
389.250648, found 389.250822. 
 
 
Methyl 3-((1S,2R)-7-hydroxy-2-(2-hydroxypropan-2-yl)-1-methyl-1,2,3,4-
tetrahydronaphthalen-1-yl)propanoate (2-133) and methyl 3-((1S,2S)-7-hydroxy-1-
methyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydronaphthalen-1-yl)propanoate (2-11). pTsOH 
monohydrate (2.03 g, 10.7 mmol) was added in one portion to a stirred solution of lactone 2-
132 (520 mg, 1.34 mmol) in methanol (10 mL) at room temperature. The resulting solution 
was stirred overnight, treated with saturated NaHCO3 solution (30 mL) and extracted with 
ethyl acetate (3 × 30 mL). The combined organic layers were washed with saturated NaCl 
solution (30 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 9:1 to 4:1) to give the two esters 
2-133 and 2-11 (2-133: 320 mg, 60%); (2-11: 160 mg, 30%) as colorless oils. 
2-11: Rf = 0.33 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.19 (s, 
3H, 1-CH3), 1.77 (s, 3H, CH3C=CH2), 1.56 (s, 3H, 5-CH3), 1.80–2.15 (m, 5H, 2′-H, 2 × 3′-H, 
2 × 3-H), 2.21–2.29 (m, 1H, 2'-H), 2.38 (dd, J = 11.4, 3.0 Hz, 1H, 2-H), 2.68–2.75 (m, 2H, 2 
× 4-H), 3.61 (s, 3H, OCH3), 4.69 (br s, 1H, =CH2), 4.94 (br s, 1H, =CH2), 6.61 (dd, J = 8.1, 
2.5 Hz, 1H, 6-H), 6.75 (d, J = 2.5 Hz, 1H, 5-H), 6.89 (d, J = 8.1 Hz, 1H, 8-H); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 22.8 (CH3C=CH2), 24.7 (C-3), 27.8 (1-CH3), 29.5 (C-2′, C-4), 34.6 
(C-3′), 41.1 (C-1), 47.0 (C-2), 51.7 (OCH3), 112.9 (C-8), 113.3 (C-6), 114.3 (C=CH2), 129.1 
(C-4a), 130.1 (C-5), 144.5 (C-8a), 146.6 (C=CH2), 154.0 (C-7), 175.0 (ester); HRMS (ESI): 
[M+Na]
+
 calcd for C18H24O3Na 311.161766, found 311.161980. 
2-133: Rf = 0.10 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.29 
(s, 3H, C(CH3)2), 1.35 (s, 3H, 1-CH3), 1.47 (s, 3H, C(CH3)2), 1.50–1.76 (m, 3H, 2 × 3-H, 2-
H), 1.92–2.10 (m, 3H, 2 × 3′-H, 2′-H), 2.17 (s, 1H, OH), 2.56–2.69 (m, 2H, 2′-H, 4-H), 2.82–
2.88 (m ,1H, 4-H), 3.60 (s, 3H, OCH3), 6.58 (dd, J = 8.3, 2.5 Hz, 1H, 6-H), 6.79 (d, J = 2.3 
Hz, 1H, 8-H), 6.85 (d, J = 8.3 Hz, 1H, 5-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 24.5 (C-
3), 26.8 (C(CH3)2), 27.2 (1-CH3), 29.6 (C-4), 30.7 (C(CH3)2), 33.2 (C-2′), 36.6 (C-3′), 43.4 
(C-1), 48.7 (C-2), 51.8 (OCH3), 75.5 (C(CH3)2), 112.9 (C-6), 113.2 (C-8), 129.6 (C-4a), 129.8 
(C-5), 146.4 (C-8a), 154.4 (C-7), 176.3 (C-1′); HRMS (ESI): [M+Na]+ calcd for C18H26O4Na 
329.172330, found 329.172482. 
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3-Isobutoxycyclohex-2-enone (2-139).
190
 pTSA (0.2 g, 1.3 mmol) was added to a stirred 
solution of cyclohexan-1,3-dione (2-140) (25.0 g, 0.22 mol) and isobutanol (62 mL, 0.67 mol) 
in benzene (300 mL) at room temperature. The reaction mixture was stirred under reflux for 
3.5 h before it was cooled to room temperature, treated with triethylamine (1 mL) and 
concentrated in vacuo. The residue was destilled at low pressure (b.p. 106–108 °C, 1 × 10–1 
mbar) to give vinylogous ester 2-139 as a colorless oil (31.4 g, 84%). Rf = 0.33 (petroleum 
ether/ EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 1.03 (d, J = 6.6 Hz, 6H, 
CH(CH3)2), 1.90–2.02 (m, 3H, 2 × 5-H, CH(CH3)2), 2.28–2.38 (m, 4H, 2 × 4-H, 2 × 6-H), 
3.55 (d, J = 6.4 Hz, 2H, OCH2), 5.29 (s, 1H, 2-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
19.0 (CH(CH3)2), 21.2 (C-5), 27.7 (CH(CH3)2), 29.0 (C-4), 36.7 (C-6), 74.7 (OCH2), 102.7 
(C-2), 178.1 (C-3), 199.8 (C-1). 
 
 
3-(3-Hydroxy-propyl)cyclohex-2-en-1-one (2-142). To a solution of 3-chloro-1-propanol 
(1.0 mL, 12.0 mmol) in THF (15 mL) a solution of MeMgCl in THF (20%, 4.4 mL, 12.0 
mmol) was added at –78 °C. The mixture was allowed to warm to room temperature, 
magnesium turnings (0.32 g, 13.1 mmol) were added and the mixture was heated under reflux 
for 3 h before it was cooled to –10 °C and treated with 3-isobutoxycyclohex-2-en-1-one (2-
139) (1.30 g, 8.0 mmol). After 1.5 h the reaction was allowed to warm to 0 °C and treated 
with saturated NH4Cl solution (5 mL). The reaction mixture was partitioned between aqueous 
hydrochloric acid (2N, 50 mL) and cold ethyl acetate (30 mL). The aqueous phase was 
extracted with ethyl acetate (4 × 30 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo, followed by flash chromatography (petroleum 
ether/EtOAc, 1:1) to give a mixture of 2-142 and 2-143 (0.83 g, 66%) as a colorless oil. Rf = 
0.25 (EtOAc). Hydroxy enone 2-142: 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.68–1.79 (m, 
2H, 2‘-H), 1.91–2.00 (m, 2H, 5-H), 2.24–2.37 (m, 7H, 1’-H, 4-H, 6-H, OH), 3.62 (t, J = 6.3 
Hz, 2H, 3’-H), 5.83-5.89 (m, 1H, 2-H); 13C NMR (100 MHz, CDCl3): [ppm] = 22.6 (C-5), 
29.7 (C-1’), 29.7 (C-2’), 34.2 (C-4), 37.2 (C-6), 61.8 (C-3’), 125.5 (C-2), 166.4 (C-3), 200.13 
(C-1). 
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3-[3-(tert-Butyldiphenylsilyl)oxy-propyl]cyclohex-2-en-1-on (2-138). A solution of 2-142 
and 2-143 (2.0 g, 13.0 mmol) in CH2Cl2 (20 mL) was treated with imidazol (1.8 g, 26 mmol) 
at 0 °C followed by dropwise addition of TBDPSCl (3.7 mL, 14.3 mmol) at the same 
temperature. The reaction mixture was allowed to warm to room temperature and stirred for 4 
h before it was treated with water (20 mL). The aqueous layer was extracted with diethyl ether 
(3 × 20 mL). The combined organic layers were washed with water (20 mL), saturated NaCl 
solution (20 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc 4:1) to give enone 2-138 (4.70 g, 
93%) as a colorless oil. Rf = 0.46 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.07 (s, 9H, C(CH3)3), 1.71–1.78 (m, 2H, 2 × 8-H), 1.89–1.97 (m, 2H, 2 × 5-H), 
2.23 (dd, J = 5.8, 5.8 Hz, 2H, 2 × 4-H), 2.30–2.34 (m, 4H, 2 × 6-H, 2 × 7-H), 3.69 (dd, J = 
6.2, 6.2 Hz, 2H, 2 × 9-H), 7.35–7.43 (m, 6H, HAr), 7.65–7.70 (m, 4H, HAr); 
13
C NMR (100 
MHz, CDCl3):  [ppm] = 19.0 (C(CH3)3), 22.5 (C-5), 26.7 (C(CH3)3), 29.5 (C-4), 29.6 (C-8),  
34.2 (C-7), 37.1 (C-6), 62.8 (C-9), 125.5 (C-2), 127.5 (CAr), 129.5 (CAr), 133.5 (CAr), 135.3 
(CAr), 165.9 (C-3), 199.4 (C-1); HRMS: calcd for C25H32O2Si 415.20638 [M+Na]
+
, found 
415.206436. 
 
 
(1R,2S,4S)-Methyl 1-(3-((tert-butyldiphenylsilyl)oxy)propyl)-5-oxobicyclo[2.2.2]octane-2-
carboxylate (2-145). A solution of enone 2-138 (4.7 g, 12.1 mmol) in hexane (40 mL) was 
added dropwise to a stirred solution of LiHMDS (1M in THF, 15.7 mL, 15.7 mmol) in hexane 
(20 mL) at –78 °C. The resulting mixture was stirred for 45 min before it was treated with 
methyl acrylate (2.2 mL, 24.1 mmol) at the same temperature. The cooling bath was removed, 
the the reaction mixture was allowed to warm to room temperature and stirred for additional 2 
h before it was treated with saturated NH4Cl solution (10 mL). The aqueous layer was diluted 
with water (100 mL) and extracted with diethyl ether (3 × 50 mL). The combined organic 
layers were washed with water (100 mL), saturated NaCl solution (100 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc 9:1) to give ester 2-145 (4.9 g, 86%) as white crystals (m.p. 99.7–
100.2 °C (n-hexane)). Rf = 0.46 (petroleum ether/EtOAc 4:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.03 (s, 9H, C(CH3)3), 1.23–1.34 (m, 2H, 2 × 1’-H), 1.36–1.50 (m, 2H, 2’-H, 6-H), 
1.52–1.67 (m, 2H, 2’-H, 6-H), 1.74–1.90 (m, 2H, 2 × 7-H), 1.95 (dd, J = 18.8, 1.5 Hz, 1H, 4-
H), 2.04 (dd, J = 8.8 Hz, 2.7 Hz, 2H, 2 × 3-H), 2.33 (ddd, J = 5.9, 2.9, 2.9 Hz, 1H, 8-H), 2.61–
2.69 (m, 2H, 4-H, 2-H), 3.57–3.64 (m, 2H, 2 × 3‘-H), 3.60 (s, 3H, OCH3), 7.35–7.44 (m, 6H, 
HAr), 7.63–7.65 (m, 4H, HAr); 
13
C NMR (100 MHz, CDCl3): [ppm] = 19.2 (C(CH3)3), 23.0 
(C-7), 26.5 (C-2‘), 26.8 (C(CH3)3), 28.0 (C-3), 29.9 (C-6), 33.9 (C-1‘), 38.4 (C-1), 41.8 (C-8), 
44.2 (C-2), 44.7 (C-4), 51.6 (OCH3), 64.1 (C-3‘), 127.6 (CAr), 129.6 (CAr), 133.9 (CAr), 135.5 
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(CAr), 175.4 (CO2Me), 215.2 (C-5); HRMS: calcd for [M+Na]
+
 C29H38O4Si 501.24316, found 
501.243420. 
 
 
(1R,2S,4S,5RS)-Methyl 1-(3-((tert-butyldiphenylsilyl)oxy)propyl)-5-
hydroxybicyclo[2.2.2]octane-2-carboxylate (2-146). Sodium borohydride (36 mg, 0.95 
mmol) was added to a stirred solution of ketone 2-145 (228 mg, 0.5 mmol) in a 
THF/methanol mixture (22 mL, 10:1) at –40 °C. The resulting mixture was stirred for 1 h at 
room temperature before it was diluted with diethyl ether (20 mL) and treated with water (20 
mL). The aqueous layer was extracted with diethyl ether (3 × 20 mL). The combined organic 
layers were washed with water (50 mL), saturated NaCl solution (50 mL), dried over MgSO4, 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc 4:1) to give alcohols 2-146-A (144 mg, 62%) and 2-146-B (34 mg, 
14%) as colorless oils.  
Diastereomer A: Rf = 0.55 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.03 (s, 9H, C(CH3)3), 1.08–1.37 (m, 4H, 2 × 6-H, 2 × 2’-H), 1.37–1.51 (m, 3H, 4-
H, 7-H, 2’-H), 1.52–1.69 (m, 3H, 4-H, 7-H, 2’-H), 1.70–1.83 (m, 2H, 4-H, 8-H), 2.07–2.15 
(m, 1H, 3-H), 2.49–2.57 (m, 1H, 2-H), 3.60 (s, 3H, OCH3), 3.55–3.63 (m, 2H, 2 × 3’-H), 
3.79–3.84 (m, 1H, 5-H), 7.34–7.44 (m, 6H, HAr), 7.62–7.67 (m, 4H, HAr); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 19.2 (C(CH3)3), 23.3 (C-3, C-7), 26.3 (C-2’), 26.8 (C(CH3)3), 29.5 
(C-6), 31.1 (C-8), 34.4 (C-1), 35.5 (C-1’), 38.9 (C-4), 44.5 (C-2), 51.7 (OCH3), 64.5 (C-3’), 
68.5 (C-5), 127.6 (CAr), 129.5 (CAr), 134.0 (CAr), 135.5 (CAr), 178.9 (Ester); HRMS (ESI): 
[M+Na]
+
 calcd for C29H40O4SiNa 503.25881, found 503.259225. 
Diastereomer B: Rf = 0.50 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.03 (s, 9H, C(CH3)3), 1.06–1.66 (m, 9H, 4-H, 6-H2, 7-H, 2 × 1’-H, 2 × 2’-H), 1.66–
1.75 (m, 2H, 3-H, 8-H), 1.76–1.85 (m, 1H, 3-H), 1.92–2.02 (m, 1H, 7-H), 2.07–2.18 (m, 1H, 
4-H), 2.38–2.48 (m, 1H, 2-H), 3.56 (s, 3H, OCH3), 3.30–3.44 (m, 2H, 2 × 3’-H), 4.10–4.18 
(m, 1H, 5-H), 7.33–7.44 (m, 6H, HAr), 7.62–7.69 (m, 4H, HAr); 
13
C NMR (100 MHz, CDCl3): 
[ppm] = 18.6 (C-7), 19.2 (C(CH3), 26.5 (C-2), 26.8 (C(CH3), 28.4 (C-3), 30.3 (C-6), 31.5 (C-
8), 34.4 (C-1), 34.8 (C-1’), 38.5 (C-4), 44.1 (C-2), 51.2 (OCH3), 64.5 (C-3’), 68.9 (C-5), 
127.6 (CAr), 129.5 (CAr), 134.0 (CAr), 135.5 (CAr), 176.4 (Ester); [M+Na]
+
 calcd for 
C29H40O4SiNa 503.25881, found 503.259104. 
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(1R,2S,4S)-Methyl 1-(3-((tert-butyldiphenylsilyl)oxy)propyl)bicyclo[2.2.2]oct-5-ene-2-
carboxylate (2-147). Xanthogenate preparation. A solution of alcohols 2-146 (150 mg, 0.31 
mmol) in THF (5 mL) was added dropwise to a stirred suspension of sodium hydride (60%, 
125 mg, 3.12 mmol) in THF (10 mL) at 0 °C. The mixture was allowed to warm to room 
temperature and stirred for 1 h before it was treated with CS2 (0.38 mL, 6.24 mmol) at 0 °C. 
The resulting mixture was stirred for 3 h at room temperature before it was treated with 
methyl iodide (0.78 mL, 12.48 mmol) at 0 °C. The mixture was allowed to warm to room 
temperature and stirred for 1 h before it was carefully treated with water (20 mL) at 0 °C. The 
organic phase was separated and the aqueous phase was extracted with diethyl ether (3 × 20 
mL). The combined organic layers were washed with water (20 mL), saturated NaCl solution 
(20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
flash chromatography (petroleum ether/EtOAc 9:1) to give a diastereomeric mixture of 
xanthogenates (138 mg, 78%) as an yellow oil. Rf = 0.47 (petroleum ether/EtOAc 9:1). 
Chugaev reaction. A solution of the foregoing xanthogenates (138 mg, 0.24 mmol) in o-
dichlorobenzene was stirred for 20 h at 180 °C before it was concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc 15:1) to give alkene 2-
147 (96 mg, 86%) as an yellow oil. Rf = 0.53 (petroleum ether/EtOAc 9:1); 
1
H NMR (400 
MHz, CDCl3): δ[ppm] = 1.04 (s, 9H, C(CH3)3), 1.11–1.19 (m, 1H, 6-H), 1.28–1.38 (m, 2H, 6-
H, 7-H), 1.42–1.68 (m, 6H, 2 × 1’-H, 2 × 2’-H, 3-H, 7-H), 1.85 (ddd, J = 12.4, 9.8, 2.8 Hz, 
1H, 3-H), 2.53 (dd, J = 9.8, 5.8 Hz, 1H, 2-H), 2.55–2.59 (m, 1H, 8-H), 3.54 (s, 3H, OCH3), 
3.65 (ddd, J = 9.8 Hz, 6.1, 4.3 Hz, 2H, 2 × 3’-H), 6.94 (d, J = 8.3 Hz, 1H, 4-H), 6.33 (dd, J = 
8.1, 6.8 Hz, 1H, 5-H), 7.35–7.43 (m, 6H, HAr), 7.63–7.67 (m, 4H, HAr); 
13
C NMR (100 MHz, 
CDCl3): δ[ppm] = 19.2 (C(CH3)3), 25.3 (C-7), 26.9 (C(CH3)3), 27.5 (C-2’), 29.7 (C-8), 30.6 
(C-6), 32.5 (C-1’), 33.4 (C-3), 39.1 (C-1), 47.1 (C-2), 51.2 (OCH3), 64.5 (C-3’), 127.6 (CAr), 
129.5 (CAr), 133.9 (CAr), 134.1 (C-5), 134.9 (C-4), 135.6 (CAr), 176.1 (ester); HRMS (ESI): 
[M+Na]
+
 calcd for C29H38O3SiNa 485.24824, found 485.247910. 
 
 
(1R,2S,4R)-Methyl 1-(3-hydroxypropyl)bicyclo[2.2.2]oct-5-ene-2-carboxylate (2-148). 
TBAF·3H2O (800 mg, 2.53 mmol) was added in one portion to a stirred solution of ester 2-
147 (760 mg, 1.64 mmol) in THF (50 mL) at room temperature. The resulting solution was 
stirred for 3 h before it was treated with water (50 mL) and extracted with diethyl ether (3 × 
50 mL). The combined organic layers were washed with saturated NaCl solution (50 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc 2:1) to give alcohol 2-148 (298 mg, 81%) as a 
colorless oil. Rf = 0.17 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 
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1.14–1.70 (m, 9H, 2 × 1’-H, 2 × 2’-H, 3-H, 2 × 6-H, 2 × 7-H), 1.86 (ddd, J = 12.5, 9.8, 2.6 
Hz, 1H, 3-H), 2.54–2.60 (m, 2H, 2-H, 8-H), 3.60 (s, 3H, OCH3), 3.61–3.67 (m, 2H, 2 × 3’-H), 
5.95 (d, J = 8.3 Hz, 1H, 4-H), 6.34 (dd, J = 8.3, 6.8 Hz, 1H, 5-H); 
13
C NMR (100 MHz, 
CDCl3): δ[ppm] = 25.3 (C-7), 27.6 (C-2’), 29.7 (C-8), 30.6 (C-6), 32.4 (C-1’), 33.3 (C-3), 
38.9 (C-1), 46.9 (C-2), 51.3 (OCH3), 63.6 (C-3’), 134.8 (C-5), 134.0 (C-4), 176.1 (ester). 
 
 
(1R,2S,4S)-Methyl 1-(3-oxopropyl)bicyclo[2.2.2]oct-5-ene-2-carboxylate (2-137). Dess-
Martin reagent
58
 (620 mg, 1.46 mmol) was added in one portion to a stirred solution of 
alcohol 2-148 (298 mg, 1.33 mmol) in CH2Cl2 (20 mL) at 0 °C. The resulting mixture was 
stirred for 2 h at room temperature before it was treated with saturated Na2S2O3 solution (30 
mL) and stirred for additional 15 min. The resulting mixture was washed with saturated 
NaHCO3 solution (100 mL). The organic phase was separated and the aqueous phase 
extracted with CH2Cl2 (3 × 50 mL).The combined organic layers were washed with saturated 
NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give aldehyde 2-137 
(295 mg, 100%) as a colorless oil. Rf = 0.64 (petroleum ether/ EtOAc 2:1); 
1
H NMR (400 
MHz, CDCl3): δ[ppm] = 1.05–1.12 (m, 1H, 6-H), 1.29–1.39 (m, 2H, 1’-H, 6-H, 7-H), 1.47–
1.56 (m, 2H, 3-H, 7-H), 1.78–1.94 (m, 3H, 1’-H, 2 × 2’-H), 2.44–2.61 (m, 3H, 2-H, 8-H, 3-
H), 3.60 (OCH3), 5.91 (d, J = 8.3 Hz, 1H, 4-H), 6.36 (dd, J = 8.3, 6.8 Hz, 1H, 5-H), 9.79 (dd, 
J = 1.6, 1.6 Hz, 1H, 3’-H); 13C NMR (100 MHz, CDCl3): δ[ppm] = 25.2 (C-7), 28.1 (C-2’), 
29.6 (C-8), 30.6 (C-6), 33.1 (C-1’), 38.7 (C-3), 39.3 (C-1), 46.6 (C-2), 51.4 (OCH3), 133.9 (C-
5), 134.6 (C-4), 175.6 (ester), 202.2 (C-3’); HRMS (ESI): [M+Na+MeOH]+ calcd for 
C14H22O4Na 277.14103, found 277.14121. 
 
 
(1R,2S,4S)-Methyl 1-(5-ethoxy-3,5-dioxopentyl)bicyclo[2.2.2]oct-5-ene-2-carboxylate (2-
149). Anhydrous tin (II) chloride
181
 (270 mg, 1.42 mmol) was added, followed by dropwise 
addition of ethyl diazoacetate (0.4 mL, 3.73 mmol) to the stirred solution of crude aldehyde 2-
137 (280 mg, 1.26 mmol) in CH2Cl2 (30 mL) at room temperature. Stirring was continued for 
1 h before the reaction was treated with water (100 mL) and the mixture extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with water (50 mL), 
saturated NaCl solution (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/diethyl ether, 4:1) to give β-
keto ester 2-149 (377 mg, 97%) as a colorless oil. Rf = 0.57 (petroleum ether/EtOAc, 2:1); 
HRMS (ESI): [M+Na]
+
 calcd for C17H24O5Na 331.15159, found 331.151403. 
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(1R,2S,4S)-Methyl 1-(4-diazo-5-ethoxy-3,5-dioxopentyl)bicyclo[2.2.2]oct-5-ene-2-
carboxylate (2-136). p-ABSA (1-120, 340 mg, 1.40 mmol) was added in one portion to a 
stirred solution of -keto ester 2-149 (360 mg, 1.17 mmol) and triethylamine (0.32 mL, 2.34 
mmol) in acetonitrile (20 mL) at 0 °C. The resulting mixture was stirred 20 h at room 
temperature before it was treated with water (50 mL) and extracted with diethyl ether (3 × 20 
mL). The combined organic layers were washed with water (50 mL), saturated NaCl solution 
(50 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
flash chromatography (petroleum ether/ diethyl ether, 4:1) to give diazo ester 2-136 (310 mg, 
80%) as a yellowish oil. Rf = 0.65 (petroleum ether/EtOAc, 2:1); 
1
H NMR (400 MHz, 
CDCl3): δ[ppm] = 1.12 (ddd, J = 11.6, 11.6, 4.7 Hz, 1H, 6-H), 1.25–1.53 (m, 4H, 6-H, 7-H, 3-
H), 1.29 (dd, J = 7.1, 7.1 Hz, 3H, OCH2CH3), 1.75–1.90 (m, 3H, 1’-H, 2’-H, 7-H), 2.52–2.56 
(m, 2H, 2’-H, 8-H), 2.91 (ddd, J = 9.8, 6.5, 4.4 Hz, 2H, 2-H, 3-H), 4.26 (ddd, J = 7.1, 7.1, 7.1 
Hz, 2H, OCH2CH3), 5.94 (d, J = 8.3 Hz, 1H, 4-H), 6.31 (dd, J = 8.3, 6.8 Hz, 1H, 5-H); 
13
C 
NMR (100 MHz, CDCl3): δ[ppm] = 14.3 (OCH2CH3), 25.2 (C-7), 29.5(C-8), 30.4 (C-6), 33.1 
(C-1’), 35.4 (C-3), 38.8 (C-1), 46.6 (C-2), 51.2 (OCH3), 61.3 (C-2’), 134.2 (C-5), 161.2 (C-4), 
175.6 (ester), 192.8 (C-3’); HRMS (ESI): [M+Na]+ calcd for C17H22N2O5Na 357.14209, 
found 357.141973. 
 
 
3-(4-Hydroxybutyl)cyclohex-2-enone (2-157). A solution of MeMgCl in THF (20%, 13.0 
mL, 35.6 mmol) was added to a stirred solution of 4-chloro-1-butanol (3.86 g, 35.6 mmol) in 
THF (10 mL) at –78°C. The mixture was allowed to warm to room temperature, then 
magnesium turnings (0.92 g, 38.0 mmol) were added and the mixture was heated under reflux 
for 3 h before it was cooled to –10 °C and treated with 3-isobutoxycyclohex-2-en-1-one (2-
139) (4.0 g, 23.8 mmol). After 1.5 h the reaction mixture was allowed to warm to 0 °C and 
treated with saturated NH4Cl solution (10 mL). The mixture was partitioned between aqueous 
hydrochloric acid (2N, 50 mL) and cold diethyl ether (50 mL). The aqueous phase was 
extracted with diethyl ether (4 × 30 mL). The combined organic layers were washed with 
saturated NaCl solution (2 × 50 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (petroleum ether/EtOAc, 1:2) to give 
alcohol 2-157 (2.00 g, 50%) as a colorless oil. Rf = 0.35 (EtOAc). 
1
H NMR (400 MHz, 
CDCl3): [ppm] = 1.54–1.62 (m, 4H, 2 × 3’-H, 2 × 2’-H), 1.97 (ddd, J = 12.8, 6.3, 6.3 Hz, 
2H, 2 × 1’-H), 2.22–2.29 (m, 4H, 2 × 5-H, 2 × 6-H), 2.35 (dd, J = 6.7, 6.7 Hz, 2H, 2 × 4-H), 
3.65 (dd, J = 5.9, 5.9 Hz, 2H, 2 × 4’-H), 5.87 (dd, J = 1.3, 1.3 Hz, 1H, 2-H); 13C NMR (100 
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MHz, CDCl3): [ppm] = 22.7 (C-5), 23.2 (C-2’), 29.6 (C-3’), 32.1 (C-1’), 37.3 (C-4), 37.7 (C-
6), 62.4 (C-4’), 125.8 (C-2), 166.1 (C-3), 199.9 (C-1). 
 
 
3-(4-((tert-Butyldimethylsilyl)oxy)butyl)cyclohex-2-enone (2-158). A solution of alcohol 2-
157 (0.70 g, 4.2 mmol) in CH2Cl2 (20 mL) was treated with imidazole (0.57 g, 8.34 mmol) at 
0 °C followed by addition of TBSCl (0.68 g, 4.59 mmol) at the same temperature. The 
reaction mixture was allowed to warm to room temperature and stirred for 1 h before it was 
treated with water (50 mL). The aqueous layer was extracted with diethyl ether (3 × 20 mL). 
The combined organic layers were washed with water (50 mL), saturated NaCl solution (50 
mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc 4:1) to give enone 2-158 (1.04 g, 89%) as a 
colorless oil. Rf = 0.51 (petroleum ether/EtOAc, 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
0.03 (s, 6H, Si(CH3)2), 0.88 (s, 9H, SiC(CH3)3), 1.49–1.61 (m, 4H, 2 × 2’-H, 2 × 3’-H), 1.97 
(ddd, J = 12.8, 6.3, 6.3 Hz, 2H, 2 × 5-H), 2.22 (dd, J = 6.9, 6.9 Hz, 2H, 2 × 1’-H), 2.27 (dd, J 
= 5.9, 5.9, Hz, 2H, 2 × 4-H), 2.35 (dd, J = 7.3, 7.3 Hz, 2H, 2 × 6-H), 3.61 (dd, J = 5.9, 5.9 Hz, 
2H, 2 × 4’-H), 5.86 (br. s, 1H, 2-H); 13C NMR (100 MHz, CDCl3): [ppm] = –5.3 (Si(CH3)2), 
18.3 (SiC(CH3)3), 22.7 (C-5), 23.3 (C-2’), 25.9 (SiC(CH3)3), 29.6 (C-3’), 32.3 (C-4), 37.4 (C-
6), 37.8 (C-1’), 62.6 (C-4’), 125.7 (C-2), 166.5 (C-3), 200.0 (C-1). 
 
 
(1R,2S,4S)-Methyl 1-(4-((tert-butyldimethylsilyl)oxy)butyl)-5-oxobicyclo[2.2.2]octane-2-
carboxylate (2-159). A solution of enone 2-158 (1.0 g, 3.55 mmol) in hexane (5 mL) was 
added dropwise to a stirred solution of LiHMDS (1M in THF, 4.6 mL, 4.60 mmol) in hexane 
(6 mL) at –78 °C. The resulting mixture was stirred for 30 min before it was treated with 
methyl acrylate (0.64 mL, 7.10 mmol) at the same temperature. The cooling bath was 
removed, then the reaction mixture was allowed to warm to room temperature and stirred for 
additional 1 h before it was treated with saturated NH4Cl solution (10 mL). The aqueous layer 
was diluted with water (50 mL) and extracted with diethyl ether (3 × 20 mL). The combined 
organic layers were washed with water (50 mL), saturated NaCl solution (50 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc 9:1) to give ketoester 2-159 (1.3 g, 100%) as a colorless oil. Rf = 0.47 
(petroleum ether/EtOAc 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 0.03 (s, 6H, Si(CH3)2), 
0.88 (s, 9H, SiC(CH3)3), 1.20–1.49 (m, 9H, 2 × 1’-H, 2 × 2’-H, 2 × 3’-H, 2 × 7-H, 6-H), 1.78–
1.86 (m, 2H), 1.96 (dd, J = 18.8, 1.6 Hz, 1H, 6-H), 2.03 (app dd, J = 8.7, 2.9 Hz, 2H, 2 × 3-
H), 2.32 (ddd, J = 6.0, 2.9, 2.9 Hz, 1H, 4-H), 2.67 (ddd, J = 8.5, 8.5, 1.8 Hz, 1H, 2-H), 3.58 
(dd, J = 6.3, 6.3 Hz, 2H, 2 × 4’-H), 3.66 (s, 3H, OCH3); 
13
C NMR (100 MHz, CDCl3): [ppm] 
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= –4.3 (Si(CH3)2), 18.8 (SiC(CH3)3), 19.5 (C-2’), 23.0 (C-8), 25.4 (SiC(CH3)3), 27.9 (C-3), 
29.9 (C-7), 33.1 (C-3’), 37.4 (C-1’), 38.7 (C-1), 41.8 (C-4), 44.0 (C-2), 45.0 (C-6), 51.7 
(OCH3), 62.4 (C-4’), 175.4 (ester), 215.2 (C-5). 
 
 
(1R,2S,4R)-Methyl 1-(4-hydroxybutyl)bicyclo[2.2.2]octane-2-carboxylate (2-160). 
TBAF·3H2O (2.95 g, 9.35 mmol) was added in one portion to a stirred solution of ester 2-159 
(3.11 g, 8.50 mmol) in THF (100 mL) at room temperature. The resulting solution was st irred 
for 1 h before it was treated with water (100 mL) and extracted with diethyl ether (3 × 50 
mL). The combined organic layers were washed with saturated NaCl solution (50 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc 1:2) to give alcohol 2-160 (1.37 g, 64%) as a 
colorless oil. Rf = 0.27 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
1.19–1.26 (m, 9H, 2 × 1’-H, 2 × 2’-H, 2 × 3’-H, 2 × 7-H, OH), 1.74–1.87 (m, 2H, 8-H), 1.96 
(dd, J = 18.8, 1.6 Hz, 1H, 6-H), 2.03 (app dd, J = 8.5, 2.9 Hz, 2H, 2 × 3-H), 2.32 (ddd, J = 
6.0, 2.9, 2.9 Hz, 1H, 4-H), 2.63 (dd, J = 19.0, 3.2 Hz, 1H, 6-H), 2.70 (ddd, J = 8.5, 8.5, 1.8 
Hz, 1H, 2-H), 3.62 (dd, J = 6.3, 6.3 Hz, 2H, 2 × 4’-H), 3.67 (s, 3H, OCH3); 
13
C NMR (100 
MHz, CDCl3): [ppm] = 19.5 (C-2’), 23.0 (C-8), 27.9 (C-3), 29.9 (C-7), 33.1 (C-3’), 37.4 (C-
1’), 38.7 (C-1), 41.8 (C-4), 44.0 (C-2), 45.0 (C-6), 51.7 (OCH3), 62.4 (C-4’), 175.4 (ester), 
215.2 (C-5); HRMS (ESI): [M+Na]
+
 calcd for C14H22O4Na 277.141030, found 277.140944. 
 
 
2-(4-Chlorobutoxy)tetrahydro-2H-pyran (2-161b).
191
 Dihydropyran (28.0 g, 0.33 mol) was 
added dropwise to a stirred solution of 4-chlorobutan-1-ol (2-161a) (30.0 g, 0.28 mmol) in 
CH2Cl2 (200 mL) at 0 °C.
192
 The resulting mixture was stirred for 2 h, before it was treated 
with triethylamine (10 mL) and washed with water (2 × 100 mL), and saturated NaCl solution 
(100 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The 
residue was distilled under reduced pressure to give the THP ether (49.9 g, 94%) as a 
colorless oil (b.p. 65–70 °C, 4 mbar). 1H NMR (400 MHz, CDCl3): [ppm] = 1.29–1.99 (m, 
10H, 2 × 2-H, 2 × 3-H, 6 × THP-H), 3.41 (ddd, J = 9.8, 9.8, 6.2 Hz, 1H, 1-H), 3.45–3.55 (1H, 
m, CH2O
THP
), 3.79 (ddd, J = 9.7, 6.6, 6.4 Hz, 1H, 1-H), 3.87 (ddd, J = 11.2, 7.7, 3.5 Hz, 1H, 
CH2O
THP
), 4.56 (1H, m, CHO2); 
13
C NMR (100 MHz, CDCl3): [ppm] = 20.4 (CH2
THP
), 25.4 
(CH2
THP
), 27.4 (C-2), 29.3 (C-3), 30.5 (CH2
THP
), 44.7 (C-4), 63.3 (CH2O
THP
), 67.7 (C-1), 
106.3 (CHO2). 
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3-(4’-((Tetrahydro-2H-pyran-2-yl)oxy)butyl)cyclohex-2-enone (2-162). THP protected 
chlorobutanol 2-161b (38.5 g, 0.20 mol) was added in one portion to a stirred mixture of 
magnesium (5.3 g, 0.22 mol) and THF (300 mL), which was preactivated with I2. The mixture 
was stirred under reflux for 5 h and then vinylogous ester
Error! Bookmark not defined.
 2-139 (26.7 g, 
0.16 mol) was added in one portion. The resulting solution was stirred under reflux for 8 h, 
cooled to –10 °C and carefully treated with half-saturated NH4Cl solution (100 mL). The 
organic phase was separated and the aqueous phase was extracted with diethyl ether (3 × 100 
mL). The combined organic layers were washed with saturated NaCl solution (100 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 4:1) to give enone 2-162 (34.3 g, 86%) as a 
colorless oil. Rf = 0.18 (petroleum ether/EtOAc 4:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 
1.43–1.78 (m, 10H, 2 × 2’-H, 2 × 3’-H, 6 × CH2
THP
), 1.91 (ddd, J = 12.8, 6.4, 6.4 Hz, 2H, 2 × 
5-H), 2.18 (dd, J = 6.6, 6.6 Hz, 2H, 2 × 1’-H), 2.22 (dd, J = 6.1, 6.1 Hz, 2H, 2 × 4-H), 2.28 
(dd, J = 6.3, 6.3 Hz, 2H, 2 × 6-H), 3.30–3.35 (m, 1H, 4’-H), 3.40–3.45 (m, 1H, CH2O
THP
), 
3.65–3.71 (m, 1H, 4’-H), 3.75–3.81 (m, 1H, CH2O
THP
), 4.49 (dd, J = 3.5, 3.5 Hz, 1H, 
CHO2
THP
), 5.81 (dd, J = 1.3, 1.3 Hz, 1H, 2-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 19.5 
(CH2
THP
), 22.6 (C-5), 23.5 (C-2’), 25.3 (CH2
THP
), 29.1 (C-3’), 29.5 (C-4), 30.6 (CH2
THP
), 37.2 
(C-6), 37.6 (C-1’), 62.2 (CH2O
THP
), 66.9 (C-4’), 98.8 (CHO2
THP
), 125.6 (C-2), 166.2 (C-3), 
199.7 (C-1); HRMS (ESI): [M+Na]
+
 calcd for C15H24O3Na 275.161766, found 275.161567. 
 
 
(1S,2S,4S)-Methyl 5-oxo-1-(4’-((tetrahydro-2H-pyran-2-
yl)oxy)butyl)bicyclo[2.2.2]octane-2-carboxylate (2-163). A solution of nBuLi in hexane 
(2.5M, 133 mL, 0.332 mol) was added dropwise to a stirred solution of 
bis(trimethylsilyl)amine (55.7 g, 0.346 mol) in a hexane/THF mixture (2:3, 500 mL) at –78 
°C. The resulting mixture was allowed to warm to room temperature and stirred for 30 min. 
and then again cooled to –78 °C. Then, a solution of enone 2-162 (33.6 g, 0.133 mol) in 
hexane (40 mL) was added dropwise during a 30 min period. Stirring was continued for 
additional 30 min followed by dropwise addition of methyl acrylate (30 mL, 0.33 mol) at the 
same temperature. The reaction was allowed to warm to room temperature, and treated with 
half-saturated NH4Cl solution (100 mL). The organic phase was separated and the aqueous 
phase extracted with diethyl ether (3 × 100 mL). The combined organic layers were washed 
with saturated NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 5:1) to 
give ester 2-163 (41.0 g, 91%) as a colorless oil. Rf = 0.20 (petroleum ether/EtOAc 4:1); 
HRMS (ESI): [M+Na]
+
 calcd for C19H30O5Na 361.198545, found 361.198321. 
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(1S,2S,4S)-Methyl 1-(4’-hydroxybutyl)-5-oxobicyclo[2.2.2]octane-2-carboxylate (2-160). 
Aqueous HCl (3M, 70 mL) was added to a stirred solution of ester 2-163 (30.6 g, 0.091 mol) 
in THF (200 mL) at room temperature. The mixture was stirred for 12 h at this temperature, 
treated with water (100 mL) and diethyl ether (100 mL). The organic phase was separated and 
the aqueous phase was extracted with diethyl ether (3 × 50 mL).The combined organic layers 
were washed with saturated NaCl solution (100 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 1:1) to give alcohol 2-160 (22.1 g, 96%) as a colorless oil. Rf = 0.20 (petroleum 
ether/ EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 1.19–1.26 (m, 9H, 2 × 1’-H, 2 × 
2’-H, 2 × 3’-H, 2 × 7-H, OH), 1.74–1.87 (m, 2H, 8-H), 1.96 (dd, J = 18.8, 1.6 Hz, 1H, 6-H), 
2.03 (app dd, J = 8.5, 2.9 Hz, 2H, 2 × 3-H), 2.32 (ddd, J = 6.0, 2.9, 2.9 Hz, 1H, 4-H), 2.63 
(dd, J = 19.0, 3.2 Hz, 1H, 6-H), 2.70 (ddd, J = 8.5, 8.5, 1.8 Hz, 1H, 2-H), 3.62 (dd, J = 6.3, 
6.3 Hz, 2H, 2 × 4’-H), 3.67 (s, 3H, OCH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 19.5 (C-
2’), 23.0 (C-8), 27.9 (C-3), 29.9 (C-7), 33.1 (C-3’), 37.4 (C-1’), 38.7 (C-1), 41.8 (C-4), 44.0 
(C-2), 45.0 (C-6), 51.7 (OCH3), 62.4 (C-4’), 175.4 (ester), 215.2 (C-5); HRMS (ESI): 
[M+Na]
+
 calcd for C14H22O4Na HRMS (ESI): [M+Na]
+
 calcd for C14H22O4Na 277.141030, 
found 277.140944. 
 
 
(1S,2S,4S)-Methyl 5-oxo-1-(4’-oxobutyl)bicyclo[2.2.2]octane-2-carboxylate (2-164). Dess-
Martin reagent (44.2 g, 0.104 mol) was added in one portion to a stirred solution of alcohol 2-
160 (24.1 g, 0.095 mol) in CH2Cl2 (300 mL) at 0 °C. The mixture was allowed to warm to 
room temperature and stirred for 5 h before it was treated with saturated Na2S2O3 solution (30 
mL) and stirred for additional 15 min. The resulting mixture was washed with saturated 
NaHCO3 solution (100 mL). The organic phase was separated and the aqueous phase 
extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were washed with saturated 
NaCl solution (100 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, 4:1 to 1:1) to give aldehyde 2-
164 (19.6 g, 82%) as a colorless oil. Rf = 0.40 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 1.21 (ddd, J = 13.0, 13.0, 5.3 Hz, 1H, 1’-H), 1.34 (ddd, J = 13.1, 
13.1, 4.6 Hz, 1H, 1’-H), 1.43–1.90 (m, 6H, 2 × 2’-H, 2 × 7-H, 2 × 8-H), 1.96 (dd, J = 19.0, 
1.8 Hz, 1H, 6-H), 2.04 (dd, J = 9.1, 3.0 Hz, 2H, 2 × 3-H), 2.33 (ddd, J = 6.0, 2.9, 2.9 Hz, 1H, 
4-H), 2.40 (dd, J = 7.1, 7.1 Hz, 2H, 2 × 3’-H), 2.64 (dd, J = 18.8, 3.2 Hz, 1H, 6-H), 2.67–2.72 
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(m, 1H, 2-H), 3.67 (s, 3H, OCH3), 9.74 (dd, J = 1.5, 1.5 Hz, 1H, 4’-H); 
13
C NMR (100 MHz, 
CDCl3): [ppm] = 16.0 (C-2’), 22.9 (C-8), 27.9 (C-3), 29.7 (C-7), 37.2 (C-1’), 38.6 (C-1), 
41.7 (C-4), 43.8 (C-2), 44.2 (C-3’), 44.9 (C-6), 51.7 (OCH3), 175.2 (ester), 201.8 (C-4’), 
214.8 (C-5); HRMS (ESI): [M+Na+MeOH]
+
 calcd for C15H24O5Na 307.15159, found 
307.151322. 
 
 
(1R,2S,4S)-Methyl 1-(3-formylbut-3-en-1-yl)-5-oxobicyclo[2.2.2]octane-2-carboxylate (2-
154). A freshly prepared solution of DIPA·TFA in THF
193
 (0.61M, 1.38 mL, 0.84 mmol) was 
added dropwise to a stirred solution of aldehyde 2-164 (210 mg, 0.84 mmol) and p-
formaldehyde (100 mg, 3.36 mmol) in THF (3 mL) at room temperature. The resulting 
mixture was stirred for 1 h before it was treated with water (20 mL) and diethyl ether (10 
mL). The organic phase was separated and the aqueous phase was extracted with diethyl ether 
(3 × 10 mL).The combined organic layers were washed with saturated NaCl solution (2 × 10 
mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 2:1) to give aldehyde 2-154 (140 mg, 64%) as a 
colorless oil. Rf = 0.31 (petroleum ether/ EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 
1.33 (ddd, J = 13.1, 13.1, 4.9 Hz, 1H, 1’-H), 1.42–1.53 (m, 2H, 1’-H, 7-H), 1.66–1.74 (m, 1H, 
7-H), 1.77–1.90 (m, 2H, 2 × 8-H), 1.98 (dd, J = 18.8, 1.6 Hz, 1H, 6-H), 2.02–2.07 (m, 2H, 2 × 
3-H), 2.17 (ddd, J = 13.3, 13.3, 4.9 Hz, 1H, 2’-H), 2.25–2.35 (m, 2H, 2’-H, 4-H), 2.67 (dd, J = 
18.8, 3.2 Hz, 1H, 6-H), 2.71–2.76 (m, 1H, 2-H), 3.67 (s, 3H, OCH3), 5.99 (s, 1H, C=CH2), 
6.22 (s, 1H, C=CH2), 9.51 (s, 1H, 4’-H); 
13
C NMR (100 MHz, CDCl3): δ[ppm] = 22.0 (C-2’), 
22.9 (C-8), 27.9 (C-3), 29.6 (C-7), 35.9 (C-1’), 38.6 (C-1), 41.7 (C-4), 43.6 (C-2), 45.0 (C-6), 
51.7 (OCH3), 134.0 (C=CH2), 150.0 (C=CH2), 175.2 (ester), 194.3 (C-4’), 214.7(C-5). 
 
 
(2S,4S,4aS)-Methyl 7-methylene-1-oxo-2,3,4,5,6,7-hexahydro-1H-2,4a-
ethanonaphthalene-4-carboxylate (2-153). K2CO3 (200 mg, 1.45 mmol) was added in one 
portion to a stirred solution of keto aldehyde 2-154 (140 mg, 0.53 mol) in methanol (5 mL) at 
room temperature. The mixture was stirred for 4 h at the same temperature, before it was 
treated with water (20 mL) and diethyl ether (10 mL). The organic phase was separated and 
the aqueous phase was extracted with diethyl ether (3 × 10 mL). The combined organic layers 
were washed with saturated NaCl solution (2 × 10 mL), dried over MgSO4, filtered, and 
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concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 2:1) to give dienone 2-153 (95 mg, 73%) as a colorless oil. Rf = 0.34 (petroleum 
ether/ EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 1.55 (ddd, J = 13.9, 8.8, 5.0 Hz, 
1H, 5-H), 1.61–1.65 (m, 2H, 2 × 9-H), 1.81–1.90 (m, 3H, 5-H, 2 × 10-H), 2.02–2.14 (m, 3H, 
2 × 3-H, 6-H), 2.26–2.33 (m, 1H, 6-H), 2.47 (ddd, J = 6.0, 2.9, 2.9 Hz, 1H, 2-H), 2.67 (dd, J = 
10.1, 6.1 Hz, 1H, 4-H), 3.59 (s, 3H, OCH3), 5.17 (s, 1H, C=CH2), 5.24 (s, 1H, C=CH2), 7.04 
(s, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): δ[ppm] = 23.3 (C-10), 26.5 (C-6), 28.4 (C-3), 
30.8 (C-5), 33.2 (C-9), 38.1 (C-4a), 41.1 (C-2), 47.3 (C-4), 51.7 (OCH3), 120.0 (C-11), 131.8 
(C-8), 137.4 (C-8a), 141.1 (C-7), 174.9 (ester), 202.4 (C-1); HRMS (ESI): [M+Na]
+
 calcd for 
C15H18O3Na 269.11482, found 269.114841. 
 
 
(2S,4S,4aR)-Methyl 1-oxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-170). K2CO3 (37.8 g, 0.274 mol) was added in one portion to a stirred solution 
of aldehyde 2-164 (23.0 g, 0.091 mol) in methanol (300 mL) at room temperature. The 
mixture was stirred for 5 h at the same temperature, before it was treated with water (200 mL) 
and diethyl ether (100 mL). The organic phase was separated and the aqueous phase was 
extracted with diethyl ether (3 × 100 mL). The combined organic layers were washed with 
saturated NaCl solution (2 × 100 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give 
tricyclic enone 2-170 (15.8 g, 74%) as a colorless oil. Rf = 0.41 (petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.36–1.48 (m, 2H, 5-H, 6-H), 1.51–1.69 (m, 3H, 6-H, 
2 × 10-H), 1.75–1.84 (m, 3H, 5-H, 2 × 9-H), 2.00–2.12 (m, 4H, 2 × 3-H, 2 ×7-H), 2.42 (ddd, J 
= 6.1, 3.0, 3.0 Hz, 1H, 2-H), 2.63 (dd, J = 10.6, 5.8 Hz, 1H, 4-H), 3.61 (s, 3H, OCH3), 6.92 
(dd, J = 4.2, 4.2 Hz, 1H, H-8); 
13
C NMR (100 MHz, CDCl3): [ppm] = 18.9 (C-6), 23.2 (C-9), 
25.1 (C-7), 28.3 (C-3), 31.4 (C-5), 33.8 (C-10), 37.9 (C-4a), 41.0 (C-2), 47.4 (C-4), 51.6 
(OCH3), 134.8 (C-8), 137.8 (C-8a), 175.1 (ester), 201.7 (C-1); HRMS (ESI): [M+Na]
+
 calcd 
for C14H18O3Na 257.114820, found 257.114860. 
 
 
(2S,4S,4aS)-Methyl 2,3,4,5,6,8a-hexahydrospiro[2,4a-ethanonaphthalene-1,2'-
[1,3]dioxolane]-4-carboxylate (2-171). TMSOTf (3 µL, 0.02 mmol) was added to a stirred 
solution of 1,2-bistrimethylsiloxyethane (80 µL, 0.32 mmol) and enone 2-170 (35 mg, 0.16 
mmol) in CH2Cl2 (3 mL) at –78 °C. The resulting mixture stirred overnight at room 
temperature before it was treated with half saturated NaHCO3 solution (20 mL) and extracted 
with diethyl ether (3 × 10 mL). The combined organic layers were washed with saturated 
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NaCl solution (2 × 10 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give acetal 2-
171 (31 mg, 68%) as a colorless oil. Rf = 0.62 (petroleum ether/ EtOAc 2:1); 
1
H NMR (400 
MHz, CDCl3): δ[ppm] = 0.96 (ddd, J = 10.8, 10.8, 1.9 Hz, 1H, 10-H), 1.25–1.39 (m, 3H, 2 
×5-H, 9-H), 1.71–1.94 (m, 5H, 2-H, 3-H, 6-H, 9-H, 10-H), 1.97–2.14 (m, 2H, 3-H, 6-H), 
2.38–2.43 (m, 1H, 4-H), 3.09 (ddd, J = 4.2, 2.3, 2.1 Hz, 1H, 8a-H), 3.63 (s, 3H, OCH3), 3.77–
4.02 (m, 4H, CH2O)2), 5.52 (br.d., J = 10.1 Hz, 1H, 8-H), 5.70 (ddd, J = 7.6, 5.1, 2.6 Hz, 1H, 
8-H); 
13
C NMR (100 MHz, CDCl3): δ[ppm] = 21.2 (C-9), 21.7 (C-6), 25.8 (C-3), 26.2 (C-10), 
30.5 (C-5), 33.6 (C-2), 34.9 (C-4a), 41.8 (C-8a), 46.4 (C-4), 51.3 (OCH3), 63.4 (CH2O)2), 
65.5 ((CH2O)2), 111.5 (C-1), 124.2 (C-8), 125.8 (C-7), 175.7 (ester); HRMS (ESI): [M+Na]
+
 
calcd for C16H22O4Na 301.14103, found 301.146766. 
 
 
(2S,4S,4aS)-Methyl 7-bromo-1-oxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-172). AIBN (10 mg) was added to a stirred solution of enone 2-170 (800 mg, 
3.45 mmol) and NBS (610 mg, 3.45 mmol) in CCl4 (10 mL) at room temperature. The 
resulting mixture was stirred under reflux for 1 h before it was treated with water (50 mL) and 
diethyl ether (20 mL). The organic phase was separated and the aqueous phase was extracted 
with diethyl ether (3 × 20 mL). The combined organic layers were washed with saturated 
NaCl solution (2 × 20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give 
diastereomeric mixture of bromides 2-172 (1:1, 900 mg, 84%) as a colorless oil. Rf = 0.38; 
0.50 (petroleum ether/EtOAc 2:1); HRMS (ESI): [M+Na]
+
 calcd for C14H17BrO3Na 
335.02533, found 335.025012. 
 
 
(2S,4S,4aS)-Methyl 1-oxo-2,3,4,5,6,8a-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-174). Acetone (31 µL, 0.42 mmol) was added to a stirred suspension of 
bromides 2-172 (13.0 mg, 0.042 mmol) and indium powder (5.8 mg, 0.050 mmol) in 
THF/water (1:1, 0.2 mL) at room temperature. The resulting mixture was stirred for 24 h 
before the solvents were removed and the residue was purified by flash chromatography 
(petroleum ether/EtOAc, 4:1) to give ketone 2-174 (4.2 mg, 43%) as a colorless oil. Rf = 0.55 
(petroleum ether/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 1.15–1.23 (m, 1H, 10-
H), 1.40 (ddd, J = 13.1, 10.8, 7.4 Hz, 1H, 5-H), 1.49–1.54 (m, 1H, 5-H), 1.72–1.90 (m, 3H, 2 
× 9-H, 10-H), 2.02–2.10 (m, 3H, 3-H, 2 × 6-H), 2.17 (dddd, J = 13.9, 8.2, 2.0, 1.9 Hz, 1H, 3-
H), 2.38 (ddd, J = 5.6, 3.7, 2.0 Hz, 1H, 2-H), 2.70 (dd, J = 10.1, 8.3 Hz, 1H, 4-H), 3.38–3.42 
(m, 1H, 8a-H), 5.71 (ddd, J = 10.1, 6.7, 3.4 Hz, 1H, 7-H), 5.87 (ddd, J = 10.1, 4.0, 2.0 Hz, 1H, 
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8-H); 
13
C NMR (100 MHz, CDCl3): δ[ppm] = 22.1 (C-6), 24.0 (C-9), 26.4 (C-10), 26.9 (C-3), 
29.5 (C-5), 37.7 (C-4a), 42.3 (C-2), 45.8 (C-4), 48.0 (C-8a), 51.6 (OCH3), 122.2 (C-8), 126.9 
(C-7), 175.4 (ester), 215.0 (C-1); HRMS (ESI): [M+Na]
+
 calcd for C14H18O3Na 257.11482, 
found 257.114654. 
 
 
(2S,4S,4aS)-Methyl 7-acetoxy-1-oxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-
4-carboxylate (2-173). A solution of bromide 2-172 (700 mg, 2.25 mmol) in glacial acetic 
acid (10 mL) was treated with silver acetate (750 mg, 4.50 mmol) at room temperature. The 
resulting mixture was stirred for 2 h before it was diluted with diethyl ether (50 mL), treated 
with water (100 mL) and extracted with diethyl ether (3 × 50 mL). The combined organic 
layers were washed with saturated NaCl solution (2 × 50 mL), dried over MgSO4, filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 2:1) to give acetate 2-173 (604 mg, 92%) as a colorless oil (one stereoisomer). 
Rf = 0.62 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): [ppm] = 1.34–2.15 (m, 
10H, 2 × 3-H, 2 × 5-H, 2 × 6-H, 2 × 9-H, 2 × 10-H), 2.03 (s, 3H, OCOCH3), 2.47 (ddd, J = 
5.8, 2.9, 2.9 Hz, 1H, 2-H), 2.67 (dd, J = 10.4, 5.8 Hz, 1H, 4-H), 3.64 (s, 3H, OCH3), 5.28–
5.31 (m, 1H, 7-H), 6.71 (d, J = 3.5 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
21.0 (OCOCH3), 23.1 (C-6), 24.8 (C-10), 27.9 (C-3), 28.2 (C-5), 33.4 (C-9), 37.8 (C-4), 40.7 
(C-2), 47.3 (C-4a), 51.7 (OCH3), 67.4 (C-7), 130.5 (C-8), 140.0 (C-8a), 170.4 (OCOCH3), 
174.6 (4-ester), 201.2 (C-1). 
 
 
(2S,4S,4aS)-Methyl 1-oxo-2,3,4,5,6,8a-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-174). A solution of MeLi (1.6M in diethyl ether, 0.42 mL, 0.68 mmol) was 
added dropwise to a stirred suspension of CuBr·SMe2 (70 mg, 0.34 mmol) in THF (2 mL) at –
78 °C. The resulting mixture was allowed to warm to room temperature and then cooled again 
to –78 °C and treated with a solution of acetate 2-173 (33 mg, 0.11 mmol) in THF (2 mL). 
The mixture was slowly warmed to room temperature, stirred for 1 h, treated with half 
saturated NH4Cl solution (20 mL) and extracted with diethyl ether (3 × 10 mL). The 
combined organic layers were washed with saturated NaCl solution (2 × 20 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 4:1) to give enone 2-174 (15.6 mg, 59%) as a 
colorless oil. Rf = 0.55 (petroleum ether/ EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 
1.15–1.23 (m, 1H, 10-H), 1.40 (ddd, J = 13.1, 10.8, 7.4 Hz, 1H, 5-H), 1.49–1.54 (m, 1H, 5-
H), 1.72–1.90 (m, 3H, 2 × 9-H, 10-H), 2.02–2.10 (m, 3H, 3-H, 2 × 6-H), 2.17 (dddd, J = 13.9, 
8.2, 2.0, 1.9 Hz, 1H, 3-H), 2.38 (ddd, J = 5.6, 3.7, 2.0 Hz, 1H, 2-H), 2.70 (dd, J = 10.1, 8.3 
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Hz, 1H, 4-H), 3.38–3.42 (m, 1H, 8a-H), 5.71 (ddd, J = 10.1, 6.7, 3.4 Hz, 1H, 7-H), 5.87 (ddd, 
J = 10.1, 4.0, 2.0 Hz, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3): δ[ppm] = 22.1 (C-6), 24.0 (C-
9), 26.4 (C-10), 26.9 (C-3), 29.5 (C-5), 37.7 (C-4a), 42.3 (C-2), 45.8 (C-4), 48.0 (C-8a), 51.6 
(OCH3), 122.2 (C-8), 126.9 (C-7), 175.4 (ester), 215.0 (C-1); HRMS (ESI): [M+Na]
+
 calcd 
for C14H18O3Na 257.11482, found 257.114654. 
 
 
(2S,4S,4aS)-Methyl 7-hydroxy-1-oxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-
4-carboxylate (2-175). Potassium carbonate (50 mg, 0.36 mmol) was added in one portion to 
a stirred solution of acetate 2-173 (100 mg, 0.34 mmol) in methanol/H2O (25:1, 5.2 mL) at 
room temperature. The resulting mixture was stirred for 30 min before it was diluted with 
diethyl ether (10 mL), treated with water (20 mL) and extracted with diethyl ether (3 × 10 
mL). The combined organic layers were washed with saturated NaCl solution (2 × 20 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 1:1) to give alcohol 2-175 (82 mg, 92%) as a 
colorless oil. Rf = 0.27 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 MHz, benzene-d6): 
[ppm] = 1.04–1.61 (m, 9H, 2 × 5-H, 2 × 6-H, 2 × 9-H, 2 × 10-H, OH), 1.95–2.06 (m, 2H, 2 × 
3-H), 2.31–2.37 (m, 2H, 2-H, 4-H), 3.35 (s, 3H, OCH3), 4.02–4.07 (m, 1H, 7-H), 7.09–7.11 
(m, 1H, 8-H); 
13
C NMR (100 MHz, benzene-d6): [ppm] = 23.0 (C-6), 28.1 (C-10), 28.2 (C-
3), 28.4 (C-5), 33.2 (C-9), 37.6 (C-4), 41.2 (C-2), 46.9 (C-4a), 51.4 (OCH3), 64.6 (C-7), 134.4 
(C-8), 138.5 (C-8a), 175.0 (ester), 200.4 (C=O). 
 
 
(2S,4S,4aS)-Methyl 1,7-dioxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-165). Dess-Martin reagent (260 mg, 0.62 mol) was added in one portion to a 
stirred solution of alcohol 2-175 (140 mg, 0.056 mol) in CH2Cl2 (10 mL) at room 
temperature. The mixture was stirred for 2 h before it was treated with saturated Na2S2O3 
solution (5 mL) and stirred for additional 15 min. The resulting mixture was washed with 
saturated NaHCO3 solution (10 mL). The organic phase was separated and the aqueous phase 
was extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were washed with 
saturated NaCl solution (10 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 1:1) to give ketone 2-
165 (130 mg, 93%) as a colorless oil. Rf = 0.40 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 1.74–1.79 (m, 1H, 10-H), 1.84–1.99 (m, 4H, 5-H, 10-H, 2 × 9-H), 
2.11–2.21 (m, 3H, 2 × 3-H, 5-H), 2.30 (ddd, J = 16.8, 7.3, 5.3 Hz, 1H, 6-H), 2.45 (ddd, J = 
16.7, 9.9, 5.8 Hz, 1H, 6-H), 2.60 (ddd, J = 5.8, 3.0, 3.0 Hz, 1H, 2-H), 2.79 (dd, J = 9.6, 6.1 
Hz, 1H, 4-H), 3.63 (s, 3H, OCH3), 6.50 (s, 1H, H-8); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
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22.7 (C-9), 28.0 (C-3), 29.8 (C-5), 31.1 (C-10), 34.4 (C-6), 38.6 (C-4a), 40.4 (C-2), 46.7 (C-
4), 52.2 (OCH3), 125.4 (C-8), 152.4 (C-8a), 174.3 (ester), 198.8 (C-7), 201.8 (C-1); HRMS 
(ESI): [M+Na]
+
 calcd for C14H16O4Na 271.094080, found 271.094073. 
 
 
(2S,4S,4aS)-Methyl 1,7-dioxo-2,3,4,5,6,7-hexahydro-1H-2,4a-ethanonaphthalene-4-
carboxylate (2-165). Pd(OH)2/C (Pearlman’s catalyst,
194
 20%, 1.1 g, 2.0 mmol) was added to 
a stirred suspension of enone 2-170 (10.0 g, 43.0 mmol), K2CO3 (1.5 g. 10.0 mmol) in CH2Cl2 
(200 mL) followed by addition of tert-butylhydroperoxide (5.0–6.0M in decaline, 43 mL, 
215.0 mmol) at room temperature. The resulting mixture was stirred overnight at room 
temperature. The reaction mixture was then filtered through a short pad of silica gel, washed 
with CH2Cl2 and concentrated in vacuo at room temperature. The residue was purified by 
flash chromatography (petroleum ether/EtOAc, 1:1) to give 1,4-diketone 2-165 (8.3 g, 78%) 
as a colorless oil. Rf = 0.40 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.74–1.79 (m, 1H, 10-H), 1.84–1.99 (m, 4H, 5-H, 10-H, 2 × 9-H), 2.11–2.21 (m, 
3H, 2 × 3-H, 5-H), 2.30 (ddd, J = 16.8, 7.3, 5.3 Hz, 1H, 6-H), 2.45 (ddd, J = 16.7, 9.9, 5.8 Hz, 
1H, 6-H), 2.60 (ddd, J = 5.8, 3.0, 3.0 Hz, 1H, 2-H), 2.79 (dd, J = 9.6, 6.1 Hz, 1H, 4-H), 3.63 
(s, 3H, OCH3), 6.50 (s, 1H, H-8); 
13
C NMR (100 MHz, CDCl3): [ppm] = 22.7 (C-9), 28.0 
(C-3), 29.8 (C-5), 31.1 (C-10), 34.4 (C-6), 38.6 (C-4a), 40.4 (C-2), 46.7 (C-4), 52.2 (OCH3), 
125.4 (C-8), 152.4 (C-8a), 174.3 (ester), 198.8 (C-7), 201.8 (C-1); HRMS (ESI): [M+Na]
+
 
calcd for C14H16O4Na 271.094080, found 271.094073. 
 
 
(2S,4S,4aS)-Methyl 8-methyl-1,7-dioxo-2,3,4,5,6,7-hexahydro-1H-2,4a-
ethanonaphthalene-4-carboxylate (2-169). A solution of diazomethane
195
 in diethyl ether 
(200 mL) was added to a stirred solution of enedione 2-165 (4.7 g, 0.019 mol) in chloroform 
(150 mL) at 0 °C. The mixture was allowed to warm to room temperature and stirred for 6 h 
before the solvents were removed with a flow of nitrogen. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 4:1 to 1:1) to give enedione 2-169 (3.9 g, 78 %) as 
white crystals (m.p. 97–98.5 °C).196 Rf = 0.45 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 
MHz, CDCl3): [ppm] = 1.61–1.68 (m, 1H, 10-H), 1.78–2.00 (m, 4H, 5-H, 10-H, 2 × 9-H), 
2.06–2.14 (m, 3H, 2 × 3-H, 5-H), 2.17 (s, 3H, 8-CH3) 2.34 (ddd, J = 16.4, 6.8, 5.0 Hz, 1H, 6-
H), 2.49 (ddd, J = 16.4, 10.9, 5.8 Hz, 1H, 6-H), 2.55 (ddd, J = 6.1, 3.0, 3.0 Hz, 1H, 2-H), 2.69 
(dd, J = 8.6, 7.3 Hz, 1H, 4-H), 3.60 (s, 3H, OCH3); 
13
C NMR (100 MHz, CDCl3): [ppm] = 
12.0 (CCH3), 22.6 (C-9), 28.1 (C-3), 29.8 (C-5), 31.1 (C-10), 34.0 (C-6), 39.8 (C-4a), 42.2 
(C-2), 47.2 (C-4), 52.0 (OCH3), 138.2 (C-8), 144.6 (C-8a), 174.6 (ester), 199.6 (C-7), 204.7 
(C-1); HRMS (ESI): [M+Na]
+
 calcd for C15H18O4Na 285.109730, found 285.109658. 
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(2S,4S,4aR,8RS,8aRS) Methyl 8-methyl-1,7-dioxooctahydro-1H-2,4a-
ethanonaphthalene-4-carboxylate (2-177). A solution of diketone 2-169 (630 mg, 2.39 
mmol) in glacial acetic acid (6 mL) was treated with zinc powder (930 mg, 14.32 mmol) at 
room temperature and stirred for 4 h under reflux. After concentration in vacuo the residue 
was purified by flash chromatography (petroleum ether/EtOAc, 4:1 to 1:1) to give compound 
2-177 (470 mg, 75%) as white crystals (mixture of two diastereomers in ratio 1.6:1). Rf = 0.45 
(petroleum ether/EtOAc 1:1); HRMS (ESI): [M+Na]
+
 calcd for C15H20O4Na 287.125380, 
found 287.125493. 
 
 
(2S,4S,4aS,8S)-Methyl 8-allyl-1-(allyloxy)-8-methyl-7-oxo-3,4,5,6,7,8-hexahydro-2H-
2,4a-ethanonaphthalene-4-carboxylate (2-179). Lithium (60 mg, 8.82 mmol) was added in 
small portions to stirred liquid ammonia (10 mL) at –78 °C. The resulting blue solution was 
stirred for 1 h before it was treated with a solution of diketone 2-169 (50 mg, 0.19 mmol) in 
THF (4 mL). After complete addition stirring was continued for 2 h at the same temperature. 
Then, allyl bromide (1.6 mL, 18.90 mmol) was added dropwise at –78 °C and the mixture 
stirred for 30 min before the cooling bath was removed and the ammonia was allowed to 
evaporate. The resulting white suspension was diluted with water (20 mL) and extracted with 
diethyl ether (3 × 10 mL). The combined organic layers were washed with saturated NaCl 
solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give ketone 2-179 (41 mg, 
63%) as a colorless oil. Rf = 0.64 (petroleum ether/EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): 
[ppm] = 1.29–1.76 (m, 7H, 2 × 3-H, 5-H, 2 × 9-H, 2 × 10-H), 1.33 (s, 3H, 8-CH3), 1.85 (ddd, 
J = 12.6, 9.7, 2.8 Hz, 1H, 3-H), 2.01–2.08 (m, 1H, 5-H), 2.25 (ddd, J = 8.5, 5.1, 2.9 Hz, 2H, 2 
× 6-H), 2.45 (dd, J = 9.8, 5.8 Hz, 1H, 4-H), 2.51 (dd, J = 13.1, 7.6 Hz, 1H, 8-(CH2CH=CH2)), 
2.80–2.86 (m, 2H, 2-H, 8-(CH2CH=CH2)), 3.60 (s, 3H, OCH3), 4.30–4.39 (m, 2H, 1-
(OCH2CH=CH2)), 4.87–4.89 (m, 2H, 8-(CH2CH=CH2)), 5.22 (ddd, J = 12.1, 1.5, 1.5 Hz, 1H, 
1-(OCH2CH=CH2)), 3.56 (ddd, J = 17.2, 3.3, 1.6 Hz, 1H, 1-(OCH2CH=CH2)), 5.55 (dddd, J = 
17.2, 10.0, 7.4, 7.4 Hz, 1H, 8-(CH2CH=CH2)), 5.99 (dddd, J = 17.2, 10.4, 5.2, 5.0 Hz, 1H, 1-
(OCH2CH=CH2)); 
13
C NMR (100 MHz, CDCl3): [ppm] = 24.8 (8-CH3), 26.1 (C-9), 30.4 (C-
2), 30.8 (C-5), 32.4 (C-3), 34.7 (C-10), 37.3 (C-6), 41.0 (C-4a), 42.9 (8-(CH2CH=CH2)), 49.2 
(C-4), 51.6 (OCH3, C-8), 68.8 (1-(OCH2CH=CH2)), 116.8 (8-(CH2CH=CH2), 1-
(OCH2CH=CH2)), 118.5 (C-8a), 134.2 (1-(OCH2CH=CH2)), 136.1 ((8-(CH2CH=CH2)), 154.5 
(C-1), 175.9 (ester), 215.2 (C-7); HRMS (ESI): [M+Na]
+
 calcd for C23H30O4Na 393.203631 
found 393.203799. 
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(2S,4R,4aS)-Methyl 8-methyl-1,7-dioxo-2,3,4,5,6,7-hexahydro-1H-2,4a-
ethanonaphthalene-4-carboxylate (2-187). A solution of ester 2-169 (75 mg, 0.28 mmol) in 
DBU (1 mL) was stirred for 30 min at 120 °C before it was diluted with water (50 mL) and 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were washed with 1M 
HCl solution (2 × 20 mL), saturated NaCl solution (20 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 4:1) to give ketone 2-187 (41 mg, 63%) as a colorless oil. Rf = 0.64 (petroleum 
ether/EtOAc 1:1); 
1
H NMR (400 MHz, CDCl3): δ[ppm] = 1.58–1.67 (m, 1H, 10-H), 1.75 
(ddd, J = 14.1, 9.0, 5.2 Hz, 1H, 5-H), 1.82–1.91 (m, 1H, 9-H), 1.97–2.10 (m, 4H, 3-H, 5-H, 9-
H, 10-H), 2.16 (s, 3H, CCH3), 2.21 (ddd, J = 13.9, 5.8, 2.5 Hz, 1H, 3-H), 2.46–2.62 (m, 3H, 
2-H, 2 × 6-H), 2.83 (ddd, J = 10.7, 5.9, 1.8 Hz, 1H, 4-H), 3.73 (s, 3H, OCH3); 
13
C NMR (100 
MHz, CDCl3): δ[ppm] = 11.9 (CCH3), 23.1 (C-9), 25.5 (C-10), 27.1 (C-3), 29.9 (C-5), 33.9 
(C-6), 39.8 (C-4a), 43.2 (C-2), 43.7 (C-4), 52.0 (OCH3), 137.0 (C-8), 146.6 (C-8a), 174.1 
(ester), 199.5 (C-7), 206.1 (C-1); HRMS (ESI): [M+Na]
+
 calcd for C15H18O4Na 285.109730, 
found 285.109658. 
 
Appendix  163 
Selected NMR Spectra for Important Compounds 
Additional spectra are included in the supporting information of the published papers 
from this work and are available free of charge via Internet at http://www.pubs.acs.org and 
http://www.thieme-chemistry.com/products/journals/synlett.html.  
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7 6 5 4 3 2 1 0
ppm
THF-d8
THF-d8
-3
.5
1
6
.6
1
7
.0
2
2
.7
2
4
.7
2
6
.4
2
9
.1
2
9
.5
3
0
.1
3
0
.8
3
3
.6
3
4
.1
3
9
.5
4
6
.8
7
1
.4
7
7
.6
8
0
.2
 
Appendix  185 
7 6 5 4 3 2 1 0
ppm
Benzene-d6
Benzene-d6
-3
.6
1
6
.5
2
1
.4
2
4
.9
2
6
.2
2
7
.2
2
8
.0
2
8
.5
2
8
.9
2
9
.8
3
9
.5
3
9
.9
4
0
.5
4
6
.1
7
9
.5
8
1
.4
2
1
0.9
 
186  Appendix 
7 6 5 4 3 2 1 0
ppm
Benzene-d6
Benzene-d6
-4
.8
-3
.6
1
6
.6
1
8
.3
1
9
.6
2
2
.3
2
6
.2
2
8
.7
2
8
.9
3
1
.8
3
4
.6
3
4
.7
4
0
.0
5
1
.8
7
9
.8
1
4
2.8
1
5
4.8
1
9
6.7
 
Appendix  187 
9 8 7 6 5 4 3 2 1 0
ppm
Benzene-d6
Benzene-d6
-4
.8
1
6
.4
2
0
.1
2
1
.3
2
6
.1
2
7
.7
2
8
.3
2
9
.7
3
1
.6
3
3
.7
4
0
.4
4
4
.2
4
5
.1
5
3
.2
7
9
.0
2
0
0.7
2
1
3.5
 
188  Appendix 
7 6 5 4 3 2 1 0
ppm
Methanol-d4
Methanol-d4
Methanol-d4
1
6
.2
2
0
.2
2
5
.3
2
8
.7
2
8
.8
3
1
.0
3
8
.4
3
8
.8
4
0
.1
5
1
.5
7
9
.4
1
1
1.8
1
1
3.9
1
2
6.9
1
3
0.7
1
5
1.7
1
5
6.1
 
Appendix  189 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
-3
.8
1
6
.1
2
1
.3
2
5
.9
2
7
.7
2
8
.5
2
9
.3
3
4
.2
3
4
.7
3
5
.1
3
5
.9
4
0
.2
4
0
.7
5
2
.2
7
8
.8
1
1
9
.8
1
7
6
.0
2
0
1
.3
 
190  Appendix 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
9
.2
2
3
.3
2
6
.3
2
6
.8
2
9
.5
3
1
.1
3
4
.4
3
5
.5
3
8
.9
4
4
.5
5
1
.7
6
4
.5
6
8
.5
1
2
7.6
1
2
9.5
1
3
3.9
1
3
4.0
1
3
5.5
1
7
8.9
 
Appendix  191 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
8
.6
1
9
.2
2
6
.5
2
6
.8
2
8
.4
3
0
.3
3
1
.5
3
4
.4
3
4
.8
3
8
.5
4
4
.1
5
1
.2
6
4
.5
6
8
.9
1
2
7.6
1
2
9.5
1
3
4.0
1
3
5.5
1
7
6.4
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7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
9
.2
2
5
.3
2
6
.9
2
7
.5
2
9
.7
3
0
.6
3
2
.5
3
3
.4
3
9
.1
4
7
.1
5
1
.2
6
4
.5
1
2
7.6
1
2
9.5
1
3
3.9
1
3
4.1
1
3
4.9
1
3
5.6
1
7
6.1
 
Appendix  193 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
5
.3
2
7
.6
2
9
.7
3
0
.6
3
2
.4
3
3
.3
3
8
.9
4
6
.9
5
1
.3
6
3
.6
1
3
4.0
1
3
4.8
1
7
6.1
 
194  Appendix 
9 8 7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
5
.2
2
8
.1
2
9
.6
3
0
.6
3
3
.1
3
8
.7
3
9
.3
4
6
.6
5
1
.4
1
3
3.9
1
3
4.6
1
7
5.6
2
0
2.2
 
Appendix  195 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
4
.3
2
5
.2
2
9
.5
3
0
.4
3
3
.1
3
5
.4
3
8
.8
4
6
.6
5
1
.2
6
1
.3
1
3
4.2
1
6
1.2
1
7
5.6
1
9
2.8
 
196  Appendix 
9 8 7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
6
.0
2
2
.9
2
7
.9
2
9
.7
3
7
.2
3
8
.6
4
1
.7
4
3
.8
4
4
.2
4
4
.9
5
1
.7
1
7
5.2
2
0
1.8
2
1
4.8
 
Appendix  197 
9 8 7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
2
.0
2
2
.9
2
7
.9
2
9
.6
3
5
.9
3
8
.6
4
1
.7
4
3
.6
4
5
.0
5
1
.7
1
3
4.0
1
5
0.0
1
7
5.2
1
9
4.3
2
1
4.7
 
198  Appendix 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
3
.3
2
6
.5
2
8
.4
3
0
.8
3
3
.2
3
8
.1
4
1
.1
4
7
.3
5
1
.7
1
2
0.0
1
3
1.8
1
3
7.4
1
4
1.1
1
7
4.9
2
0
2.4
 
Appendix  199 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
1
.2
2
1
.7
2
5
.8
2
6
.2
3
0
.5
3
3
.6
3
4
.9
4
1
.8
4
6
.4
5
1
.3
6
3
.4
6
5
.5
1
1
1.5
1
2
4.2
1
2
5.8
1
7
5.7
 
200  Appendix 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
2
.0
2
2
.6
2
8
.1
2
9
.8
3
1
.1
3
4
.0
3
9
.8
4
2
.2
4
7
.3
5
2
.0
1
3
8.2
1
4
4.6
1
7
4.6
1
9
9.6
2
0
4.7
 
Appendix  201 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
2
2
.1
2
4
.0
2
6
.4
2
6
.9
2
9
.5
3
7
.7
4
2
.3
4
5
.8
4
8
.0
5
1
.6
1
2
2.2
1
2
6.9
1
7
5.4
2
1
5.0
 
202  Appendix 
7 6 5 4 3 2 1 0
ppm
Chloroform-d
Chloroform-d
1
1
.9
2
3
.1
2
5
.5
2
7
.1
2
9
.9
3
3
.9
3
9
.8
4
3
.2
4
3
.7
5
2
.0
1
3
7.0
1
4
6.6
1
7
4.1
1
9
9.5
2
0
6.1
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